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RÉSUMÉ 
 
Introduction 
La Nature produit une quantité et une variété éblouissantes de protéines à partir de 
vingt éléments constitutifs que sont les acides aminés.  
Les protéines constituées de feuillets plissés β, qui s'enroulent sur eux-mêmes pour 
former des structures cylindriques, sont les membres d'une famille importante nommée 
barriques (ou tonneaux) β. Les protéines issues de cet assemblage structurel 
tridimensionnel partagent des caractéristiques communes :  
- le nombre de chaînes β est pair, 
- toutes les chaînes sont antiparallèles et connectées par des coudes ou des 
longues boucles avec leurs voisines immédiates, 
- huit chaînes β au minimum sont nécessaires, pour des raisons de contraintes 
stériques de la structure cylindrique. 
De part la structure des feuillets β, le squelette tubulaire de ces barriques β est 
constitué par les corps des acides aminés et est stabilisé par les nombreuses liaisons 
hydrogènes s'effectuant entre le groupement amine d’un résidu sur une chaîne et le 
groupement carbonyle d’un résidu sur la chaîne voisine. Aussi, cet arrangement 
secondaire oriente alternativement les chaînes latérales des acides aminés vers l'intérieur 
et l'extérieur du tonneau. Les caractères hydrophiles, hydrophobes ou catalytiques des 
faces internes ou externes peuvent donc être variables en fonctions des séquences 
peptidiques, conférant aux barriques β des fonctions diverses telles que transporteurs, 
canaux ioniques transmembranaires ou enzymes.  
Attirés par les nombreuses fonctionnalités qu'offrent ces protéines, les chimistes et 
biochimistes s'intéressent à la conception et à la synthèse de barriques β artificielles. Ces 
travaux n'en sont qu'à leurs balbutiements, à cause entre autres de la complexité de la 
structure tridimensionnelle. Les principaux axes de développement se concentrent donc 
sur une meilleure compréhension du motif structurel feuillet β, et les barriques 
synthétiques résultent en fait pour la plupart de modifications de la séquence peptidique 
de protéines naturelles, plutôt que de la production d'une nouvelle entité.  
Stefan Matile a introduit le concept de "rigid-rod β-barrel" afin de simplifier la 
synthèse de ces protéines. Le principe est très similaire à la fabrication des barriques de 
Résumé 
ii 
vieillissement du vin. Tout comme le tonnelier rapproche les douves en bois et les scelle 
avec des cercles en fer, des baguettes rigides moléculaires portant des courtes chaînes 
peptidiques s'auto assemblent et forment des feuillets plissés β qui stabilisent la structure 
(Figure 1). 
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Figure 1: Représentation du concept des barriques β à structure rigide "rigid-rod β-barrel". Les baguettes 
rigides formées par les p-octiphényles, comparables aux douves de tonneau, sont colorées en gris, alors que 
les chaînes peptidiques représentées par des flèches noires s'assimilent aux cercles du tonneau. La vue de 
dessus illustre l'orientation des chaînes latérales des acides aminés, avec les résidus hydrophobes inscrits en 
noir sur blanc et les résidus hydrophiles inscrits en blanc sur noir. 
Il est nécessaire de respecter certaines conditions afin d'assurer la formation de la 
barrique transmembranaire par auto-assemblage d'une unité : 
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- la longueur de la baguette est ajustée pour correspondre à la largeur des 
membranes, 
- la non planarité de la baguette promeut une structure cylindrique plutôt que 
linéaire en fibrilles, 
- la nature des acides aminés ABCDE est soigneusement choisie afin de 
contrôler les propriétés des surfaces internes et externes de la supra structure. 
Usuellement la leucine est placée sur l'extérieur de la barrique afin de promouvoir 
son insertion et sa stabilisation dans les membranes, alors que l'espace intérieur offert est 
fonctionnalisé avec des résidus hydrophiles divers suivant les applications escomptées. 
Parmi les propriétés notoires autres que la formation de canaux ioniques et la 
reconnaissance moléculaire communes à toutes les barriques conceptualisées, une activité 
enzymatique catalytique a été développée avec la présence d'histidine (14,16), ainsi que la 
bio-imitation de métallopores en introduisant des acides aspartiques (17). 
 
Conceptualisation et synthèse d'une nouvelle barrique 
L'arginine présente des propriétés intéressantes de reconnaissance et d'interaction 
avec les anions carboxylates ou phosphates grâce aux liaisons hydrogènes et aux 
interactions ioniques possibles avec le groupement guanidinium qu'elle porte. Une 
nouvelle séquence peptidique a donc été construite afin d'étudier et exploiter ces 
propriétés : 
- les leucines ont été maintenues comme promoteur d'insertion, 
- une histidine, dont les propriétés catalytiques ont été démontrées, a été placée à 
l’intérieur, 
- une arginine a été introduite en quatrième position du pentapeptide. 
La séquence obtenue est donc la suivante : -Leu-Arg-Leu-His-Leu (LRLHL 39). 
La synthèse de la baguette 38m portant cette séquence peptidique a été réalisée et la 
caractérisation de la molécule 38m obtenue par spectrométrie de masse à ionisation 
attestait d’ores et déjà de l'affinité des groupements guanidinium pour les anions 
phosphates. En effet, malgré une étape précédente de déprotection dans le TFA et des 
conditions d'ionisation impliquant de l'acide acétique, entre 0 et 6 phosphates ont été 
détectés sur le spectre de masse obtenu avec la molécule 38m. 
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Les expériences en fluorescence avec des vésicules ont montré que la baguette 
engendrait la formation de pores dans la bicouche lipidique, perméables au passage 
d'anions telle que la molécule de carboxyfluoresceine.  
 
Après une caractérisation de cette nouvelle baguette active x, en déterminant la 
dépendance de l'activité en fonction du pH et de la concentration en baguette 38m, l'intérêt 
s'est porté sur la reconnaissance et l'amplification d'hélices α. 
 
Reconnaissance de l'acide poly-glutamique 
L'hélice α est une structure secondaire adoptée par 40 % des acides aminés dans 
les protéines. La structure tridimensionnelle joue un rôle primordial dans la régulation des 
fonctions des protéines; elle est même présumée être plus importante que la nature des 
acides aminés dans certains cas. Les recherches pour comprendre la formation, la 
stabilisation ou l'amplification d'hélices α sont nombreuses, afin d'élargir les 
connaissances théoriques et de synthétiser des biomolécules d’intérêt thérapeutique. 
L'acide poly-glutamique s'est révélé être un bon candidat pour étudier la formation 
du complexe à l'intérieur du pore 38 :  
- il possède des chaînes carboxyliques latérales, 
- le diamètre de l'hélice correspond au diamètre interne du pore (Figure 2), 
- l'hélicité du polypeptide dépend du pH, 
- l'hélice comporte un moment dipolaire dont les interactions avec les 
membranes polarisées sont intéressantes à étudier.  
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Figure 2: Représentation schématique de l'incorporation de l'acide poly-glutamique hélical dans le pore 38. 
Les études de blocage du pore 38 par les acides L et D-poly-glutamiques à 
différents pH ont révélé une affinité accrue entre le récepteur et le bloqueur, en d'autres 
termes un meilleur blocage, lorsque le pH du milieu augmentait. Or ces variations de pH 
correspondent à une déprotonation progressive des groupements carboxyliques, et une 
dénaturation progressive de la structure en hélice α en structure aléatoire. On peut donc 
conclure que le pore 38 reconnaît mieux les chaînes polypeptidiques anioniques que les 
hélices alpha neutres (Tableau 1, entrées 1-7). Les résultats montrent une légère 
différence non interprétable comme de la stéréosélectivité entre les valeurs de KD 
obtenues pour les deux énantiomères L et D du polymère.  
Les mesures faites avec des membranes polarisées ont attesté de l'incorporation de 
la barrique et de l'hélice dans la membrane, ainsi que de la coopérativité entre le dipôle de 
l'hélice et le potentiel de la membrane. En effet, sous la forme hélicoïdale, l'acide poly-
glutamique possède un moment dipolaire dû à l'alignement des liaisons carboxyles ; sous 
la forme aléatoire, ce moment dipolaire n’existe pas. Or lorsque la membrane des 
vésicules est polarisée, l'affinité de l'hélice poly-glutamique pour le pore x est 10 fois 
supérieure à la valeur obtenue sans polarisation de la membrane, d'où une coopérativité 
dipôle-potentiel (Tableau 1, entrée 8 versus 1). De plus cette coopérativité est inexistante 
lorsque le polymère est sous forme aléatoire, puisque dans ce cas les mêmes constantes 
d'affinité ont été mesurées avec ou sans polarisation de la membrane (Tableau 1 entrée 9 
versus 3).  
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Tableau 1: Résultats des études de blocage du pore 38 par les acides L et D-poly-glutamiques en fonction 
du pH, et de la polarisation de la membrane. 
Entrée pH pEa fDb V (mV)c KD (nM) 
1 4.5 L 0.0       0 150 
2 5.0 L 0.3       0   50 
3 5.5 L 0.8       0   45 
4 6.0 L 0.9       0   13 
5 4.5 D 0.0       0 100 
6 5.0 D 0.3       0   44 
7 5.5 D 0.8       0   30 
8 4.5 L 0.0 - 150   13 
9 5.5 L 0.80 - 150   48 
 
a pE = acide poly-glutamique 
b fraction de dénaturation de l'hélice α déterminée par dichroïsme circulaire. 
c potentiel de Nernst appliqué aux vésicules. 
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Figure 3: Représentation schématique de la formation de complexe entre l'acide poly-glutamique et le pore 
38, sous forme hélicoidale dans les membranes polarisées (a), et sous forme aléatoire (b). 
 
Détection d'activités enzymatiques 
Le développement de détecteurs d'activité enzymatique est un sujet qui présente de 
nombreuses perspectives intéressantes, tant pour les chimistes organiciens qui rêvent 
d'utiliser ces catalyseurs sélectifs dans les étapes difficiles de synthèse, que pour les 
biochimistes qui envisagent de développer de nouvelles molécules thérapeutiques en 
inhibant ou activant des enzymes. 
La reconnaissance moléculaire a été explorée plus en profondeur avec le pore 42, 
dont la séquence peptidique est -Leu-Arg-Try-His-Val et présente les mêmes 
caractéristiques en double couche lipidique sphérique que le pore 38. Réalisant que de 
petites modifications structurales des hôtes engendrent des changements notoires des 
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constantes de dissociations pour le même pore 42, l'idée d'utiliser la barrique en tant que 
senseur a émergé. Le principe est de suivre une réaction enzymatique en mesurant la 
variation de blocage du pore au cours de la réaction. Pour ceci, il est nécessaire que l'un 
des réactifs ou des produits bloque préférentiellement le pore. Ainsi, la dégradation d'un 
substrat bloqueur ou l'apparition d'un produit bloqueur se traduit par une activation 
progressive de l'activité lytique du pore ou une désactivation respectivement. 
Concrètement, les réactifs sont incubés avec l'enzyme dans les conditions appropriées à la 
réaction. Après un certain temps de réaction, un échantillon de ce milieu réactionnel est 
prélevé et ajouté dans une cuvette de mesure de fluorescence contenant des vésicules 
enfermant de la carboxyfluorescéine, dont la fluorescence est annihilée par "self-
quenching" dû à la concentration. Le pore est ensuite additionné et l'activité lytique du 
pore est directement proportionnelle à la quantité de carboxyfluorescéine relâchée dans le 
milieu, phénomène qui se manifeste par une augmentation de la fluorescence de la 
molécule (Figure 4). Dans le cas d'un substrat qui bloque le pore, au temps t = 0, l'activité 
lytique du pore est nulle puisqu'il est fermé par le substrat, et au fur et à mesure de la 
dégradation du substrat, la fraction de pores ouverts augmente, et l'activité lytique aussi. 
Lorsque l'activité initiale de la barrique est recouvrée, la réaction est terminée. Des 
mesures effectuées à différents temps de réaction enzymatique permettent ensuite de 
reporter sur un graphique l'activité relative de l'enzyme (qui est proportionnelle à l'activité 
du pore) en fonction du temps de réaction. Ces séries de mesures sont effectuées avec des 
concentrations différentes d'enzyme, et même sans enzyme afin de prouver que l'activité 
reportée est bien due à la réaction enzymatique.  
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Figure 4: Schéma représentatif de la détection par fluorescence de l'activité enzymatique dans le cas où le 
substrat est le bloqueur du pore.  
 
Les premières investigations se sont concentrées sur la dégradation de l'acide poly-
L-glutamique par différentes protéases, son excellente affinité pour le pore étant connue et 
de l'ordre de grandeur nanomolaire et le monomère produit par la réaction, l'acide L-
glutamique, étant un bien plus faible bloqueur du pore 42 (Tableau 2, entrée 1). La 
distinction entre le produit et le substrat étant assurée, l'acide poly-L-glutamique a été 
incubé avec différentes protéases (Tableau 2, entrées 1-5). Dans tous les cas, une 
activation progressive de l'activité lytique du pore, dépendante de la concentration en 
enzyme a été relevée, prouvant la détectabilité des protéases par la barrique 42 (Figure 5). 
L'incubation de la Subtilisine avec l'acide poly-D-glutamique n'a pas abouti à l'ouverture 
progressive du pore. Des études plus approfondies ont démontré qu'en mélangeant les 
deux énantiomères de l'acide poly-glutamique, la proportion de conversion de 
l'énantiomère L était nettement amoindrie par rapport à la conversion attendue dans les 
mêmes conditions sans la présence de l'énantiomère D. L'acide D-poly-glutamique est 
donc un inhibiteur de la Subtilisine et se complexe plus fortement avec celle-ci que 
l'énantiomère L du polymère.  
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L'utilisation de la barrique 17 dont la surface interne est anionique a permis de 
suivre la dégradation de deux polymères cationiques que sont la poly-arginine et la poly-
lysine (Tableau 2, entrées 7-8).  
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Figure 5: Screening de protéases; détection de la dégradation de l'acide poly-L-glutamique par la pronase 
(A), la ficine (B), l'elastase (C) et la subtilisine (D); détection de l'acide poly-L-arginine par la papaïne (F). 
Les cercles pleins correspondent à une concentration élevée d'enzyme, les carrés à une concentration faible 
d'enzymes et les croix aux contrôles sans enzyme. 
En s'assurant du blocage sélectif du pore 42 par le polymère [poly(dA,dT)]2 utilisé 
pour imiter la double hélice d'ADN (Tableau 2, entrées 10-11), les réactions de 
dégradation de la double chaîne et de polymérisation à partir des nucléosides 
triphosphates ont pu être détectées. La sensibilité de la méthode est à souligner 
particulièrement dans ce cas puisque seulement 370 pM de polymère ont été mis en jeu 
dans chaque réaction.  
Enfin, dans la grande famille des polysaccharides, l'héparine et l'acide 
hyaluronique ont été digérés respectivement par l'héparinase et la hyaluronidase (Tableau 
2, entrées 12-13), et les réactions ont été suivies grâce à la barrique 42. Le β-D-glucan est 
un dérivé de la cellulose ramifié pour augmenter sa solubilité. Or la cellulase elle-même 
s'est révélée être un meilleur bloqueur que le substrat dans les conditions requises 
d'incubation. Le couplage de deux réactions enzymatiques a donc été tenté afin de 
dégrader l'enzyme cellulase dans un second temps pour ne mesurer plus que le polymère 
β-D-glucan. La ficine seule digère la cellulase, mais des conditions appropriées au 
couplage des deux enzymes n'ont pas été trouvées pour permettre la détection de la 
cellulase. 
Résumé 
xi 
La détectabilité de l'héparine a abouti au développement d'une méthode permettant 
de repérer des inhibiteurs potentiels de l'enzyme. En comparant l'avancement de la 
réaction de l'héparine incubée en présence d'un inhibiteur potentiel avec la réaction de 
l'héparine seule, il est rapidement possible de voir si le composé étranger a diminué la 
réactivité de l'enzyme, et de conclure s'il agit comme un inhibiteur ou non.  
 
Tableau 2: Valeurs des constantes de dissociation (KD) des substrats et produits mis en jeu au cours des 
différentes réactions enzymatiques testées. 
En
tré
e 
Enzyme 
Substrats 
(S) 
KD (S) 
en M 
KD(monomer) 
en M 
Produits  
(P) 
KD (P)  
en M 
1 pronase pLE 1.4 x 10-8 1.3 x 10-6 L-glutamate (E) > 5 x 10-4 
2 papaïne " " " " " 
3 ficine " " " " " 
4 élastase " " " " " 
5 subtilisine " " " " " 
6 subtilisine pDE 1.9 x 10-8 1.6 x 10-6 D-glutamate > 5 x 10-4 
7 papaïne pLR 1.9 x 10-8 1.3 x 10-6 L-arginine (R) > 5 x 10-4 
8 papaïne pLK 1.1 x 10-8 1.5 x 10-6 L-lysine (K) > 5 x 10-4 
10 DNA exonuclease III [poly(dA,dT)]2 1.9 x 10
-10 2.3 x 10-6 
5’-dAMP
5’-dTMP 
1.2 x 10-3 
2.5 x 10-3 
11 DNA polymerase  I Klenow 
dATP 
dTTP 
2.9 x 10-5 
n.d. 
 
[poly(dA,dT)]2 
PP 
1.9 x 10-10 
1.0 x 10-3 
12 héparinase I heparin 4.7 x 10-8 n.d. ∆DiHs n.d. 
13 hyaluronidase HA 1.6 x 10-10 1.0 x 10-6 ∆DiHAs n.d. 
14 cellulase β-D-glucan 5.3 x 10-7 1.8 x 10-3 glucose > 1 
15 ficine cellulase 12 mg / L  n.d.  
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Après avoir démontré la détectabilité de nombreuses classes d'enzymes agissant 
sur des biopolymères, l'intérêt a été porté sur la sélectivité de la méthode de détection 
développée avec les barriques. On a ainsi cherché à déterminer les limites au delà 
desquelles la différenciation des composés impliqués dans une réaction n'était plus 
suffisante pour permettre de suivre cette réaction, les KD étant trop proches. La glycolyse 
offre des possibilités adéquates à cette étude, puisque les composés subissent des petites 
modifications au cours des réactions enzymatiques, telles que la phosphorylation ou 
l'isomérisation. En s'intéressant aux trois premières étapes de la glycolyse, on a constaté 
qu'en optimisant les concentrations du meilleur bloqueur de la réaction il était possible de 
suivre des réactions enzymatiques dont deux des composés ont des KD aussi proches que 
82 et 250 µM, soit un ratio R= 250/82 = 3. Par contre, dans le cas de la phosphoglucose 
isomérase, le substrat et le produit ont des affinités trop semblables pour détecter 
sélectivement le glucose-6-phosphate au cours de l'isomérisation. Le ratio des KD est dans 
ce cas de R= 2600 / 1900 = 1.4. La limite de détection de l'activité d'une enzyme par la 
méthode développée avec les barriques correspond à un ratio entre les KD des meilleurs 
substrat et produit compris entre 1.4 et 3. Si R >3, la différenciation est suffisante pour 
envisager de suivre la réaction enzymatique (Figure 6). 
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Figure 6: Premières étapes de la glycolyse mentionnée avec les constantes d'affinité des éléments 
impliqués. Les enzymes soulignées ont été détectées grâce à la barrique alors que la différenciation était 
insuffisante pour la phosphoglucose isomérase.  
 
Enfin une méthode de quantification du taux de sucre dans les boissons a été mise 
au point en couplant deux réactions enzymatiques. La molécule communément nommée 
sucre est l'association d'une molécule de glucose et d'une molécule de fructose. Les 
conditions réactionnelles de leur séparation sous l'action de l'enzyme invertase, puis de 
leur phosphorylation en glucose-6-phosphate et fructose-6-phosphate ont été mises au 
point afin de pouvoir quantifier l'ATP consommé. De la quantité d'ATP convertie en ADP 
découle ensuite la quantité initiale de sucre incubée. Et de la dilution de l'échantillon 
incubé découle la concentration en sucre de la boisson (Tableau 3). 
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Tableau 3: Détermination de la quantité de sucre dans des boissons. 
Boissons 
Méthode développée avec 
la barrique (en g /L) 
Information de l'étiquette 
(en g /L) 
Pepsi® 95 120 
Cola light® non détectable 0 
Jus d'orange 74 90 
Jus d'orange frais 20 n.d. 
Monbazillac  65 n.d. 
Ice tea 90 80 
n.d. : non déterminé 
 
Conclusion 
Ce travail présente le design et la synthèse d'une nouvelle baguette, incorporant 
pour la première fois une arginine dans la séquence peptidique. L'auto-assemblage de 
cette unité forme une barrique qui agit comme un pore dans les doubles couches 
lipidiques, laissant passer les ions inorganiques, mais aussi des molécules telles que la 
carboxyfluorescéine. Les études de blocage avec l'acide poly-glutamique ont mis en 
évidence la formation d'un complexe entre le polymère et la barrique transmembranaire 
ainsi qu'une coopérativité dipôle-potentiel. La mise au point et l'utilisation de la structure 
supramoléculaire comme senseur d'enzymes ont été largement illustrées sur des 
biopolymères ou des enzymes intervenant dans différents processus biologiques. 
L'utilisation d'un seul pore permet la détection d'une large variété d'enzymes et de 
substrats à intérêt biologique, sans requérir aucune modification chimique des composés 
impliqués. Des applications telles que la recherche d'inhibiteurs d'enzymes ou la 
quantification du sucre dans les boissons ont découlé de cette recherche. Bien d'autres 
applications impliquant la détection d'une activité enzymatique sont envisageables, et la 
fonctionnalisation aisée de l'espace intérieur de la barrique en modifiant la chaîne 
peptidique de la baguette laisse présager de nombreux autres emplois. 
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Chapter I: INTRODUCTION 
1. Rigid rod β-barrel pores 
1.1. Natural β-barrels 
The two main structural features in proteins, α-helix and β-sheet motifs, were 
discovered on 1951 by Linus Pauling and Robert Corey.1 The peptide chain constituting 
the β-sheet is in its most relaxed form; however, the β-sheet conformation is a very 
compact structure thanks to the numerous hydrogen bonds formed between the amide 
hydrogen and the carbonyl oxygen atoms from neighboring strands. There are two types 
of β-sheets: 1) the antiparallel β-sheet where the two peptide strands constituting the layer 
are parallel and run in opposite directions; 2) the parallel β-sheet where the two peptide 
strands constituting the layer are parallel and run in the same direction. The peptide side 
chains alternate above and below the plane formed by the peptide backbones (Figure I-1).  
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Figure I-1: Representation of parallel and antiparallel β-sheet conformation. Hydrogen bonds are depicted 
as dashed bonds.  
The β-barrel is equivalent to a β-sheet that is rolled up to form a cylinder. From 
this structure arise several characteristics. In brief, the number of β strands must be even, 
all β strands must be antiparallel and connected to their next neighbors with tight turns or 
longer loops, and the minimum possible size is eight strands because of packing 
constraints in the barrel interior.2 The hydrophobic and hydrophilic faces of the barrel 
result from the disposition of the amino acids along the strands pointing alternatively 
inside and outside.  
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We can discriminate two general families of β-barrels. The lipocalin family, which 
comprises a large variety of small extracellular proteins with an external hydrophilic face 
and a hydrophobic interior, is characterized by an eight-stranded structure with a ligand 
binding site enclosed. The lipocalins exhibit great functional diversity, including roles in 
retinol transport, olfaction and pheromone transport.3 The β-barrel membrane proteins, 
which are found in the outer membranes of bacteria, mitochondria and chloroplasts, 
present hydrophobic amino acids side chains on their outer surfaces to anchor the protein 
in the membrane. A variety of functions are provided by β-barrel membrane proteins, 
which also present a large variety of structures due to the range in the number of strands 
(from eight to twenty-two have been observed), and the possibility of oligomerization, as 
shown in Table I-1 and Figure I-2.2, 4  
 
Table I-1: Examples of function and structure of outer membrane β-barrel proteins. 
Functional category Example Strands Subunits 
Non-specific porin OmpF 16 trimer 
Facilitated transporter Maltoporin 18 trimer 
Energy-dependent transporter influx FepA 22 mono 
Protein pore-forming toxin α-Hemolysin 14 heptad 
Lipase OmpLA 12 mono 
Protease OmpT 10 mono 
Adhesin OmpX  8 mono 
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Figure I-2: Examples of β-barrel membrane protein structures. A: The 8-stranded barrel OmpX. B: 
OmpLA is a dimer of 12-stranded barrels which hydrolyses phospholipids in the active side activated by 
dimerization and located at the extracellular interface of the two units. C: One of the biggest β-barrels 
isolated, containing twenty-two strands: FepA is an iron transporter. D: The pore toxin α-hemolysin 
assembles into a heptameric 14-stranded β-barrel. 
 
1.2. Artificial pores 
As shown in the particular example of β-barrels, Nature has evolved an enormous 
variety of protein structures, as well as protein functions. In a goal to improve our 
understanding on natural protein folding and to design novel macromolecules with 
interesting properties such as catalysts, receptors, and drug deliverers, chemists have 
begun to design and synthesize compounds to mimic the proteins. Among the functions of 
proteins, one is the ability to form transmembrane pores or channels i.e. proteins that 
incorporate into the bilayer membrane and facilitate the diffusion of inorganic ions or 
larger entities across the membrane by passage through the hole formed by the protein. 
Ion channel proteins figure in a wide variety of biological processes and diseases5 
that involve rapid changes in cells, such as electrical signaling in nerves. The natural 
proteins have been extensively studied in the past fiveteen years. Notably, the 2003 Nobel 
Prize in chemistry was shared between Peter Agre and Roderick MacKinnon for 
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discoveries concerning channels in cell membranes. However, many efforts have also 
been focused on the development of artificial molecules designed to mimic the natural 
ones. 
 
1.2.1. Derivatized from biological scaffolds 
A convenient way to design de novo ion channels and pores is to synthetically 
modify natural known pore-forming compounds and to characterize them by determining 
their stability in the membrane, their ion or molecule selectivity, their size, their 
incorporation in the bilayer etc… 
 
1.2.1.1. Derivatives of β-barrels 
Studies on artificial β-barrels are still beginning, and essentially concentrated on 
the understanding of β-sheets.6-9 The difficulties rising from the instability of an isolated 
β-strand and their tendency to aggregate limits the de novo design to the alteration of 
existing barrels.10 Thus the concept of natural protein architecture onto which unnatural 
elements can be attached to create new biochemical activities has emerged. Data on 
protein design studies based on members of the lipocalin members have been reviewed by 
Skerra.11 Variants of the structurally simple bilin-binding protein (BBP) were engineered 
by, for example, introducing a metal binding site, or by reshaping the natural binding 
pocket of the protein.  
Among several examples of modified pore-forming proteins, Bailey et al. have 
concentrated their efforts on α-hemolysin, a bacterial toxin. By using targeted chemical 
modification and genetic engineering, "new" pores were made with diverse functional 
properties. For example a specific binding site was introduced in the pore to bind 
phosphate esters,12 a cysteine residue was introduced in a particular position to observe on 
the single-molecule level a reaction occurring on this specific site,13 or similarly a 3,4-
dimethoxy-6-nitrobenzylcarbamate group 1 was covalently attached to the interior wall 
and its successive rearrangement and decomposition under illumination was observed in a 
planar bilayer as taking place in three steps (Figure I-3).14 
 
  
Chapter I:  Introduction 
 I–5
N
H
R O
O
OMe
OMe
NO2
hν
N
H
R O
O
N
H
R O
O
OMe
OMe
N
OO
NH3R
1A
B
2
3
4
 
Figure I-3: Three-steps reaction observed on a single molecule within an α-hemolysin pore. A: A model of 
the modified α-hemolysin with a 3,4-dimethoxy-6-nitrobenzylcarbamate group covalently attached to one 
of the seven subunits. B: Possible steps undergone by the protected carbamate substrate 1 after UV-
irradiation and their corresponding current level observed in planar bilayer i.e. by monitoring the ionic 
current through the pore during single-molecule chemistry taking place within the pore. The 3,4-dimethoxy-
6-nitrobenzyl group rearranges to a nitronate (aci-nitro) intermediate 2 after photon absorption. The 
protecting group then dissociates to leave a carbamic acid 3 that loses CO2 and yields the primary amine 4.  
 
1.2.1.2. Small natural channel-formers as models 
Numerous natural products inspire the biochemists for the design and synthesis of 
ion channels. Among them, the natural membrane-associated molecules amphotericin, 
gramicidin and alamethicin were studied in depth and mimics were constructed, because 
of their behaviour typical of many protein channels, such as ion selectivity, voltage 
dependence and blocking.  
The amphotericin is a polyene antibiotic, flanked with a hydrophilic head, and a 
more rigid body functionalized with hydroxyl groups. In the same way that the staves of a 
barrel form a cylinder, the molecules aggregate to form a pore. The gramicidin is a 
cation-selective channel made up of a pentadecapeptide containing alternating L-and D-
amino acids that dimerizes into a tail-to-tail arrangement to form a helix that acts as an 
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antibiotic against gram-positive bacteria. Alamethicin is an antibiotic active upon "barrel-
stave" aggregation of the monomeric helices, each composed of twenty amino acids 
among which eight are α-isobutyric acids (Aib). These natural pore-formers provide a 
great source of inspiration for chemists, who have modified the natural structures to 
assess the influence of scaffold modifications. 
 
1.2.2. Synthetic pores 
In addition to the wide variety of new pores created by modifying natural pore-
forming scaffolds, there is a large area of research, which is involved in the creation of 
purely synthetic transmembrane pores. The approaches under consideration for the design 
vary, in terms of supramolecular construction as well as molecular structure. However, 
the topic has been extensively reviewed during the last few years,15-17 and will be very 
briefly presented here, by citing each of the supramolecular-assembly categories shown in 
Figure I-4.  
A B C D
Barrel-stave Barrel-hoop Barrel-rosette
Supramolecular assembliesUnimolecular structure  
Figure I-4: Schematic representation of the different pore constructions. A: Unimolecular macromolecule. 
B: Barrel-stave supramolecular assembly. C: Barrel-hoop supramolecular assembly. D: Barrel-rosette 
suparmolecular assembly. 
A general pathway to design unimolecular pores is to attach ionic relays on rigid 
or semi-rigid scaffolds that span the bilayer membrane (Figure I-5). Thus oligocrowns5, 18, 
19 and azacrowns of different type were investigated as well as different scaffolds. The 
semi-rigid α-helical scaffold 5 was used to align the crown ether on top of each other. 
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Combining the functions of relay and scaffold, polyethers20 such as 6 showed also ion 
channel activity. 
Bolaamphiphiles and dimeric steroids are representative members of the barrel-
stave category (Figure I-5). They are usually conceived with two hydrophilic ends 
separated by a length sufficient to span a lipid bilayer membrane and contain a core 
presenting a hydrophobic face and a hydrophilic one. The bolaamphiphile stave 721 
revealed a dimeric active structure in spherical bilayers, while the dimeric steroid stave 
822 revealed a trimeric active structure. 
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Figure I-5: Polycrown 5 and polyether 6 which form unimolecular ion channels and bolamphiphile 7 and 
steroid 8 staves. 
p-Oligophenyls can also serve as staves. This category will be treated in the next 
paragraph. 
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Ghadiri and co-workers designed in 199423 a new class of organic nanotubes made 
from cyclic peptides (Figure I-6). They showed that cyclic peptides composed of 
alternating D- and L- amino acids adopt flat, ring-shaped conformations, and stack through 
antiparallel β-sheet-like hydrogen bonding network, thus forming nanotubes. The cyclic 
peptide 9 was the first transmembrane ion channel of this category, and extension to a 
larger cyclic peptide by introducing two more amino acids D-Leu and L-Trp led to a 
transmembrane pore through which glucose may pass.24 The lack of functionalization on 
the inner surface is nonetheless a limitation. Roeske and coworkers25 designed the cyclo-
(L,L,L,D)3-α-peptide 10 with two serines and one aminopropionate pointing inside the 
macrocycle.  
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Figure I-6: A: Examples of macrocyclic peptides that form ion channels by self-assembly into barrel-hoop 
motifs. Axial views of the structures 9 and 10 are illustrating as well as a schematic representation of the 
tubular assembly of 9 emphasizing the antiparallel staking and the network of intermolecular hydrogen-
bonds. B: The isophthalic derivative 11 aggregates into a barrel-rosette. 
The barrel-rosette motif can be seen as a short barrel stave, too short to span the 
bilayer length. Thus, vertical tail-to-tail dimerization is necessary to span the membrane, 
assuming that the head bears the hydrophilic end, and horizontal aggregation occurs to 
create a hydrophilic pathway. The very simple isophthalic acid derivative 1126 (Figure 
I-6) belongs to this family, despite the fact that the exact supramolecular structure is not 
known. It is guessed to consist of two to ten molecules. 
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1.2.3. Rigid rod β-barrels 
Attracted by the several interesting functionalities offered by the β-barrel pores 
that act as binding proteins, ions channels, or enzymes, Matile and coworkers designed a 
p-oligophenyl scaffold flanked with short peptidic arms that self-assemble into a 
cylindrical supramolecular structure following the barrel-stave model cited above. The 
development of synthetic β-barrels faces the problem of handling long and complex 
peptides, and the problem of folding them into a desirable or functional structure. 
Furthermore, certain characteristics have to be maintained, such as the length of the 
barrel, which should match the bilayer thickness, and the exterior and interior face 
environments should be controlled. Thus the introduction of non-peptidic staves that 
preorganize the self-assembly, and fulfill the prerequisites appeared to be an important 
and promising concept to develop de novo synthetic β-barrels.  
LaBrenz and Kelly27 introduced for the first time in 1995 a template that promotes 
antiparallel β-sheets. A peptidomimetic host 12, made of a dibenzofuran bearing two 
peptide strands, was constructed as well as a complementary strand 13. The guest 13 was 
shown to bind the host 12 and form stable antiparallel β-sheets (Figure I-7).  
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Figure I-7: Structure of host 12 and guest 13 and their assembly into antiparallel β-sheets.  
Observing that two strands attached on each arene of a biphenyl compound would 
lead to an interspacing of ~ 4.9 Å which equals the distance separating two 
complementary strands in the antiparallel β-sheet motif, Matile designed a p-octiphenyl 
scaffold with short peptides attached to each arene that would preorganize the strands in a 
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suitable distance to form interdigitating, antiparallel β-sheets between adjacent rods, 
resulting in minimal entropy loss and maximal enthalpy gain (Figure I-8). 
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Figure I-8: Analogy between the model of Kelly27 (A) and the design of p-oligophenyls as barrel-staves 
introduced by Matile (B).28 
The design of the scaffold also fulfills other conditions required to form a 
transmembrane barrel. The length of the rod was adjusted to roughly match the thickness 
of bilayer membranes by using p-octaphenyls. The curvature needed to obtain a 
cylindrical assembly was induced by the non-planarity of the rod. Finally the nature of the 
interior and exterior of the barrel was directed thanks to the amino acid side chains 
oriented alternatively in opposite directions. The internal crowding resulting from the 
circular self-assembly orients the side chain of the first amino acids next to the rod on the 
outer surface. Thus, as shown on Figure I-9, for a pentapeptide strand ABCDE, the amino 
acid side chains ACE are placed outside, while the amino acid side chains BD are pointing 
inside the barrel. The functional plasticity of the rigid-rod β-barrels rises from the facility 
to tune the peptide sequence. Ion channels are constructed with external hydrophobic 
residues, usually leucines, to anchor the barrel in the membrane and internal residues are 
selected to functionalize the accessible intratoroidal space. All the barrels were fully 
characterized29 as ion channels with determination of their internal diameter, conductance 
and selectivity, showing also molecular recognition (14-17),30, 31 catalytic activity 
(14,16),31-34 fibrillogenic activity (16)35 and metallopore behavior (17).36, 37 
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Figure I-9: Synthetic rigid-rod β-barrels 14-17 formed from the self-assembly of p-octaphenyls 14m-17m. 
Peptide sequences ABCDE are specified using single-letter abbreviation, with hydrophilic amino acids 
written white on black and hydrophobic amino acids written white on black.  
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2. α-Helix recognition and amplification 
It is estimated that about 40 % of the amino acids in known proteins are involved 
in α-helices38 which hold important functional roles in bioactive peptides. For example, 
Kaiser et al. have demonstrated that the α-helical character in many bioactive peptides is 
more important than the specific amino acids sequence to establish function.39, 40 
Some amino acid residues are more common in α-helices than others. For example 
the small, uncharged residues as alanine, leucine and phenylalanine are often found, while 
the more polar residues like aspartate, serine and arginine tend to destabilize the 
secondary structure by intercharge repulsion. Many attempts have been made to predict 
the formation of α-helices from the amino acid sequence, but the complexity of the 
interactions among the residues led only to partial success.  
Therefore the research onto recognition, stabilization and orientation of α-helices 
is important to test our understanding of protein folding, and to apply this knowledge to 
the design of de novo proteins of medicinal41 or materials science42 interest.  
Many efforts focus on the synthesis of three or four helix bundles because of their 
structural simplicity and functional diversity (the motif is found in the active centers of a 
large variety of proteins) in order to mimic the bioactivities of proteins by using smaller 
entities. The general strategy based on Template-Assembled Synthetic Proteins (TASP) 
was introduced by Mutter et al.43, 44 consisting of the assembly of short amphiphilic 
peptides into three or four helix bundles on templates such as flexible peptides45 or more 
rigid porphyrins,46-48 cavitands49 and metal ions (Figure I-10).50 These templates increase 
the helicity of the peptides and were successfully applied, for example, to the design of a 
synthetic cytochrome b.51  
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Figure I-10: Examples of template-assembled synthetic proteins (TASPs) to design artificial α-helix 
bundles. A: Metal ion template. Helical wheel of the peptide sequence designed to self-assemble into a 
triple α-helix bundle by metal coordination with the histidine side chains.50 B: Tertiary model of A showing 
the six histidine residues on the helix backbone and the Ni (II) as a sphere. C: Cyclic peptide containing 
turn mimetics (solid balls) and amino acids (empty circles).45 D: Chemical structure of a proton channel 
formed by attaching four peptides on a tetraphenylporphyrin template. The unnatural amino acid α-
aminoisobutyric acid (Aib) was introduced to enhance the solubility.48 E: Energy minimized computer 
structure of D. 
Studies on helix orientation aim to construct polypeptide monolayers oriented 
perpendicular to the surface of the water or of solid substrates as the orientation of 
segments in proteins is known to govern molecular recognition and electrochemical 
communication through electron transfer.42 Two ways can be distinguished to achieve this 
goal. One method consists in attaching the polypeptides to an orienting template. For 
example, directionally oriented polymerization of polyalanine was done on a gold 
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surface.52 The initiation sites (aminotrithiols) on the surface are appropriately spaced at 
distances consistent with the helical diameter of the peptide to promote the helicity and 
the perpendicular orientation during polymerization (Figure I-11 B). A similar approach 
was developed by Miura and Kimura53 where a crown ether was connected to the 
polypeptide, in order to complex an ammonium moiety bound on the gold surface (Figure 
I-11 A). 
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Figure I-11: A: Schematic representation of helical peptide with N-terminal crown ether complexed with 
ammonium on gold surface.53 B: Structure of aminotrithiol and schematic representation of the helical 
polypeptide on a monolayer of aminotrithiols represented cylinders.52 
The other method consists of spreading the polymer on a surface where it 
spontaneously forms helical monolayers. It can be on gold surface from aqueous solutions 
with disulfide bond at the N-terminus,54, 55 or on hexane-water interface with 
trimethylammonium group at the N-terminal56 or β-cyclodextrin at the C-terminal.57 
 
Another area of interest consists of stabilizing monomeric α-helices. In this 
domain, poly-glutamic acid (pE) is often used42, 54, 58 because it offers carboxylate groups 
on the side chains to enable ion pairing, and it offers a variable degree of helicity 
(dependent on the pH) to investigate on helix amplification. One approach to stabilizing 
helical peptides is to introduce covalent or non covalent bond between adjacent turns in 
the chain. Lactam bridges59, 60 between aspartate and lysine side chains and side chains 
disulfides61 are examples of such covalent links (Figure I-12), but the rigidity introduced 
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in these cases can be incompatible with a given biological function. Salt bridges,38 metal 
coordination62 and hydrophobic interactions63 are possible non covalent intrahelical links.  
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Figure I-12: A: Helical net diagram of an amphiphilic α-helical peptide with multiple lactam bridges 
linking Lysi, Glui+4 residue pairs. Hydrophobic leucines are shown in bold.59 B: Schematic representation of 
the disulfide bond bridging the i and i+7 residues with the amino acid introduced at theses positions.61 
Research focusing on protein surface recognition includes the design of 
complementary molecules that recognize and also stabilize helical structures.64 Hamilton's 
approach is based upon hydrogen-bonding complementarity between peptidic carboxylate 
side chains and synthetic receptors containing guanidinium oligomers,65 and in one case 
upon cation-π interactions.66 Starting from a simple diguanidinium molecule 18 designed 
to bind aspartate residues positioned at i, i +3 or i, i +4, i.e. spaced on one turn away from 
each other, their model became more complicated when they increase the number of 
guanidinium-carboxylate interactions. Extension of the binding motif with a tetracationic 
molecule such as spermine 19, which was expected to increase the affinity, did not lead to 
any helicity enhancement if the aspartate residues were in an i, i +3, i +6, i +9 orientation. 
On the contrary, the tetraguanidinium receptor 20 showed good stabilization of this helix 
thanks to the superhelical arrangement introduced in the design of the receptor 20. Further 
evidence of the importance of the shape complementarity between the orientation of the 
functional groups on the helix and the receptor molecule was given by Sasaki et al.67 
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where they placed the carboxylates linearly along one face of the helix in an i, i +4, i +7, i 
+11 orientation, and observed helicity induction with spermine (Figure I-13). 
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Figure I-13: A: Diguanidinium derivative 18 designed to bind diaspartate i, i +3 peptides. B: 
Tetraammonium 19 (spermine) and tetraguanidinium 20 structures designed to bind carboxylate side chains 
with respect to their orientations on the α-helix. C: Schematic representation of the side chain functional 
groups orientations and their shape complementarity with the receptors.  
Few complementary molecules’ designs have been based upon metal coordination. 
Hamachi and al.68 prepared a series of receptors bearing two dipicolylamine Zn(II) 
complexes tethered by a length-variable linker that binds and stabilizes peptides having 
two histidine residues at specific positions (i and i +4 or i +7 or i +11) (Figure I-14).  
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Figure I-14: Schematic representation of peptide recognition by a dipicolylamine Zn(II) receptor.68 
 
3. Sensing 
Enzymes play an important role in bioanalytical chemistry, because they are 
involved in essential and varied biochemical processes. It is of interest to develop rapid 
and sensitive assays with low detection limits and with, in ideal cases, real-time readout 
of enzyme kinetics. One important goal is to develop new potential therapeutic drugs by 
screening enzyme inhibitors. 
Some sensors are developed to recognize a specific compound, by host-guest 
complexation or interaction that leads to a signal of some type revealing the presence or 
absence of the guest. As an example, Czarnik69 designed a chemosensor that 
discriminates between pyrophosphate (PPi) and phosphate (Pi) ions. Real-time 
monitoring of inorganic pyrophosphatase hydrolysis could thus be accomplished. 
However, this chemosensor was too specific to be applied to others substrates. I will omit 
discussion of those sensors designed for a specific reaction or a specific compound, while 
trying to give examples of methods developed to sense categories of products or 
reactions, which could thus maximize the number of reactions detected. These methods 
can be divided into two categories. In one case the substrates are modified by the 
attachment of a label, while in the other case enzymes assays are run with natural, 
unmodified substrates.  
 
3.1. Enzymes sensors with labelled substrates 
3.1.1. Colorimetric or fluorometric assays 
Different approaches are used to sense enzymatic reactions by UV or fluorescence 
spectroscopy. One approach is to design substrates that release a chromophore or a 
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fluorophore during reaction. The conversion is then proportional to the emission intensity 
measured in real time. In this case, the substrates need to be designed and synthesized, 
limiting thus the library of possible substrates, especially the natural ones, which are not 
included. The goal here is to screen a series of enzyme on one specific substrate.  
A good example is the screening of hydrolases or lipases: synthetic chemists are 
always interested in resolving racemates. Exploiting the very high enantioselectivity of 
hydrolytic enzymes is often a cheap and selective method to prepare enantiomerically 
pure compounds. For each substrate, a set of enzymes is screened, requiring the 
measurement of the enantioselectivity of the reaction; the reaction conditions are then 
optimized. To facilitate the time-consuming method consisting of working up each 
reaction and determining the enantiomeric excess by spectroscopy or by separatory 
chromatography the, colorimetric methods have been developed to speed up this process. 
In 1997 Kazlauskas70 et al. screened a series of lipases, following by UV spectroscopy the 
increase of released chromophore p-nitrophenoxyde during the hydrolyze of pure (S) or 
(R) 4-nitrophenyl 2-phenylpropanoate. The initial rate of hydrolysis of each enantiomer 
was thus determined, but the ratio of these rates doesn’t reflect the enantioselectivity of 
the enzymes, the pure enantiomers being separately hydrolyzed. Therefore another ester, 
used as a reference, resorufin tetradecanoate, was added to the reaction to mimic the 
competition. This allowed for the calculation of the selectivity of the hydrolases for the 
(S) or the (R) enantiomer over the reference and thus calculation of the enantiomeric 
ratio. 
Another idea is to attach on to natural substrates a fluorophore or/and a quencher. 
Their relative spatial position changes during the enzymatic reaction (increasing or 
decreasing the distance between the fluorophore and the quencher, in case of coupling or 
bond breaking, for example), which leads to a change in fluorescence intensity during the 
course of the reaction. Here the substrates are derived from natural products. Their 
modification can be costly in terms of synthesis, but more importantly, the enzyme 
recognition of the non-natural substrate could differ from the natural substrate.  
Many years ago synthetic substrates were designed to release upon enzymatic 
cleavage chromogenic or fluorogenic derivatives as unbelliferone, p-nitrophenol, 
nitroaniline. Proteases,71 lipases, esterases and glycosidases have been sensed by this 
method, despite the difference of reactivity from normal substrates: from the natural 
aliphatic leaving groups are much less reactive than the aromatic ones introduced for 
sensing. Klein and Reymond72 overcame this limitation by introducing a new type of 
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substrates, which undergo a β-elimination following enzymatic cleavage, and liberate thus 
the active fluorescent unbelliferone. Further development has allowed the development of 
assays with a very large variety of enzymes.73 
 
3.1.2. With fluorescent probes 
The group of Whitten74 recently developed a method to detect proteolytic 
enzymes, by incorporating a reactive peptide sequence T (as Tether or Target) into a 
recognition site biotin B and a quencher Q to form the substrate BTQ. Addition of a 
fluorescent polymer P equipped with a biotin binding protein BB leads to the formation of 
a complex P-BB-BTQ. In the absence of reaction on BTQ, the fluorescence of P is 
quenched by the proximity of Q. When the target T is recognized by the enzyme, and 
cleaved, the components B and T are dissociated, resulting in an increase of polymer P 
fluorescence (Figure I-15). Attempt to run reaction and sensing altogether failed, 
probably because the enzyme was inhibited by the polymer sensor P. But if BTQ was first 
incubated with the enzyme, and then the reaction mixture was added to a solution with P-
BB, it resulted in a very sensitive assay for enzyme activity. This assay has been 
confirmed with enterokinase, where the activity of as low as 380 10-18 M enzyme was 
detected within 15 min incubation, caspase-3/7 (involved in apoptosis) and β-secretase 
(involved the deposit of β-amyloids) and with one known inhibitor of β-secretase. 
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Figure I-15: Schematic representation of protease assay using fluorescent polymers developed by Whitten 
et al. 
Schanze et al.75 also developed a method involving water-soluble fluorescent 
polymers to detect protease activity. One approach is to label a cationic substrate peptide 
with a quencher (p-nitroanilide) 20. As the cationic peptide ion pairs with the anionic 
fluorescent polymer (poly (phenylene-ethylene) sulfonate ) 21, its fluorescence is 
quenched. By action of the protease, the quencher is then hydrolysed from the peptide, 
and since it is neutral, it does not interact further with the polymer, which leads to an 
increase in fluorescence (Figure I-16 B). Validation of this method was done with 
thrombin, giving an efficiency close to the best reported in the literature.76 Real-time 
detection and high sensitivity of the system allowed the detection of thrombin within 100 
s with enzyme concentrations ≥ 100 ng.mL-1. A second approach consisted of trapping 
the quencher within two peptidic substrates. In particular, bis-arginine derivatives of 
rhodamine (Arg-Rho-Arg 22) are not fluorescent, and do not quenching the anionic 
fluorescent polymer (poly(phenylene-ethylene) carboxylate 23). But hydrolysis of one 
side of the bis-Arg rhodamine leads to a very good fluorescent quencher 24 of the cited 
polymer (Figure I-16 C). Thus, protease activity is in this case followed as a decrease of 
fluorescence with as a function of reaction time and was demonstrated with papain.  
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Figure I-16: Sensing of proteases using water fluorescent polymers. A: Structure of the polymers and the 
substrate-quencher. B: Schematic representation of the "turn-on" approach, where the activity of the 
protease leads to an increase in polymer fluorescence. C: Schematic representation of the "turn-off" 
approach where the initial polymer fluorescence is quenched by enzymatic activity. 
 
3.2. Enzyme sensors with unmodified substrates 
3.2.1. Physical parameters: temperature change measured by IR-thermography 
Calorimetry is a universal method to get information on thermodynamic 
parameters, such as enthalpy and entropy, by directly measuring the energy associated 
with a reaction. Calorimetry was used to measure the heat generated during an enzymatic 
reaction since long time.77 Improvement of the method with the development of 
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isothermal power-compensation calorimeters currently allows access to enzyme kinetics, 
with determination of Km and kcat as well as enzyme inhibition. This technique consists of 
two cells (sample and reference) that are maintained at the same temperature by providing 
heat to the sample cell throughout the addition of enzyme or substrate. Variations of the 
heat energy supplied to the cell after addition of enzyme or substrate are proportional to 
the enzymatic rate. Recent demonstration of the wide applicability of the method was 
shown by Todd and Gomez.78 For a representative enzyme from each EC classification 
they accessed to the kinetic parameters, which in most cases agreed well with published 
values.  
To overcome the constraints of large sample volume and lengthy time 
measurement, the miniaturization of the devices was investigated. Design principles and 
fabrication of a nanocalorimetry detector is reported by workers at the SCRIPPS-PARC 
Institute for Advances Biomedical Sciences.79 Nanotechnology enabled the fabrication at 
low cost of a detector that reduced by a factor of 1000 the sample volume and 
measurement time, and that consisted of 96-detector arrays. The principle is to merge two 
drops (one enzyme drop and one substrate drop of approximately 250 µL each) by the 
application of a voltage to a detector region to measure the enthalpy of the reaction, 
ascompared with a reference consisting of the fusion of a buffer drop with a substrate 
drop. A single enzymatic reaction was used as a test system, the phosphorylation of 
glucose by hexokinase with ATP. A change in temperature due to the reaction was 
observed after mixing the glucose-containing drop with the hexokinase-containing drop.  
Calorimetry is a simple and universal methodology to determine or detect 
enzymatic activity. It does not need any labeling or modification of the substrates or 
enzymes. With the miniaturization of the detector, it can now be run for high-throughput 
screening at very low cost, thanks to the small amounts of reagents involved, and the 
rapidity of the measurement times. 
 
Surface plasmon resonance (SPR) is highly sensitive to small changes in the 
numbers of molecules at a surface, and detects molecules directly without the need for 
secondary labels. Telomerase (a DNA polymerase) was continuously sensed by SPR in an 
assay developed by Maesawa et al.80, following the elongation of surface immobilized 
telomeric repeat primer. The assay is rapid, reproducible and sensitive, but the materials 
required are expensive. 
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3.2.2. By addition of a reagent 
The presence (in real-time assays) or addition at measurement time (in endpoint 
assays) of a chromogenic or fluorogenic sensor that responds proportionally to the 
product formation or substrate consumption can be a way to develop inexpensive assays 
with high throughput potential. 
 
3.2.2.1. pH indicators 
The group of Kazlauskas developed in 1998 a general method81 to sense 
enantioselective ester hydrolyses using pH indicators. At neutral pH, the hydrolysis of an 
ester releases a proton (Scheme I-1). Once the pH indicator and the reaction conditions 
are carefully set to ensure that the color change is proportional to the number of protons 
released, the initial rates of the hydrolyses are rapidly determined for each enantiomer. As 
the enantiomers are run separately, the selectivities measured are qualitative, but this 
method allows screening the hydrolysis of any ester (not necessarily choromogenic) and 
many enzymes simultaneously, in micro plate wells for example. The major disadvantage 
of these methods is that the pure enantiomers are required. To demonstrate this method, 
seventy-two hydrolases were screened for the hydrolysis of solketal butyrate 25 with 4-
nitrophenol as a pH indicator. 
O
O
O
O
O
O
OH
O
-O
+ +  H+Hydrolase, bufferpH 7.2
25  
Scheme I-1: Hydrolysis of solketal butyrate 25 at neutral pH. 
 
Demirjian et al.82 introduced a very similar method one year later to screen 
hydrolases’ enantioselectivities based also on the pH drop as the reaction proceeds, but 
using visible color change of the indicator. For example, bromothymol blue turns from 
blue at pH 7.2 to yellow at pH 6.5. Pure enantiomers are separately sensed and the time 
difference between the two enantiomers to change the indicator color reflects the 
enantioselectivity. Seven acetate substrates described in the literature were thus 
hydrolyzed by PSL (Pseudomonas cepacia lipase) in micro-titer plates to assess the 
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enantioselectivity of the reaction. This method provides only an estimation of the 
enantioselectivity, but presents the advantage of being rapid for high-throughput 
screening. 
Hexokinase reaction can also be followed by a pH indicator as a proton is released 
during the reaction83. Spectrophotometric detection of this proton in presence of the acid-
base indicator cresol red leads to a linear relation ship between acid production and the 
change in optical density.  
 
3.2.2.2. Reaction with acetaldehyde 
Bornscheuer84 developed a high-throughput screening method to determine the 
synthetic activity of lipases and hydrolases. The transesterification activity of the 
enzymes is measured following the amount of acetaldehyde 26 (keto-enol tautomere of 
vinyl alcohol) released during the coupling of a vinyl ester 27 and an alcohol 28. The 
acetaldehyde 30 liberated reacts in situ with the hydrazine 4-hydrazino-7-nitro-2,1,3-
benzoxadiazole 31 to produce the fluorescent corresponding hydrazone 32 (Scheme I-2). 
The reactions can take place in organic solvents, at room temperature and sensing may be 
done in real time. The esterification between vinyl laurate and 1-propanol was 
investigated with ten different enzymes in a micro-titer plate and showed typical reaction 
kinetics as monitored by fluorometry. 
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Scheme I-2: Model reaction for the evaluation of synthetic activity of lipase and esterase. 
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3.2.2.3. Titration by adrenaline 
Wahler and Reymond85 developed a back-titration assay in which the product of 
an enzymatic reaction was oxidized by addition of a known amount of added periodate 
(NaIO4). Assays are selected to involve non-periodate-sensitive substrates. Thus, the 
excess of unreacted periodate is back titrated in a third step, by adding adrenaline 33, that 
reacts instantly with NaIO4 to form the red dye adrenochrome 34, quantified by optical 
density (Figure I-17).  
Despite the limitations of this method, which requires non-periodate sensitive substrates 
to be transformed into periodate sensitive products (or vice versa), the feasibility has been 
demonstrated in numerous examples involving vicinal diols, amino-alcohols, diamines 
and α-hydroxyketones as substrates or products.  
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Figure I-17: Back-titration of product formation by the adrenaline test. 
 
3.2.2.4. Intercalation into double-stranded DNA 
The group of Tolun86 recently introduced the fluorescent dye PicoGreen®, used to 
selectively quantify double-stranded DNA (dsDNA) in solution, using real-time nuclease 
assays. Upon intercalation into the double helix, the fluorescence of the dye increases. 
Progressive digestion of dsDNA results in decrease of fluorescence as the dye is released. 
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The substrate specificity is high with this method, as is sensitivity (substrate in picomolar 
range), and the family of nucleases wich may be sensed counts several members involved 
in disease. 
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Figure I-18: Schematic representation of real-time nuclease assay. Upon binding to dsDNA, PicoGreen® 
fluorescence increases. Then digestion of the double helix releases free nucleotide 5'-monophosphates and 
the poorly- fluorescent dye. 
 
3.2.2.5. Sensing the environment 
2-p-Toluidinylnaphtalene-6-sulfonate (2,6-TNS) is a compound that is hardly 
fluorescent in water, but whose fluorescence increases in a hydrophobic environment. 
Thus it may be used as a probe for proteins. The group of Sendra87, 88 developed a method 
to determine by flow-injection analysis the depolymerization of amylose (linear glucose 
polymer) and amylopectin (ramified glucose polymer) by α-amylase (endo-enzyme) and 
β-amylase (exo-enzyme) following the fluorescence of the 2,6-TNS-substrate complex. 
At constant average molecular weight of the polymer, the fluorescence intensity of the 
complex depends linearly on the polymer concentration, while at constant polymer 
concentration the fluorescence intensity of the complex depends nonlinearly on its 
average molecular weight. Assuming that one molecule attacked by β-amylase is almost 
completely digested into β-maltose, and new species do not originate from intermediate 
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molecular weight, Sendra et al. determined an equation describing the concentration of 
detectable substrate as a function of depolymerization time, and subsequently obtained 
the kinetics constants Km and Vm. Assuming that with high initial average molecular 
weight of substrate, the concentration of substrate attacked by α-amylase stays constant at 
the beginning of the reaction (reducing the average molecular weight), they also 
determined the constants Km and Vm for this enzyme.  
 
3.2.2.6. Template-directed excimer formation 
Czarnik developed in 199089 a method to sense enzymatic polyanion hydrolysis. 
He observed that DNA and RNA hydrolyses can be easily followed by monitoring the 
changes in their UV spectra, while the degradation of polyanions, such as heparin and 
polyglutamates, may only be indirectly monitored (often by radiolabelling) because of 
their lack of a chromophore. He reported in this paper89 that the formation of excimer 
from anthrylpolyamines 35 is promoted in presence of heparin and polyglutamates. 
Therefore titration (as monitored by fluorescence) of anthrylpolyamine with the 
polyanions led to a decrease in the characteristic peak intensity (422 nm) by increasing 
the guest concentration until a saturation point, and to a new emission peak at 510 nm 
(excimer of anthracene) simultaneously increasing. The method’s adaptability to enzyme 
sensing was demonstrated by following heparin and poly-L-glutamic acid 
depolymerization by heparinase and pronase respectively, adjusting the concentration of 
the probe that confers the minimum of fluorescence intensity as a result of excimer 
formation. Enzymatic hydrolyses of the polyanion template resulted in an increase of 
fluorescence intensity with time as a consequence of aggregation disappearance (Figure 
I-19). This method could be applied to a large variety of polyanions, as it is not necessary 
to induce excimers formation. Simple fluorescence quenching (as seen with double or 
single-stranded DNA) should be sufficient to follow polyanion fragmentation as a 
function of time-dependent fluorescence increase.  
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Figure I-19: Template-directed formation of excimers as an enzymatic sensor for polyanions.  
 
3.2.2.7. pM 
The group of Reymond has developed a fluorescent assay for enzymes that release 
weak copper or nickel ligands90 without any modification of the enzyme, substrate or 
product. The fluorescence of sensor 36, derived from quinacridone, is almost completely 
quenched in presence of a small amount of Cu2+ or Ni2+. Simple bidentate ligands, such as 
free amino acids produced by enzymatic reaction from nonchelating amide precursors, 
compete with 36 for metal coordination. This results in an increase in fluorescence 
proportional to amino acid concentration. The sensor 36 could be mixed with an enzyme 
assay for real-time sensing, but the organic solvent necessary to solubilize the sensor 
reduces the enzymes activity. This was overcome by addition of an aliquot of the reaction 
mixture (substrate, enzyme, buffer) at different times to a sensor containing solution 
(ligand, metal, solvent).  
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The solubility problem was surmounted a few years later91 with the discovery of 
the water-soluble calcein 37, whose fluorescence is also quenched by Cu2+. Real-time 
sensing was done in micro-titer plate with bovine serum albumin as the substrate and 
using subtilisin, elastase, trypsin, thermolysin, α-chymotrypsin and pepsin as proteases to 
demonstrate the feasibility of the method. The limitation of this method is the low 
sensitivity. The concentration of the amino acids should be around 10-3 M (Figure I-20). 
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Figure I-20: Schematic representation of pM assays for amino acids (AA) using copper-ligand (L) 
complexes. 
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4. Objectives 
The synthetic rigid-rod β-barrels developed within the Matile group had 
demonstrated the possibility of mimicking biological β-barrels, while keeping the aspects 
of functional plasticity associated with those occurring naturally. The intricate 
engineering of their internal nanospaces, provided by the cylindrical assembly, holds the 
key to their function as synthetic multifunctional pores. 
In order to enlarge the range of applications for these synthetic pores, as well as 
our understanding of the mechanism of pore formation in the bilayer membrane, we 
envisioned the introduction of an as-yet unused amino acid. Thanks to the properties of 
their guanidinium groups, arginine residues play an important role in numerous 
recognition and catalytic sites of natural proteins, as well as in the stabilization of 
secondary and tertiary structures of proteins. Therefore a rigid-rod β-barrel with Leu-Arg-
Leu-His-Leu peptidic strands was synthesized, and characterized in bilayer membranes. 
This pore was expected to act as an excellent host for anionic helical polypeptides. To 
exploit this predicted activity, studies on poly-glutamic acid recognition, stabilization and 
amplification were conducted. 
Initial results concerning the use of rigid-rod β-barrels as enzyme sensors had been 
encouraging. The scope and limitations of the sensors were therefore investigated further. 
The main goal being to develop a "universal sensor", applicable to enzyme or substrate 
screening using biologically relevant targets in a non-invasive manner. The objective was 
also to clarify the selectivity and sensitivity limitations of enzyme sensing with artificial 
pores.  
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Chapter II: RESULTS AND DISCUSSION 
1. Design and synthesis of a new artificial β-barrel  
α-Helix recognition, stabilization and amplification are important topics in 
bioorganic chemistry, as pointed out in Chapter I:2. Poly-glutamic acid (pE) is often the 
helix model chosen to study the different strategies adopted in this domain. As we have 
seen in Chapter I:1.2.3, the possibility to design the inner as well as the outer surface of 
the rigid-rod β-barrel pores is very attractive with regards to the different applications 
conceivable and the convenience of the synthesis. As the affinity of guanidinium cations 
for organic anions, such as carboxylates,92 is well established, arginine residues were 
introduced in the pentapeptide sequence to design a new interior pore. The second 
hydrophilic amino acid was kept as histidine to provide a pH gated pore, as well as 
catalytic properties previously demonstrated for the 8-LHLHL β-barrel 16.31, 33, 34 
Hydrophobic leucine residues were used to cover the outer surface and promote the 
incorporation of the pore into membranes. 
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Figure II-1: Designed rigid rod β-barrel 38. A: Anti-parallel β-strands are depicted with hydrophilic amino 
acids (one letter abbreviation) written white on black, hydrophobic amino acids written black on white and 
hydrogen bonds : dotted lines. B: Tetrameric self-assembly structure of 38 in lipid bilayer. C: Top view of 
the expected barrel with "H-R" dyads inside and leucines pointing outside. 
The synthesis and characterization of the barrel 38 made of LRLHL peptidic 
strands are presented in the following paragraphs, as well as its evaluation for α-helix 
recognition and further applications developed with regards to the properties pointed out 
for the new dyad "H-R". 
 
1.1. Synthesis 
The pentapeptide H-Leu-Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39 was synthesized in 
solution from the previously reported tripeptide33 H-Leu-His(Trt)-Leu-NH2 and using 1-
(3-dimethylaminopropyl)-3-ethyl-carbodiimide•HCl (EDC), 1-hydroxybenzotriazole 
(HOBt) and triethylamine (TEA) as coupling reagents. Arginine and histidine side chains 
were protected by acid labile groups 2,2,5,7,8-pentamethylchroman-6-sulfonyl (Pmc) and 
trityl (Trt) respectively. The N-termini of the intermediates were protected by 9-fluorenyl-
methoxycarbonyl (Fmoc, removal by Pd-catalyzed hydrogenation in methanol) in the 
case of histidine (deprotected by piperidine) and the other residues by benzyloxycarbonyl 
(Z, deprotected by piperidine). Isolation, purification and characterization were carried 
out for each intermediate.  
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Scheme II-1: Pentapeptide H-Leu-Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39 synthesis. a) EDC, HOBt, TEA, 
CH2Cl2, overnight, rt, 64%; b) piperidine 5% in DMF, 15 min, rt, 92%; c) EDC, HOBt, TEA, CH2Cl2 , 
overnight, rt, 60%; d) Pd/C, H2, MeOH, 4 h, rt, 93%; e) EDC, HOBt, TEA, CH2Cl2, overnight, rt, 93%; f) 
Pd/C, H2, MeOH, 4 h, rt, 91%; g) EDC, HOBt, TEA, CH2Cl2, overnight, rt, 84%; h) Pd/C, H2, MeOH, 4 h, 
rt, 80%.  
Pentapeptide 39 was coupled with the p-octiphenyl scaffold 40 (prepared 
following established protocol33) in the presence of HATU in DMF to give the protected 
peptide rod 41 in 66% yield after purification by PTLC. Deprotection of the peptide side 
chains of 41 with TFA gave quantitatively the final peptide-rod 8-LRLHL 38m.  
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Scheme II-2: Peptide coupling with octiphenyl acid stave. a) HATU, DMF, 3 h, rt, 66%; b) TFA, 1 h, rt, 
quantitative. 
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1.2. Mass spectroscopy 
Electrospray ionization mass spectrum as shown in Figure II-2 of the peptide-rod 
38m was carried out in MeOH-MeCN-H2O-AcOH = 50 : 37 : 12 : 1. Despite the peptide-
rod deprotection having been done in TFA and the presence of 1% acetic acid content in 
the ionization solvent, up to 6 phosphates were detected together with the peptide rod. 
This result points out the high affinity of guanidinium cations for phosphate anions, rather 
than carboxylates under these conditions.  
[M + 8H+ + 0-3 H3PO4]8+
[M + 7H+ + 0-4 H3PO4]7+
[M + 6H+ + 0-5 H3PO4]6+
[M + 5H+ + 0-5 H3PO4]5+
[M + 4H+ + 1-6 H3PO4]4+
*
**
 
Figure II-2: Electrospray ionization mass spectrum of 38m; (∗) peaks assigned with more complex counter 
anions combinations involving TFA (trifluoroacetic acid) and phosphates. 
Furthermore, those results corroborated data obtained by conductance experiments 
in planar bilayer93 carried out in our laboratory. Inversion of ion selectivity of the pore 
formed by peptide-rod 38m was observed at pH ~ 5 with permeability ratios changing 
from PCl- / PK+ = 0.5 at pH 6 to PCl- / PK+ = 3.8 at pH 4.0. Arginine residues are always 
protonated (pKa ~ 12.5) while histidines (pKa ~ 6.0) oscillate from neutral to positively 
charged in this pH range. The pKa of guanidinium-HPO42- complexes in the barrel are 
unknown, but it can be easily imagined to be different from pKa = 6.8 for HPO42- in 
water. Lehn94 reported a pKa = 4.8 for HPO42 in a hydrophobic solvent (MeOH-H2O = 9 : 
1) in the presence of non complexing tetramethylammonium cations. The inversion of ion 
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selectivity with pH may be explained by the binding of inorganic phosphates within pore 
38m, therefore providing an anionic interior at high pH, and a cationic interior at low pH, 
as drawn in Scheme II-3. 
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Scheme II-3: Binding of inorganic phosphates within pore 38, supporting the ion selectivity observed. Only 
the peptide sequence -RLH- is shown for clarity. 
 
2. Pore formation and characteristics 
The ability of the new peptide-rod 8-LRLHL 38m to form active pores was 
assessed in large unilamellar vesicles composed of egg yolk phosphatidylcholine (EYPC) 
loaded with the anionic fluorophore ANTS and the cationic quencher DPX (EYPC-LUVs 
⊃ ANTS/DPX). In these assays, the efflux of either ANTS or DPX through pores formed 
by 38m results in an increase in ANTS fluorescence intensity (Figure II-3). Upon 
nanomolar addition of 38m, an increase of the fluorescence emission intensity was 
observed, indicating the leakage of either ANTS or DPX from the vesicles. Taking 
advantage of the pH independence of the fluorophore ANTS, opposed to another common 
dye CF, ANTS/DPX leakage was studied at different pH to investigate the influence of 
the protonation state of the interior pore surface (Figure II-4) on the activity of 38m (fixed 
concentration of monomer Cm = 160 nM).  
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Figure II-3: Schematic representation of the EYPC-LUVs ⊃  ANTS/DPX assay. 
The pH profile was similar to that of barrel 16 with an all histidine interior.32 This 
precedent profile was rationalized by the Internal Charge Repulsion (ICR) Theory that 
assumes that the presence of internal charges on the interior surface is essential for the 
barrel open probability, preventing the collapse and maintaining the intratoroidal space. 
Despite the permanent protonation of arginines, the pH profile of barrel 38 was mainly 
regulated by the histidines, because of the weak electrostatic interactions of the 
guanidinium moieties.95 
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Figure II-4: pH Profile of pore 38 (Cm = 160 nM) determined using EYPC-LUVs ⊃ ANTS/DPX. 
 
To obtain information on the pore formation mechanism, the EYPC-LUVs ⊃  
ANTS/DPX leakage experiments were done varying the concentration of 38m.  
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Figure II-5: Relative ANTS emission intensity versus concentration of peptide-rod 38m at pH 4.5. 
The Michaelis-Menten like curve (Figure II-5) led to the conclusion that the 
formation of the β-barrel pore from 38m is highly favorable, i.e. that the pores are formed 
before they insert into the membrane. The rapid saturation observed is probably related to 
the precipitation of 38m, forming polymers of fibrils, as it was observed with the 
comparable peptide-rod 8-LHLHL 16m at a concentration above 3 µM.35 Prepore 
formation in solution leads to a rapid and high activity of the rod in membranes at low 
concentration. While further aggregation occurs in solution by increasing the rod 38m 
concentration, the effective concentration of pore in bilayer membrane reduces, thus 
limiting its activity in terms of vesicle leakage; this gives the saturation curve observed. 
Transmembrane orientation of the rod 8-LRLHL 38m was confirmed by 
fluorescence depth quenching in lipid bilayer (N. Sakai unpublished results). Based on 
evidence formerly collected on very similar artificial β-barrels in the group,28, 96-98 all the 
data presented on 38m corroborated the formation of active pores in spherical bilayer 
membranes and a mechanistic suggestion for the self-assembly of 38m into tetrameric 
rigid rod β-barrel 38 was proposed (Figure II-6).  
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Figure II-6: Putative mechanism for rigid-rod 38m self-assembly in aqueous solution, and the subsequent 
insertion in lipid membranes.  
 
3. Poly-glutamic acid recognition 
α-Helix recognition by barrel 38, designed to provide exalted carboxylate or 
phosphate binding sites on its inner surface, was explored. Poly-glutamic acid (pE) was 
chosen to conduct the studies firstly because its diameter roughly matches the inner 
diameter of the barrel and it has carboxylate groups to promote favorable electrostatic 
interactions, also its shape is either helical or random coiled depending on pH, and finally 
the helical form has a dipole moment. The influence of these different parameters on α-
helix recognition by β-barrel 38 is presented in the following studies. 
 
In order to assess the pE influence on the activity of pore 38, the leakage of 
EYPC-LUVs ⊃ ANTS/DPX was measured at a constant and high concentration of pore, 
sufficient to induce almost complete lysis of the vesicles. By then increasing the pE 
concentration until complete inhibition of the pore activity, Hill analyses of the dose 
response curves provided the dissociation constant KD via Equation 1: 
Dlog]blockerlog[
1log Knn
Y
Y −=−  Equation 1 
were Y is the fractional pore activity. At pH 4.5, in unpolarized membrane, as low as 400 
nM of poly-L-glutamic acid (pLE) was sufficient to suppress the activity of pore 38 
(Figure II-7) with a low KD of 150 nM. 
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Figure II-7: Changes in ANTS emission intensity (I = (It - I0) / (I∞ - I0)) over time during addition of 300 
nM 38m at 50 s and triton X at 250 s, and in presence of variable concentrations of pLE (from top to 
bottom: 0, 50 nM, 200 nM, 400 nM, 1000 nM), at pH 4.5. 
 
3.1. Anion recognition in unpolarized membranes 
Increasing pH results in the gradual deprotonation of α-helical poly L- or D-
glutamic acid (pLE, pDE), and thus in a conformational change from α-helical towards 
random coil because of the augmentation of intramolecular charge repulsion. From the 
circular dichroism (CD) spectra recorded for poly-L-glutamic acid (pLE) and poly-D-
glutamic acid (pDE) at different pH (Figure II-8), it was determined that half of the 
denaturation occurs around pH 5.2, meaning that above pH 5.5, the random-coiled 
conformation is predominant. Measuring KD of pE at different pH would thus allow us to 
associate the affinity of pE for pore 38 with either the helical conformation or the charges.  
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Figure II-8: A: CD spectra of pDE (solid line) and pLE (dashed line) as function of pH in buffer (10 mM 
MES, 100 mM KCl). For pDE, from top to bottom, pH 4.57, 4.75, 4.87, 5.00, 5.14, 5.32, 5.82, 7.07; for 
pLE, from bottom to top, pH 4.56, 4.74, 4.94, 5.10, 5.22, 5.64, 9.89. B: Fractional denaturation (fD) 
calculated from molar CD (∆ε) at 222 nm fD = (∆ε - ∆ε 4.5 ) / (∆ε - ∆ε ∞) and reported as a function of pH. 
 
The results obtained with pLE (Table II-1, entries 1-4) showed that the affinity for 
pore 38 increases with pH in unpolarized vesicles. Therefore the recognition is more than 
ten fold better for anionic random-coiled pLE than for neutral α-helix. As the histidine 
residues are gradually deprotonated within this pH range, we can claim that the barrel-
pLE recognition occurs mainly thanks to the carboxylates-guanidinium cations 
electrostatic interactions. 
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Table II-1: Dissociation constants (KD) of pE for pore 38 determined from Hill plots of ANTS/DPX 
leakage assays. 
Entry pH pE fDa V (mV)b KD (nM) 
1 4.5 L 0.0       0 150 
2 5.0 L 0.3       0   50 
3 5.5 L 0.8       0   45 
4 6.0 L 0.9       0   13 
5 4.5 D 0.0       0 100 
6 5.0 D 0.3       0   44 
7 5.5 D 0.8       0   30 
8 4.5 L 0.0 - 150   13 
9 5.5 L 0.80 - 150   48 
a Fractional helix denaturation calculated from CD spectra. 
b Nernst potential applied. 
 
3.2. Anion recognition in polarized membranes 
Membrane polarization was done following a procedure already described within 
our group99, 100 and adapted to the ANTS/DPX assays. EYPC-LUVs ⊃ ANTS/DPX were 
loaded with ANTS and DPX in KCl buffer while the outer KCl was exchanged on size 
exclusion chromatography column with isoosmotic NaCl to create Na+ and K+ gradients. 
Addition of the selective K+ ion carrier valinomycin created inside negative membrane 
potentials, and the potential V was assumed from previous calibration with the Nernst 
equation (in conditions applied: V = -150 mV). Polarization of the membrane was 
followed by the increase in the fluorescence emission intensity of Safranin O. Potential-
sensitive Safranin O and the ANTS dye were simultaneously monitored during the assays. 
After addition of pore 38, a rapid efflux of ANTS/DPX was observed while the 
membrane depolarization was slower. This delay underlines the unfavorable cations (Na+, 
K+) flux through the pore compared to the unhindered anionic ANTS flux (Figure II-9). 
Chapter II:  Results and discussion 
 II–43
Addition of pLE induced a reduction in the activity of pore 38 in polarized 
membranes, and KD’s were calculated as described in Chapter II:3.1 from ANTS emission 
dose response curves. At pH 4.5 a KD = 13 nM was determined in polarized vesicles ten-
fold less than that determined (KD = 150 nM) in unpolarized vesicles (Table II-1, entry 8 
versus entry 1). This supported a positive dipole-potential interaction between α-helical 
pLE and polarized membranes, and led to the conclusion that pore 38 recognizes the α-
helix in polarized membranes. This difference in KD difference also proves that pLE is 
bound to the active pore (i.e. inserted in the membrane) rather than to the inactive rod 38m 
aggregates or barrel in the external medium. As a consequence of this dipole-potential 
interaction the α-helix is oriented through the pore, with intravesicular N-terminus and 
extravesicular C-terminus in case of inside negative potentials.  
Similar KD’s were observed at pH 5.5 in both polarized and unpolarized 
membranes (Table II-1, entries 3 and 9). It corroborated the previous result of potential-
dipole dependence on α-helix recognition, because at pH 5.5, the pLE helix is almost 
denaturated (Figure II-8), and thus the dipole moment is reduced. Reduced dipole-
potential interaction and repulsion between the negative charges along pLE and the 
negative potentials inside the vesicles could be parameters explaining the identical KD’s 
observed at pH 5.5. 
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Figure II-9: A: Changes in ANTS emission intensity (I = (It - I0) / (I∞ - I0)) over time during addition of 
600 nM valinomycin at 50 s, 300 nM 38m at 250 s and melittin at 450 s, and in presence of variable 
concentration of pLE (filled circles: 0, filled triangles: 5 nM, empty triangles: 20 nM, empty circles: 50 
nM), at pH 4.5. B: Changes in Safranin O emission intensity recorded simultaneously and in the same 
conditions as described for A. 
 
3.3. Enantioselective recognition 
We were interested to see whether the introduction of arginine residues in the 
barrel could provide sufficient asymmetry to induce some chiral recognition of pE. Pore 
38 recognized slightly better pDE than pLE at pH 4.5, 5.0 and 5.5 (Table II-1, entries 1-3 
versus 5-7). So no obvious selectivity between the enantiomers was observed in both α-
helical or random-coiled shapes.  
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3.4. Comparison of the pore 42 with natural melittin 
In the following studies the pore 42 made from peptide-rod 8-LRWHV 42m was 
used. This pore was designed to explore the influence of the outer surface, while the 
interior was kept as pore 38 with "H-R" dyads that showed remarkable affinity for both 
carboxylate and phosphate anions (see above), esterase activity and a long lifetime as a 
single ion channel.101 Replacement of all L on the outer surface with LWV triad had a 
low impact on the interior functionalities as expected with the same interior surface. Thus 
pH profile, inversion of ion selectivity in planar bilayer and transmembrane orientation 
were comparable for pores 38 and 42. However the outer surface modification, with 
introduction of the LWV triad, had a big impact on the pore formation mechanism and 
partitioning in the lipid bilayer. Pore 42 was found to be more active in terms of dye 
leakage through spherical bilayer membranes, with undetectable prepore formation or 
fibrillogenis in solution102 deducted from fourth power dependence on monomer 
concentration. Therefore it was preferable to continue the studies in vesicles using pore 
42. 
In order to compare the activity as well as the sensitivity of the barrel 42 with a 
natural pore-forming compound, we selected the natural bee toxin melittin. Melittin is a 
26-residue polypeptide that has non-cell selective lytic activity. It has the sequence 
G*IGAVLK*VLTTGLPALISWIK*R*K*R*QQ-NH2 presenting six positive charges 
(marked by *) and is suspected of forming tetrameric aggregates in the membrane.103 With 
these similarities with the pore 42 the comparison is meaningful. Fluorescent dye efflux 
leakage through EYPC-LUVs ⊃ CF was the assay selected to compare the activity of the 
pores. Concentrations of the pores were adjusted to cause almost complete lysis of the 
vesicles within 200 s and were found to be almost similar. Then, as described in Chapter 
II:3.1 with EYPC-LUVs ⊃ ANTS/DPX assays, the recognition of pLE was measured as 
the ability of pLE to inhibit pore 42 or melittin activities. While 200 nM pLE inhibited 
completely pore 42 activity, up to 25 µM pLE did not affect the dye leakage through 
melittin. pLE Affinity for pore 42 is ten thousand times higher than for melittin (KD =15 
nM and 155 µM respectively) (Figure II-10) proving thus that the recognition is not only 
due to charge neutralization between host and guest but implies some more specific 
recognition such as shape fitting. 
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Figure II-10: Fractional pore activity Y of pore 42 (250 nM of rod 42m filled circles) and melittin (300 nM 
empty circles) versus pLE concentration. 
 
3.5. Conclusion 
A new rigid-rod β-barrel pore 38 was designed and successfully synthesized 
introducing for the first time arginine residues on the interior surface. Characterization of 
peptide-rod 8-LRLHL 38m by electrospray mass spectroscopy already underlined the 
affinity of guanidinium cations for phosphates anions. Further characterizations in 
spherical lipid bilayer demonstrated the formation of active β-barrels, and gave 
information on the mechanism. The pH profile (dye leakage activity measured at fixed 
rod concentration and variable pH) revealed the poor contribution of the charged 
arginines to the internal charge repulsions necessary to keep the pore open and 
emphasized the role of the histidines in generating a pH gated pore. Concentration 
dependence of pore activity on the concentration of the monomer 38m exhibited a so 
called "premature" saturation, i.e. with increasing monomer concentration the distribution 
is favorable to the solution rather than to lipid bilayer. 
Affinity of the guanidinium cations for carboxylates was determined by measuring 
the molecular recognition of poly-glutamic acid by pore 38 in the lipid bilayer and was 
remarkably in the nanomolar range. Further investigations with pLE and pDE 
demonstrated that pore 38 recognizes negative random coiled strands rather than neutral 
α-helices in unpolarized vesicles, but that α-helix recognition occurs with polarized 
membranes. The membrane polarization dependence proved the α-helix recognition by 
active pores inserted into membranes. 
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The significant comparison of the β-barrel pore with the natural pore forming 
melittin (both form tetrameric assembly in membranes, induce dye leakage and have 
almost the same number of positive charges) revealed the much larger affinity of pLE for 
the artificial pore than for the natural one, indicating that host-guest shape 
complementarity counts more than charge neutralization. 
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Figure II-11: Schematic representation of barrel 38. a) Self assembly of peptide-rod monomer 38m into 
"prepore" and b) polymers in solution. c) Barrel insertion in bilayer membrane. d) α-Helix recognition in 
polarized membrane. e) Anion recognition in unpolarized membrane. 
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4. Enzyme sensing 
4.1. Concept 
It is of interest to develop high throughput screening assays on enzymatic reactions 
to develop new useful tools in synthetic organic chemistry as well as in the field of drug 
discovery.  
Molecular recognition by rigid-rod β-barrels was explored with internally 
functionalized barrels. Studies on the very active pore 42 indicated its sensitivity (shown 
above with pLE) and that guests with slight structural changes block differently the same 
pore i.e. the binding constants (KD’s) are different. From these observations emerged the 
idea that the enzymatic conversion of a good pore blocker into a poor one (or a poor pore 
blocker into a good one) could be followed as pore activation (or inactivation) with time 
(Figure II-12). As ATP’s pore affinity was over thirty times higher than that of AMP and 
PP’s, conversion of adenosine triphosphate (ATP) into adenosine monophosphate (AMP) 
and pyrophosphate (PPi) by potato apyrase offered the possibility of being detected by β-
barrel 42. The procedure developed by Das and al104 is as follows: enzyme and substrates 
were incubated under the appropriate conditions, i.e. buffer, pH, temperature, 
concentrations. After a certain time of reaction, an aliquot of the reaction mixture was 
added to a solution of vesicles containing the self-quenched CF dye (EYPC-LUVs ⊃ CF). 
Addition of pore 42 induced dye leakage and an increase in the fluorescence intensity 
because of CF dilution (Figure II-13). The level of the emission intensity relates to the 
pore activity, which is dependent directly on the concentration of the pore blocker in the 
media. Repetition of this procedure at different time intervals during the enzymatic 
reaction led to a collection of data that linked the fractional pore activity YE with the 
reaction time. The plot of YE versus time revealed a progressive increase in pore activity 
proportional to the diminishing concentration of pore blocker (ATP). Sensing of aldolase, 
alkaline phosphatase and galactosyltransferase was achieved successfully in the same way 
so as to prove the feasibility of the method. 
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Figure II-12: Schematic representation of enzyme sensing with pore 42 exemplified with the conversion of 
ATP into AMP by potato apyrase, leading to enzymatic pore activation. 
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Figure II-13: Fluorometric detection of enzyme in the case of pore activation i.e. KD(substrate) < KD’s 
(products). Aliquot of the reaction mixture is added to a solution of EYPC-LUVs ⊃ CF followed by 
addition of pore. No increase in fluorescence intensity is observed at the beginning of the reaction because 
the CF emission is blocked by the substrate, while the disappearance of blocker at the end of the reaction 
leads to complete recovery of pore activity. 
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Presented with this simple and attractive system which does not require any 
labelling of substrate or enzyme, separation of the components in reaction mixture, or use 
of sophisticated instruments or reagents,105 we decided to further study and exemplify 
enzyme sensing with rigid-rod β-barrels. A selection of enzymes and biopolymers was 
made to prove the high-throughput and the versatility of the method, but also to determine 
its limits.  
Two different supramolecular assemblies 42 and 17 with cationic and anionic 
interior surfaces respectively were used to sense anionic, cationic and neutral polypeptide 
degradation by proteases, while the sensing of a large variety of useful enzymes was then 
demonstrated with the same β-barrel 42.  
A prerequisite to enlarge this method to other enzymes is to determine the 
affinities of all the components involved in the reaction, to identify the "barrel-preferred 
products and substrates", to verify the selectivity, and finally to adjust the concentrations 
to assure the detectability of the best barrel-blocker. The selectivity S can be defined as 
the ratio of the lowest KD among the substrates to the lowest KD among the products: 
)(
)(
min
)(
min
)(
productK
substrateK
S
monomerD
monomerD=  Equation 2 
Then S ≠ 1 insures a substantial differentiation in pore affinity between substrate 
and product required for enzyme detection. In the case of polymers, the KD per monomer 
has to be used to take into account the stoichiometry of the reaction.  
The calibration and calculation are described in the next section and given by the 
example of poly-L-glutamic acid (pLE) degradation by papain.  
 
4.2. Proteases 
Proteases counts for a very large amount of enzymes which "cleave peptide bonds 
that link amino acids together in protein molecules"* and are involved in physiological 
and pathological processes,106, 107 such as prohormones processes, blood coagulation, 
fibrinolysis, growth factors, protein activation etc. For example, the popular approach to 
Alzheimer’s disease is to find drugs that inhibit the catalytic site of the β-secretase 
enzyme (BSEC). BSEC cleaves the amyloid precursor protein into insoluble amyloid β-
peptides, that deposit into plaques responsible for the disease. 
                                                 
* http://www.jic.bbsrc.ac.uk/exhibitions/bio-future/glossary.htm#P 
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Poly-L-glutamic acid (pLE) was the substrate of choice to explore the possible 
detection of proteases because it has shown very good affinity for rigid-rod β-barrel 8-
LRWHV 42 (molecular recognition was in nanomolar range 14 nM and ten thousand 
times better than by the natural pore melittin). Similar experiments to those described in 
Chapter II:3.4 with entrapped CF in vesicles were done to determine the dissociation 
constant of L-glutamic acid (LE). Addition of up to 0.5 mM monomer LE did not affect 
the pore 42 activity, meaning that KD > 0.5 mM. Calculated selectivity S < 3 x 10-3 was 
undoubtedly good to ensure specific recognition of pLE by pore 42 during the reaction 
and detectability of its degradation into LE.  
The initial concentration of pLE for enzymatic degradation was carefully 
premeditated to give the desirable concentration c obtained after hundred fold-dilution for 
fluorometric measurement. c Should be higher than KD to assure a sufficient difference in 
pore activity between the beginning and the end of the reaction, but lower than the 
concentrations that give saturation of pore blockage, otherwise consumption of the 
polymer would not be detectable as progressive pore activation. A general rule can be 
proposed, and was followed except in mentioned cases: KminD ≤ c ≤ 10 KminD.  
As such 10 µM pLE and 2.64 u/mL∗ papain (cysteine endopeptidase from latex of 
the papaya) were incubated in 0.2 M NaCl, 1 mM EDTA, 5 mM cysteine, 10 mM 
HEPES, pH 5.0 at 37˚C.#108 For real time detection, aliquots of 20 µL of the reaction 
mixture were added at different points in time to a 2 mL fluorescent cell containing 
EYPC-LUVs ⊃ CF solution, and the activity of the pore 42 was measured (Figure II-14 
B). Concentration of pLE at the beginning of the reaction is therefore 100 nM in the 
fluorescent cell, corresponding to the relative pore activity Y = 0.05 i.e. almost complete 
inhibition of the pore (Figure II-14 A). In agreement with the degradation of a good pore 
blocker (pLE) into a poor one (LE), the ability of the reaction mixture to block β-barrel 
42 decreased with reaction time, reflecting enzyme activity (Figure II-14 C). The same 
procedure was done both with and without additional enzyme to ensure that the observed 
changes in pore activities were due to the enzyme activity.  
                                                 
∗ One enzyme unit is the quantity of enzyme needed to cause a reaction to process 1 micromole of 
substance per minute under specified conditions. 
(http://www.unc.edu/~rowlett/units/dictE.html#enzyme_unit) 
# Conditions inspired from the reference 
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Figure II-14: Detection of papain activity. A: Fractional pore activity Y in function of [pLE]. B: Incubation 
of 10 µM pLE with 2.64 u/mL papain in appropriate conditions described in the text. Change in CF 
emission are recorded in presence of aliquot of reaction mixture at reaction times of 0 (a), 20 (b), 50 (c), 
100 (d), 190 (e), 340 (f) and 430 (g) min. C: Fractional pore activity YE of pore 42 with reaction time at 
high (9.24 u/mL; filled circles), low (2.64 u/mL; empty squares) and no (X) enzyme concentrations. 
In a very similar manner, detection of pLE hydrolyses by pronase (streptomyces 
griseus protease), ficin (cysteine endopeptidase, a major proteolytic component of the 
latex of fig), elastase (from mammalian pancrease) and subtilisin (serine endopeptidase 
produced by various bacillus subtilis) (all have broad specificity) was successfully done 
under the appropriate reaction conditions. With all these enzymes progressive pore 
activation with reaction time was observed, as well as a completion-time dependant on 
the enzyme concentration, and no auto-hydrolyses confirmed with the controls without 
enzyme (Figure II-15 A-D).  
 
Chapter II:  Results and discussion 
 II–53
Table II-2: Proteases screening: 
En
try
 
Enzyme Pore 
Substrates 
(S) 
KD (S)a 
 in M 
KD(monomer)b
 in M 
Products 
(P) 
KD (P)a  
in M 
Sc 
1 Papain 42 pLE 1.4 x 10-8 1.3 x 10-6 LE >5 x 10-4 <3 x 10-3 
2 Pronase " " " " " " " 
3 Ficin " " " " " " " 
4 Elastase " " " " " " " 
5 Subtilisin " " " " " " ‘ 
6 Subtilisin " pDE 1.9 x 10-8 1.6 x 10-6 DE " " 
7 Papain 16 pLR 1.4 x 10-8 1.3 x 10-6 LR " " 
8 n.d. " pLK 1.1 x 10-8 1.5 x 10-6 LK " " 
a K
D
 determined from Hill analyses of dose response curves . 
b dissociation constant calculated per monomer, using average DP (degree of polymerization) specified by the supplier, K
D(monomer) 
= K
D
 / DP. 
c Sensitivity defined in Equation 2 
 
Subtilisin enantioselectivity was rationalized by Colombo et al.109, 110 using 
molecular dynamics and modelling experiments and was in agreement with experimental 
observation on the model study used, i.e. transesterification involving acylated vinyl 
acetate and racemic sec-phenethyl alcohol. Steric and charge factor differences between 
the (R) and (S)-sec-phenethyl alcohol due to the environment determined by the enzyme 
are shown to play an important role in asymmetric induction. We were curious to test a 
potential enantioselectivity of subtilisin towards poly-glutamic acid degradation. Not 
surprisingly, determination of the KD’s of poly-D-glutamic acid and D-glutamic acid 
(Table II-2, entry 6) showed affinities for pore 42 very close to those obtained with the L-
enantiomers, meaning that the detection of the enzymatic reaction is possible using this 
substrate. Incubation of pDE and subtilisin did not result in any pore activation within a 
reaction time ten times longer that the time necessary to completely digest pLE under the 
same conditions (Figure II-15 E, open triangles). pDE Was obviously not degraded by 
subtilisin. To test the potential inhibiting ability of pDE, mixtures of pDE and pLE in 
different proportions (molar ratio of pLE x = [pLE]/ ([pLE] + [pDE] = 0.75; 0.5, with 
total concentration [pDE] + [pLE] = constant) were then incubated with subtilisin. 
Fractional pore activities were expected to reach YE = 0.75 and 0.5 respectively for x = 
0.75 and 0.5 in case of total and selective degradation of pLE. 
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Following up to four days incubation, a fractional pore activity YE ≈ 0.3 was observed for 
the mixture x = 0.75, a value clearly below 0.75 with no detectable degradation of pLE 
noticed for x = 0.5, i.e. 1 : 1 mixture pLE-pDE. Apparently the poly-glutamic acid 
digestion by subtilisin is stereoselective and is slowed down considerably in the presence 
of pDE, which would mean that pDE inhibits pLE conversion and has a tighter affinity 
for subtilisin than pLE. 
Detectability of peptidic digestion was also exemplified with poly-cationic 
residues. As the interior surface of the self-assembly 42 composed of 8-LRWHV is also 
cationic, unfavourable electrostatic interactions prevent good recognition of cationic 
moieties. Therefore the cation selective37 rigid rod β-barrel 8-LDLDL 17 was introduced 
for enzymatic detection of cationic substrates. Internal aspartic side chain residues 
provide a negatively charged surface that recognized well poly-L-arginine (pLR) and 
poly-L-lysine (pLK) and did not detect the monomers L-arginine (LR) and L-lysine (LK) 
with comparable KD’s as determined for the couples pLE-pore 42 and LE-pore 42 (Table 
II-2, entries 7-8). Sensitivity values predicted no problematic detection with the 
conversion of pLR into LR, and that was experimentally confirmed by degrading pLR 
into LR by papain∗111 (Figure II-15 F). 
                                                 
∗ Experimental conditions inspired from 
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Figure II-15: Proteases screening; real time detection of pLE degradation by pronase (A), ficin (B), 
elastase (C) and subtilisin (D); pLE + pDE degradation by subtilisin (E); and pLR degradation by papain 
(F). Filled circles refer to high enzyme concentration, empty squares to low enzyme concentration and 
crosses to controls without enzyme, except for (E) were substrate is defined by x = [pLE]/([pLE] + [pDE]) 
= 1 (filled circles), = 0.75 (empty squares), = 0.5 crosses, = 0 (open triangles). 
 
4.3. Polynucleotides 
DNA exonuclease and DNA polymerase catalyze the degradation of double 
stranded DNA and the template-directed DNA growth respectively and are both widely 
used in biotechnology, for example in noteworthy DNA sequencing and amplification112, 
113 and in biology for DNA replication, repair and recombination.114 
DNA exonucleases III catalyze the excision of nucleoside monophosphates from 
3’-DNA termini, releasing nucleotide 5’-monophosphates. One specificity of this enzyme 
is to act only on duplex DNA while also being the major apurinic/ apyrimidinic DNA-
repair in Escherichia coli.115 This makes it interesting to study DNA structure and 
metabolism and it was thus selected as an example for rigid-rod β-barrel sensing. 
The copolymer duplex poly(deoxyadenylic acid, thymidylic acid) ([poly(dAdT)]2) 
is generally used as a model substrate of exonuclease III. It remains double stranded even 
after extensive hydrolyses, because of its alternating, repeating sequence and so can be 
hydrolysed to almost completion.116 
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Figure II-16: schematic 3’→5’ exonuclease action of DNA exonuclease III represented on dAdT 
copolymer duplex. 
To detect exonuclease III activity with the supramolecular assembly 42, KD’s both 
of the substrate [poly(dAdT)]2 and the products 2’-deoxyadenosine 5’-monophosphate 
(5’-dAMP) and 2’-deoxythymidine 5’-monophosphate (5’-dTMP) were determined. This 
was done following the method described in Chapter II:3.4, measuring the ability of the 
guests to block CF efflux from large unilamellar vesicles, through pore 42. Hill analyses 
from the dose-response curves obtained by varying [poly(dAdT)]2 concentration yielded a 
remarkable dissociation constant KD = 190 pM (Table II-3, entry 1). Monophosphate 
nucleotides 5’-dAMP and 5’-dTMP revealed 107 times poorer affinities for the same pore 
42. This considerable difference was not enough to allow the claim of detection of the 
reaction with the β-barrel 42 due to the fact that the hydrolysis of the duplex 
[poly(dAdT)]2 of high DP (~6175 bases per chain) yields a large number of free bases. 
The determination of KD(monomer) = 2.3 µM per monomer for the duplex and comparison 
with the products KD’s led to a selectivity S = 2.10-3 (Figure II-17 A) which revealed a 
considerable differentiation between substrate and products, and therefore unproblematic 
detection of exonuclease III by pore 42. 37 nM [poly(dAdT)]2 and 1.5 u/mL exonuclease 
III were consequently incubated in buffer (50 mM NaCl, 50 mM Tris-HCl, 3 mM MgCl2, 
1 mM β-mercaptoethanol, pH 8.0)∗113 at 37˚C. 20 µL of the reaction mixture were tested 
for pore blockage at different points in time and revealed an increase in the pore activity 
with reaction time, and complete hydrolysis of the duplex within 40 min. Attempts to 
decrease the enzyme concentration in the reaction mixture to reduce the reactivity failed, 
                                                 
∗ conditions adapted from 
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leading to the incomplete hydrolyses of the substrate, and stagnation of the fractional pore 
activity YE << 1 after 50 min reaction. The "lifetime" of the exonuclease used in these 
conditions was found to be about 50 min, which was also observed by Guo,112 who 
suggests the necessity to compensate the drop of the exonuclease III digestion rate by 
addition of fresh enzyme during the reaction in order to reach complete hydrolysis, 
especially in the case of long duplexes. A compromise between digestion rate and 
inactivation of the enzyme was found by decreasing the temperature of incubation to 
30˚C. The enzyme "lifetime" increased while the reaction rate decreased, but the 
proportions were sufficient to monitor complete [poly(dAdT)]2 digestion at two different 
enzyme concentrations (Figure II-17 C).  
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Figure II-17: Exonuclease III activity. A: Fractional pore blockage Y in function of substrates and products 
blockers concentration with [poly(dAdT)]2: filled circles per duplex, open squares per nucleotide; dAMP: 
crosses; dTMP: open triangles. B: Incubation of 37 nM [poly(dAdT)]2 with 0.416 u/mL exonuclease III in 
appropriate conditions described in the text. Changes in CF emission are recorded in presence of aliquot of 
reaction mixture at reaction times of 0 (a), 20 (b), 35 (c), 60 (d), 105 (e) min. C: Fractional pore activity YE 
of pore 2014 with reaction time at high (0.833 u/mL; filled circles), low (0.416 u/mL; empty squares) and 
no (X) enzyme concentrations. 
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Table II-3: DNA polymerase and DNA exonuclease: 
En
try
 
Enzyme Substrates (S) 
KD (S)a 
 in M 
KD(monomer)b
 in M 
Products  
(P) 
KD (P)a  
in M 
Sc 
1 
DNA 
exonuclease 
III 
[Poly(dAdT)]2 1.9 x 10-10 2.3 x 10-6 
5’-dAMP
5’-dTMP 
1.2 x 10-3
2.5 x 10-3 
2.0 x 10-3 
2 
DNA 
polymerase I 
dATP
dTTP 
2.9 x 10-5
n.d. 
 
[Poly(dAdT)]2
PPi 
1.9 x 10-10
1.0 x 10-3 
1.3 x 101 
n.d.: not determined 
a K
D
 determined from Hill analyses of dose response curves . 
b dissociation constant calculated per monomer, using average DP (degree of polymerization) specified by the supplier, K
D(monomer)
 = K
D
 / DP. 
c Sensitivity defined in Equation 2 
 
DNA Polymerase I of E. Coli catalyzes the addition of mononucleotide units of 
deoxynucleoside 5’-triphosphates to the 3’-hydroxyl terminus of a pre-existing chain, the 
primer. It was the first such enzyme to be discovered by Kornberg in 1956.117 The added 
nucleotide follows the Watson and Crick rules, pairing in response to a DNA chain called 
the template. Thus primer and template are necessary to initiate and direct DNA 
polymerization. Intact duplex and intact double-stranded DNA are inert for all 
polymerases. One exception of the absence of added primer or template chains is de novo 
DNA synthesis, reported with the so called "Kornberg fragment".118 The copolymer 
dAdT was synthesized both with and without [poly(dAdT)]2 as primer, by incubating the 
enzyme in the presence of 2’-deoxyadenosine 5’-triphosphate (dATP), 2’-
deoxythymidine 5’-triphosphate (dTTP) and MgCl2, and led in both cases to 
polymerization, but with a long lag period without any detectable reaction, followed by 
rapid synthesis of the polymer in the absence of primer. Up to 80 % of the 
deoxynucleosides 5’-triphosphates was consumed. Ten years later Klenow developed the 
conditions to obtain the same polymer [poly(dAdT)]2 in the presence of template, with the 
so called Klenow fragment,119 and claimed almost 100 % polymerization of the free 
acids.  
The commercial duplex [poly(dAdT)]2 presented characteristics that made it also 
suitable for template-primer function firstly because the flexibility of the two strands 
along each other and the mixture of different chain lengths might unpair some bases 
making thus a template, and also because the free 3’-hydroxyl end acts as primer. To test 
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polymerase I detectability with pore 42, template-primer strategy was adopted, by 
incubating enzyme, dATP and dTTP in appropriate conditions. Both Klenow and 
Kornberg fragments were tested, the Kornberg fragment because it is reported to catalyze 
de novo DNA synthesis, which could help the polymerization, and the Klenow fragment 
as it has a number of applications in biochemistry. 
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Figure II-18: Template directed chain elongation catalysed by DNA polymerase I. Single letter 
abbreviation is used: A for adenine, T for thymine and P for phosphate; hydrogen bonds between 
complementary nucleobases are depicted with dashed lines  
As is usual before starting the monitoring of an enzymatic reaction, the KD’s of 
both substrates and products were determined. KD’s of pyrophosphate (PPi) and dATP 
were measured, the KD of [poly(dAdT)]2 was already known and dTTP’s affinity for the 
pore was assumed to be about the same as that of dATP, on account of the similarity of 
the structures. Not surprisingly, two more phosphate moieties on dAMP giving dATP led 
to an increase in affinity for pore 42 of two orders of magnitude (Table II-3, entry 2). The 
contribution of released pyrophosphate during the reaction process was negligible. A 
sensitivity S = 13 >> 1, was calculated, indicating no differentiation problem in 
monitoring the polymerase reactivity. This did not reflect exactly the reality in this case 
as some template-primer, the best blocker among the substrates is added at the beginning 
of the reaction. In the case of polymerization, the conversion of poor pore blockers into 
good ones are identified by progressive pore inactivation with reaction time. A careful 
calculation had to be done to find each initial substrate concentration that would not block 
the pore at the beginning, and that would provide enough material to build up detectable 
pore blockers at the end of the reaction. From the fractional pore blockage Y plotted in 
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function of the analytes concentration, it was determined that 3.65 x 10-11 M 
[poly(dAdT)]2 should not affect the pore. Then comparing the curve of dATP with the 
curve calculated for the duplex, plotted per monomer was very convenient to determine 
the suitable initial concentrations of dATP and dTTP. Moving a vertical axis on the graph 
at the intersection with the dATP curve gives the initial pore blockage Y, observed in 
function of [dATP] + [dTTP] loaded, and at the intersection with the duplex/ per 
monomer curve the fractional pore blockage YE that will be found following 
polymerization. Thus, the best range of detectability (Y – YE as high as possible) was 
established with [dATP] = [dATP] = 2.5 x 10-6 M (Figure II-19 A). 
dATP, dTTP and duplex template-primer were incubated in buffer (KH2PO4 41 
mM, pH 7.5, previously reported conditions119) with either the polymerase I Klenow or 
Kornberg fragment and monitored at different points in time for pore 42 blockage. 
Known to have exonuclease activity, the Kornberg fragment showed at the beginning of 
the reaction a depolymerization of the template, followed by incomplete polymerization. 
Contrary to this, the Klenow fragment followed the forecast in terms of Y and YE 
predicted (Figure II-19 B) with nice kinetic curves (Figure II-19 C). 
The sensitivity of this method should be underlined. We were able to monitor the 
degradation and the formation of as low as 370 pM [poly(dAdT)]2. Furthermore, the 
polymerization of the copolymer dAdT was done with two thousand one hundred times 
less template-primer (comparison done from ratio: template / nucleobases) than reported 
by Klenow.119 
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Figure II-19: Detection of Polymerase I Klenow activity. A: Fractional pore activity Y in function of 
substrates and products blockers concentration with [poly(dAdT)]2: filled circles per duplex, open squares 
per nucleotide; dATP: open triangles; PPi: crosses. B: Incubation of 3,65 nM [poly(dAdT)]2, 0.25 mM 
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dATP, 0.25 mM dTTP with 125 u/mL polymerase I Klenow in appropriate conditions described in the 
experimental part. Changes in CF emission are recorded in presence of aliquot of reaction mixture at 
reaction times of 0 (X), 0.16 (●), 0.41 (□), 0.92 (▲), 2.25 (∆), 4.6 (♦), 24 h (◊). Curves for full pore 
blockage (dashed line) and no blockage (solid line) are also ploted. C: Fractional pore activity YE of pore 42 
with reaction time at high (125 u/mL; filled circles), low (30 u/mL; empty squares) and no (X) enzyme 
concentrations. 
 
4.4. Polysaccharides and screening of inhibitors  
To exemplify the application of "β-barrels as enzyme sensors" method to 
polysaccharides, we choose three biologically interesting polymers, and their 
corresponding digesting enzymes and we tested the capacity of the supramolecular-
assembly 42 to monitor the reactions. 
 
Hyaluronic acid (HA) is a linear polysaccharide composed of N-acetyl-
glucosamine (GlcNAc) and D-glucuronic acid (GlcA) with the repeating structure …D-
GlcNAc-(1,4)-D-GlcA-(1,3)…disaccharide units. HA is ubiquitous in the organism and 
plays important biological roles.120 It is found in all connective tissues as a major 
component of the extracellular matrix and in the vitreous body of the eye. It is also used 
in plastic surgery due to its viscoelastic properties. Hyaluronidase is an endoglycosidase, 
which randomly cleaves internal 1,4-glucosidic bonds in HA. The enzyme is 
administrated prior to or simultaneously with a fluid that has to be delivered intradermally 
in a large volume when intravenous injections are contra-indicated.  
This facilitates the passage of the fluid through the derma.121, 122 The hyaluronidases of 
mammals hydrolyze the β-1,4 bonds to yield tetrasaccharides (Figure II-20) while 
enzymes from bacteria hydrolyze the same bonds resulting in disaccharides.123  
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Figure II-20: Depolymerization of hyaluronic acid by mammalian enzyme. 
The ability of hyaluronic acid to block the pore 42 was tested with EYPC-LUVs 
⊃ CF and showed a notable KD = 160 pM. As the product of degradation is not 
commercially available, we were unable to measure its affinity for the pore. However 
thanks to our previous experience with the unproblematic degradation of [poly(dAdT)]2 
(also of high molecular weight) we assumed that the differentiation between substrate and 
products should not be problematic in the present case. Hyaluronic acid (1.4 x 10-7 M) 
was incubated with bovine testes hyaluronidase in 0.15 M NaCl, 0.1 M NaH2PO4, pH 5.3 
at 30˚C.124 The ability of the reaction mixture to block the pore was checked at different 
points in time and showed progressive and complete activation of the pore with time, 
revealing the feasibility of the method in the case of hyaluronic acid and demonstrating 
the sufficient selectivity (Table II-4, entry 2).  
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Table II-4: Polysaccharides: 
En
try
 
Enzyme 
Substrates 
(S) 
KD (S)a 
 in M 
KD(monomer)b
 in M 
Products  
(P) 
KD (P)a  
in M 
Sc 
1 Hyaluro-nidase HA 1.6 x 10
-10 2.0 x 10-6 Tetra-saccharide n.d. n.d.
 
2 Cellulase β-D-glucan 5.3 x 10-7 1.8 x 10-3 Glucose > 1 < 1.8 x 10-3 
3 Ficin cellulase 12 mg / L   n.d.  
4 Heparinase heparin  4.9 x 10-8 4.9 x 10-7 ∆4,5 U n.d. n.d. 
n.d.: not determined 
a K
D
 determined from Hill analyses of dose response curves . 
b dissociation constant calculated per monomer, using average DP (degree of polymerization) specified by the supplier, K
D(monomer) 
= K
D
 / DP. 
c Selectivity defined in Equation 2 
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Figure II-21: Fractional pore activity YE of pore 42 with reaction time during incubation of hyaluronic acid 
with high (solid circles, 0.0240 u/mL) and low (empty squares, 0.0171 u/mL) concentrations of 
hyaluronidase. 
Cellulose is a linear polysaccharide of glucose residues linked by β-1,4 bonds and 
is found in the cell walls of plants. It is the most abundant compound in nature found as a 
source of food, fuel and chemicals. However its usefulness depends upon its hydrolysis to 
glucose, which is done by cellulases, enzymes mainly present in fungi and bacteria. 
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However the substrate, cellulose, is not water soluble because of the linearity of the 
chains and the hydrogen bonds that pack it. Another polymer, barley β-D-glucan,125 can 
be used to study the activity of cellulase because it consists of β-1,4 and β-1,3 linkages 
(3:1) that renders it water soluble by introducing some ramification, thus breaking 
hydrogen bonds.  
β-D-Glucan is a hydrophilic, neutral polymer. It revealed a KD = 5.3 10-7 M = 
0.302 mg/mL as a blocker of the self-assembly 42, measured with conventional 
fluorescent EYPC-LUVs ⊃ CF assays. Attempts to degrade it by cellulase following the 
conditions described by Henrissat126 did not result in pore activation. It became apparent 
that the enzyme was also acting as a pore blocker in the medium. A KD = 0.012 mg/mL 
confirmed the necessity to optimize the assay to get selective detection of the substrate. 
One way is to reduce the enzyme concentration to avoid pore blockage by the enzyme, 
but the ratio of substrate to enzyme is then too low to observe β-D-glucan degradation. 
The ratio of β-D-glucan to cellulase used by Henrissat126 equals ten while under our 
conditions it should be higher than five hundred to avoid the cellulase blockage (Figure 
II-22). Therefore we envisaged the degradation of the cellulase by a protease prior to the 
fluorescent measurement. Among the proteases already described, ficin was found to 
convert cellulase into a poor pore blocker. Once the conditions were set, the two steps 
were coupled, but again no pore activation was observed, despite the fact that cellulase 
was no longer acting as a pore blocker. Further investigation of the reaction conditions 
were complicated by the fact that any modification of the first step with cellulase was 
reflected in the second step with ficin, and ficin’s activity depended on the new 
conditions; therefore controls had to be put in place before coupling the two steps. Also 
poor sensitivity in this case, with the relatively high amount of polymer necessary to be 
detectable by the pore (due to relative high KD), increased the difficulty in terms of the 
solubility of the substrate and the high amount of enzymes required. Finally the enzyme 
was demonstrated by Henrissat126 to have no effect on the β-1,3 linkages, which could 
lead to good blocker products undistinguishable from the substrates and might thus 
explain the undetectable change of the lytic activity of the pore. For these reasons, we did 
not further investigate the depolymerization of cellulose. 
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Figure II-22: Fractional pore activity Y in function of cellulase (empty squares) and β-D-glucan (filled 
circles) concentrations. 
 
Heparin was discovered in 1916 by Jay McLean.127, 128 The structure was 
elucidated by Perlin et al.129 in 1968 using NMR spectroscopy. It is a complex linear 
polymer comprised of a mixture of sulphated polysaccharide chains of different lengths of 
variable sequences. A heparin molecule consists of the repetition of a basic disaccharidic 
motif which includes an uronic acid and a glucosamine. The nature of the uronic acid (D-
glucuronic, or L-iduronique) and that of the unit of glucosamine (N-acetyl, N-sulfonato, 
free amine), as well as the position of the ester sulphates carried by these 
monosaccharides result in the need to consider the presence of a large number of basic 
disaccharidic structures. The disaccharide  →4)-(L-iduronic-2-O-sulfo acid)-(1-4)-(6-O-
sulfo-2-N-sulfo-α-D-glucosamine)-(→  represents more than 80% of the structure (regular 
structure). Heparin is a substance that prevents blood coagulation and prevents the 
agglutination of the platlets; moreover, it is able to support the resorption of a clot. It’s 
widely used for these purposes, but it has been shown in recent years to have a large 
number of potential therapeutic applications in the treatment of cancer, both viral and 
bacterial infections, Alzheimer’s disease…The remarkable anticoagulant activity is no 
longer the only attraction, and the discovery and development of heparin mimics is now 
of great interest.130, 131 
Among the heparinases, heparinase I (heparin lyase I) has been widely studied and 
characterized, and is used in diverse applications. Heparinase I cleaves the α(1→4) bond 
in the major sequence between the glucosamine and the L-iduronic acid moieties (Figure 
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II-23). The mode of action is random endolytic, producing a complex mixture of ∆4,5 
unsaturated polysaccharides (∆4,5 U).132  
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Figure II-23: Structure of heparin, heparinase I (heparin lyase I) cleavage site specificity, and ∆4,5 
unsaturated products structure. 
Low molecular weight heparin (MW ≈ 3000) was used, and was at first tested for 
pore 42 inhibition. A KD of 49 nM was determined, corresponding to the lowest KD per 
monomer measured, which is thought to reflect the high density of negatively charged 
sulfonate and carboxyl groups. Heparin has the highest negative charge density among all 
biomolecules known.129 Heparin (10.6 µM) was incubated with heparinase I at rt, in 
buffer (0.15 M NaCl, 10 mM HEPES, 5 mM CaCl2, pH 7.5). The pore blockage induced 
by the reaction mixture was examined at different points in time and revealed a 
progressive increase in pore activity with time, suggesting the degradation of the polymer 
(Figure II-24).  
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Figure II-24: Detection of heparinase I activity: fractional pore activity YE of pore 42 with reaction time for 
high (50 u/mL; filled circles), low (12.5 u/mL; empty squares) and no enzyme (X) concentrations. 
With the capability to now follow heparinase I activity in hand, it was of interest to 
screen inhibitors of this enzyme. Indeed heparinase inhibitors might be heparin mimics 
with a potential use in the inhibition of tumor metastasis, arteriosclerosis and 
inflammation.133, 134 To determine possible competitive inhibitors, the reaction conditions 
were standardized. Concentrations of heparin and heparinase I were fixed, while the 
amounts of tested molecules incubated were varied. The measurements of the fractional 
pore activity YE were done once per reaction mixture at the same reaction time t, before 
complete depolymerization of the control (heparin and heparinase are incubated in 
parallel as control of the enzyme reactivity). Measuring YE after completion of the control 
degradation may lead to wrong results, as the lapse of time from when the control is 
finished might be enough to compensate for the slower reactivity in the presence of 
inhibitor, and thus giving the same YE for both samples. Comparing the progression of 
heparin degradation in the inhibitor-containing mixture with the control was a rapid 
assessment of the inhibitory effect. In case of the reduction of heparinase activity in the 
presence of an external compound, the molar ratio of inhibitor to heparin was then varied 
to verify inhibitor concentration-dependent inhibition, and thus prove the effect of the 
tested molecule. 
To improve the speed of the method, as well as its sensitivity, the initial 
concentration of heparin was reduced to 3.3 µM. This corresponds to a concentration 
lower than the KD for the pore blockage measurement, where the slope on the fractional 
pore activity curve in function of the blocker concentration is maximum, and means that 
even a small drop in heparin concentration leads to a big change in fluorescence intensity. 
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We selected anionic compounds to test as inhibitors. Poly-L-glutamic acid and the 
p-octiphenyl stave bearing eight carboxylic acid moieties 40 were readily available and 
highly negatively charged. A known inhibitor trypan blue135 43 was also tested as a 
positive control of the method.  
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Figure II-25: Structure of the heparin inhibitors tested. 
Not surprisingly, the affinities of the tested molecules for the barrel 42 were in the 
range of heparin. As the success of the method rests on the specific detection of heparin 
degradation, the amount of barrel used was adjusted for each measurement, depending on 
the concentration of the co-substrate to compensate for its blockage. For example, 
incubating heparin and pLE in a one to one ratio leads to [pLE] = 33 nM during the 
EYPC-LUVs ⊃ CF assay and reduces the CF leakage through the pore. At first a 
reference curve was recorded, consisting of EYPC-LUVs ⊃ CF in solution followed by 
addition of the standard rod 8-LRWHV 42m concentration (250 nM, Figure II-26 B), and 
finally lysis by triton X. The emission intensity relating the lysis caused by pore 42 is 
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noted Ip. Then 33 nM pLE was mixed with EYPC-LUVs ⊃ CF vesicles in a cell and the 
rod 8-LRWHV 42m was added stepwise (Figure II-26 B1, B2) until the observed leakage 
intensity I ≈ Ip. Representative reference and calibration curves are shown in Figure II-26. 
The total concentration of barrel Cp required was then used for all the measurements 
related to this particular case of pLE : heparin 1 : 1. Three curves for each set were 
necessary: the initial control at t = 0 before the incubation starts, one at reaction time t, 
and one at t = ∞ i.e. the calibration curve reflecting complete hydrolyses of heparin. For 
each set of curves, t = 0 and t = ∞ are actually two controls that have to be comparable 
with the similar one obtained for the control (without inhibitor) before continuing the 
measurements, otherwise the calibration done to obtain Cp is not correct. If not, the 
measurement at t can be done and the emission intensity Iit obtained in the presence of 
inhibitor is compared with that of control without inhibitor Ict. If Iit < Ict then the co-
substrate slows down the progression of heparin degradation.  
A stoichiometric mixture of pLE and heparin did not give any indication of 
heparin degradation by heparinase after t = 2h. A progressive decrease of the pLE ratio 
compared with heparin resulted in reduced heparinase inhibition in a dose-dependent 
manner (Figure II-27). Fractional pore activities YE were then calculated for each set of 
experiments, to determine finally the percentage of inhibition %I following Equation 3: 
100   I % ×−= c
E
i
E
c
E
Y
YY
 Equation 3 
were YcE = YE without inhibitor (control) and YiE = YE in presence of inhibitor. 
The p-octiphenyl rod 40 was tested in the same way. Up to three molar equivalents 
of 40 did not show any inhibitory activity of heparinase. We did not attempt to augment 
the ratio of 40, as the goal was to find heparin mimics with comparable or better affinity 
for heparinase. Finally the known inhibitor trypan blue 43 was, as expected, found to 
inhibit heparinase in a dose-dependent manner.  
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Figure II-26: Representative reference (solid line) and calibration (dashed line) curves, in the case of [pLE] 
= 33 nM for the adjustment of barrel concentration to measure co-substrate inhibition.  
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Figure II-27: Representative curves of fractional emission intensity I monitored for t = ∞ (calibration, solid 
line), for t = 0 (initial control, dotted line) and for t = 2h (reaction, dashed line) for four sets of experiments: 
a control and three different concentrations of pLE. 
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Figure II-28: Percentage of inhibition observed for heparin degradation by heparinase in presence of pLE, 
8-COO- 40 and trypan blue 43.  
 
Hyaluronidase and heparinase I were sensed successfully by rigid-rod β-barrels 
while cellulase activity could not be followed because of its affinity for the sensor. An 
inhibitor screening method was developed to rapidly indicate heparinase inhibitors. From 
this method poly-L-glutamic acid was found to have an excellent inhibitory effect on 
heparinase I.  
 
4.5. Determination of the selectivity using glycolytic enzymes 
The concept of "rigid-rod β-barrels as enzyme sensors" is based on the ability of 
the pore to distinguish the substrate from the product or vice-versa, in terms of molecular 
recognition. It is of interest to develop a sensor with a very good selectivity i.e. one that 
differentiates between a substrate and product with very similar KD’s. Two approaches 
can be imagined to elaborate on sensor selectivity. The assay itself can be designed to 
satisfy this demand, or the internal surface of the pore can be altered to improve upon the 
selective detectability. In the latter case, the design of a specific sensor for a particular 
reaction or enzyme destroys its primary objective of having a broad spectrum of 
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application. Therefore the development of an assay format is important to satisfy the 
selectivity requirement with respect to each pore. In order to introduce a palpable value 
that would characterize the pore, the selectivity S was defined as 
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monomerD=  Equation 2  
The purpose of the following study discussed below was to determine a value of S 
beyond which the differentiation between substrates and products is no longer possible 
with the barrel 42. 
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Figure II-29: First stage of the glycolytic pathway: conversion of glucose into fructose 1,6-biphosphate in 
three steps. 
Glycolysis offers an interesting pool of enzymatic reactions involving slight 
structural changes of the participating components. The study on selectivity was thus 
undertaken with hexokinase, phosphoglucose isomerase and phosphofructokinase, all 
important enzymes in controlling energy metabolism.136 
Hexokinase acts as the first enzyme in the process of glycolysis by converting α-D-
glucose and ATP into glucose-6-phosphate (G-6-P) and adenosine 5’-diphosphate (ADP) 
in the presence of Mg2+. It was clear that the phosphate moieties would influence the 
molecular recognition by the self-assembled 8-LRWHV, because of the dyad "RH" 
placed on the interior surface of the barrel. Affinities of all four analytes were determined 
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with EYPC-LUVs ⊃ CF assays, whith the progressive increase in guest blocker resulting 
in the decrease of dye leakage. As the enzyme hexokinase requires Mg2+ in order to be 
active, the cation had to be considered during the measurement of ATP and ADP 
dissociation constants. Indeed, the delicate differentiation between ATP and ADP can be 
upset by the complexation of Mg2+ as they do not bind the cation with the same apparent 
dissociation constant.137 With the knowledge that Mg2+ binds ATP and ADP differently, 
and knowing that an excess of the cation would probably lead to a total neutralization of 
the ATP and ADP charges, destroying chances to differentiate between the two 
components, the Mg2+ concentration was optimized to one equivalent (taking the 
nucleotide as reference). Hill analyses of the dose response curves with Mg-ATP and Mg-
ADP revealed KD’s of 82 and 250 µM respectively, corresponding to S = 0.27. Would the 
selectivity of pore 42 be sufficient to take up the challenge of hexokinase detection with S 
= 0.27 ??   To address this question, the Mg-ATP conversion into Mg-ADP was simulated 
by measuring the activity of the pore, as described above, in the presence of both 
nucleotides by keeping the total concentration constant, while varying their relative 
proportions. The total concentration was optimized to give the most accurate fluorometric 
measurement. It corresponded to a concentration of 80 µM of Mg-ATP, causing 
incomplete pore blockage and leading to incomplete pore activation after its total 
conversion into Mg-ADP (Figure II-30 A). The simulated fractional pore activities Y 
plotted in function of the molar ratio x resulted in a linear curve with a slope of 0.37 
(ideal: 1.0) (Figure II-30 B, solid line). This simulation informed us of the possibility to 
detect hexokinase activity with the β-barrel 42. Moving forward a step, α-D-glucose, 
ATP, Mg2+ and hexokinase were incubated and the ability of the reaction mixture to 
block the pore was determined at different points in time. The fractional pore activity YE 
increased with reaction time, consistent with the progressive conversion of Mg-ATP into 
Mg-ADP, and the rate of the reaction was dependent on the concentration of hexokinase 
(Figure II-30 C).  
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Figure II-30: Development of hexokinase assay. A: EYPC-LUVs ⊃ CF assay in presence of a) pore 42; b) 
pore + 80 µM Mg-ADP; c) pore + 80 µM Mg-ATP; d) background. B: Simulation mixing curves; fractional 
pore activity Y versus molar ratio of ADP (filled circles, x = [ADP] / [ADP] + [ATP] with [ADP] + [ATP] = 
constant) or of F-6-P (empty triangles, x = [F-6-P] / [F-6-P] + [G-6-P] with [F-6-P] + [G-6-P] = constant). 
C: Fractional pore 42 activity YE with reaction time at high (0.26 u/mL; filled circles) low (0.1 u/mL; empty 
squares) and no (X) hexokinase concentrations. 
As a result, it was apparent that the selectivity of pore 42 was sufficient to follow 
assays characterized by a selectivity S = 0.27. Conversion of ATP into the very similar 
ADP derivative was sensed in the presence of other analytes. 
 
Table II-5: Glycolyses: 
En
try
 
Enzyme Substrates (S) 
KD (S)a 
 in M 
Products 
(P) 
KD (P)a  
in M 
Sc 
1 Hexokinase 
Mg-ATP
Glucose 
8.2 x 10-5
> 1 
Mg-ADP
G-6-P 
2.5 x 10-4
1.9 x 10-3 
0.27 
2 Phosphogluco isomerase G-6-P 1.9 x 10
-3 F-6-P 2.6 x 10-3 0.73 
3 phosphofructokinase 
Mg-ATP
F-6-P 
8.2 x 10-5
2.6 x 10-3 
Mg-ADP
FBP 
2.5 x 10-4
6.2 x 10-4 
0.27 
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In the glycolytic pathway, another enzyme, phosphofructokinase, provides us with 
a similar scenario, with the conversion of fructose-6-phosphate (F-6-P) into fructose-1,6-
biphosphate (FBP) taking place in presence of Mg2+ and ATP. Again, the best blockers 
amongst the substrates and products were Mg-ATP and Mg-ADP, but in this case, the 
analytes were better blockers than those in the hexokinase assay, and thus the level of 
difficulty increased slightly. As the simulation became more complicated, now with five 
analytes (ATP, ADP, Mg2+, F-6-P, FBP) to consider in the mixing curve, the feasibility of 
the method was assessed experimentally by incubating the substrates with 
phosphofructokinase in appropriate conditions138 and by measuring the fluorescent 
emission of aliquots. A progressive pore activation with reaction time was observed, as 
well as an enzyme concentration dependence on rate (Figure II-31).  
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Figure II-31: Detection of phosphofructokinase activity. A: Incubation of 8 mM F-6-P, 8 mM MgCl2, 8 
mM ATP and 1 u/mL phosphofructokinase. Changes in CF emission are recorded in presence of 20 µL of 
reaction mixture at reaction times of 0 (a), 0.5 (b), 0.833 (c), 1.16 (d), 2.16 (e), 3.75 h (f). Curve for free 
pore is also plotted (dotted line). B: Fractional pore 40 activity YE with reaction time at high (1 u/mL; filled 
circles), low (0.5 u/mL; empty squares) and no (X) enzyme concentrations. 
 
Another attractive challenge was offered with the second step of the glycolytic 
pathway involving phosphoglucose isomerase. Reasonably close KD’s were determined 
for the two isomers glucose-6-phosphate and fructose-6-phosphate (F-6-P) with a 
selectivity S = 0.73. Optimization of the assay conditions and simulation of the variations 
of the pore activity during the isomerization with a substrate / product mixing curve did 
not give much hope for the feasibility of the method. Although the pore activity was 
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linearly dependent on the molar ratio of F-6-P, the changes although detectable, were 
very small (slope= 0.16, Figure II-30 B, dashed line). Detection of the activity of the 
enzyme was not possible in this case, because the error level would have been too high to 
obtain accurate values during the isomerization process.  
 
It was therefore clear that the selectivity of pore 42 was not sufficient to follow 
assays characterized by a selectivity S = 0.73. From these studies on the selectivity carried 
out using the glycolytic enzymes, practical information relating to the selectivity of pore 
42 was obtained. Enzymatic assays involving numerous analytes, and characterized by a 
selectivity S = 0.27 can be sensed with β-barrel pores, while a selectivity S = 0.73 is 
problematic.  
 
4.6. Determination of sucrose content in drinks 
Hexokinase is relatively unselective and catalyses the transfer of the phosphate 
group from ATP to hexoses such as D-glucose, D-fructose and D-mannose, but not to D-
galactose or D-xylose, and neither to the disaccharide maltose nor the sucrose139 (see also 
experimental).  
Invertase, another enzyme, splits the sucrose (what is known as household sugar, a 
disaccharide consisting of glucose and fructose molecules joined together, also called 
saccharose) into glucose and fructose. Developing an assay combining the two enzymes 
invertase and hexokinase would allow for the quantification of saccharose in drinks or 
other products.  
The assay was first developed with a solution of known concentration of 
saccharose, to find the best conditions for both enzymes, and was then used for the 
quantification of sugar in drinks. Invertase deals with substrates and products that are 
very poor blockers of pore 42, so the conversion of sucrose into glucose and fructose is 
not detectable as an enzyme-gated pore. The products must be converted into their 
phosphorylated derivatives, with assurance of completion, in order to sense invertase 
activity. Therefore the method was initially developed using hexokinase. As the scope of 
detection of hexokinase is limited by the selectivity of the pore (Chapter II:4.5), the 
concentrations of the detectable analytes i.e. Mg-ATP and Mg-ADP must be kept 
optimized in the range of 0-8 mM. The principle behind the determination of the sucrose 
level is that it is split into glucose and fructose which are then phosphorylated by ATP. 
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The initial concentration of ATP is kept constant C = 8 mM, while the sucrose 
concentration S is of course variable, but is adjusted by a dilution series (x is dilution 
factor) in the range of C. Thus two cases must be considered (Figure II-32). If S > C/2, 
glucose and fructose are in excess compared to Mg-ATP which is completely consumed, 
and no calculation of S is possible. Whereas if S < C/2, Mg-ATP is in excess and its 
fractional conversion into Mg-ADP is detectable and quantifiable, because it was shown 
that the fractional pore activity Y is linear with [Mg-ADP] (Figure II-30 B, solid line). 
 
Sucrose
S  > C/2
S  < C/2
Glucose   +   Fructose
     S        +       S 
  S        +       S
Mg-ADP   +   G-6-P 
                  +   F-6-P
 
   C 
   2S
Invertase Hexokinase
[Mg-ATP] = C
Aliquot 20 mL
CF assay
Mg-ADP   +   G-6-P
                  +   F-6-P
  
   C /100
   2S /100
 
Figure II-32: Principle of sucrose determination by using enzymatic tools. C refers to the concentration of 
Mg-ATP added for the second reaction, and S refers to the unknown concentration of sucrose in a sample to 
measure. 
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Figure II-33: Enzymatic reactions for sucrose determination. 
The incubation of fructose, glucose, or the two mixed together (total is 8 mM or 
above) with 8 mM Mg-ATP and 1.85 u/mL hexokinase during 30 min in buffer Bhexo 
(Tris-HCl 100 mM, pH 8.0, 30˚C) resulted in the reproducible and complete conversion 
of Mg-ATP into Mg-ADP. Subsequent efforts were focused on invertase and on the 
combination of the two enzymes, running under different conditions. The incubation of 
40 mM saccharose with 12.4 u/mL invertase at 55˚C during 45 min in buffer Binv (NaOAc 
50 mM, pH 4.5),140 followed by the addition of Mg-ATP, hexokinase and buffer Bhexo 
(100 mM Tris-HCl, pH 8.0, to then run hexokinase in the appropriate concentration and 
buffer conditions) with incubation proved to be good conditions for the completion of the 
reactions of both enzymes.  
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To measure the error level of the method, a stock solution of known concentration 
85 mg/mL = 0.25 M of saccharose was prepared. 10 µL of diluted samples of this stock 
(xa = 4 and xb = 1.66) were incubated in the conditions described above, and finally 
fluorescence emission in EYPC-LUVs ⊃ CF assays with 20 µL aliquot of the enzymatic 
reaction mixture were measured. Normalization of the dose response curves, and 
calculation of fractional pore activities YE allows the back calculation of S with: 
g/Lin        342
2
4010.8S
3
××××=
− xYE  Equation 4 
The values obtained Sa = 77 g/L and Sb = 81 g/L correspond to an error level of 7 %.  
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Figure II-34: Exemplification of sucrose determination in the case of a known solution of 85 mg/mL. 
Changes in CF emission intensity were recorded over time after addition of 250 nM rod 42m, and in 
presence of 80 µM Mg-ATP or 80 µM Mg-ADP (black lines) for the controls, or samples (grey lines), a) 
for xa dilution and b) for xb dilution). Corresponding fractional pore activities YE are given. 
The method was applied to the quantification of sucrose in freshly squeezed 
orange juice and commercial drinks. The only sample treatment was dilution. The curves 
obtained for Pepsi® with four different dilutions showed comparable results, except with 
the higher dilution (Figure II-35). In this case, the sucrose content calculated is much 
lower. The accuracy is clearly negligible with very low concentrations of sugar. With the 
method of dilution, a repetition of the measurements is not necessary, as we can obtain 
three or four values with one sample. A comparison of these values allows a very good 
assumption of the reproducibility and the accuracy. In all cases, the curves corresponding 
to a fractional pore activity YE < 0.2 gave the sucrose content "back calculated" out of the 
range of the other values with YE > 0.2 and thus were not considered.  
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Otherwise, the final values given in the Table II-6 were obtained by averaging the values 
of the relevant curves.  
 
Table II-6: Application of the method to sucrose determination in drinks.  
Drinks Sensor method (in g /L) On label (in g /L) 
Pepsi® 95 120 
Coke light® Not detectable 0 
Orange juice 74 90 
Squeeze of orange 20 n.d. 
Monbazillac (sweet white wine) 65 n.d. 
Ice tea 90 80 
n.d.: not determined 
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Figure II-35: Exemplification of sucrose determination in Pepsi. Changes in CF emission intensity were 
recorded over time after addition of 250 nM rod 42, and in presence of 80 µM Mg-ATP or 80 µM Mg-ADP 
(black lines) for the controls, or samples (grey lines) with the dilution series: xa = 8 (a); xb = 6.65 (b); xc = 
2.88 (c); xd = 2.5 (d). Sucrose concentrations deducted from the curves are reported in g /L.  
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In conclusion, we demonstrated that it's possible to determine the sugar content in 
drinks by using enzymes and with a β-barrel as a sensor. No sample preparation is 
needed. The conditions were not optimized to be competitive with available commercial 
kits. For example, the sucrose assay kit sold by Sigma requires an initial sample 
concentration of 0.1 – 1 mg /mL that corresponds to a final concentration of 5 – 50 µg 
/mL detectable by UV after a process which includes a dilution of twenty times. In our 
case, the final detectability is in the same range 5 to 27 µg /mL, but the method comprises 
three consecutive dilutions that lead to a final dilution factor of four thousands. 
Improvement and optimization could be made easily by decreasing the reaction volume 
for each step, and removing the last dilution step, which cost a lot in terms of a dilution 
with a factor of 100. Running the reactions in the final measurement cell could solve this 
problem. 
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5. Summary 
This work presents the design and the synthesis of a new rigid-rod β-barrel. An 
arginine was introduced for the first time in the peptidic strands, which form the "hoops" 
of the barrel in order to exploit the characteristics of the guanidinium moieties. The 
"staves" 38m were found to self-assemble to form a barrel-like a pore in the bilayer 
membrane, allowing the passage of inorganic ions as well as organic anions like CF and 
ANTS. 
The recognition and amplification of an α-helical polypeptide was investigated. 
Poly-glutamic acid was chosen to serve as a model helix. The blockage studies in 
spherical bilayers with poly-glutamic acid highlighted the excellent affinity of the 
polypeptide for the transmembrane barrel, with KD's in the nanomolar range as well as a 
cooperative dipole-potential interaction. In unpolarized spherical membranes, the 
decrease in KD with increasing pH indicated that the β-barrel 38 recognizes anionic 
random-coiled polypeptides rather than α-helices. However, in polarized membranes, the 
KD of the α-helix was found to drop because of positive cooperation between the axial 
dipole of the α-helix (resulting from the alignment of the carbonyl groups) and the 
potential applied to the membrane. This result was a testament both to the incorporation 
of the guest (the β-barrel in the membrane), and to the recognition of the host (the helical 
poly-glutamic acid).  
Comparing the recognition of poly-glutamic acid by the pore 42 with a meaningful 
natural pore forming polypeptidic toxin of a similar charge and aggregation number 
revealed a sensitivity more than four orders of magnitude higher for the synthetic 
architecture.  
The development and use of this supramolecular structure as an enzyme sensor 
were illustrated with a wide selection of biopolymers and enzymes that were found to 
intervene in various biological processes. Enzymes catalyzing the synthesis or 
degradation of biopolymers such as DNA, polypeptides and polysaccharides were sensed 
by rigid-rod β-barrel pores. The selectivity was investigated by using glycolytic enzymes. 
Thus it was shown that the rigid-rod β-barrel pore is sufficiently selective to serve as a 
sensor during the conversion of ATP into the very similar derivative ADP in mixed 
analytes.  
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The adaptability of a single pore to the detection of a wide variety of enzymes and 
substrates of biological interest, without the need for chemical modification or labelling 
of the substrates has thus been made possible. The activity of the pore at nanomolar 
concentrations and a high degree sensitivity have allowed the use of the synthetic pore as 
an attractive enzyme sensor. 
Applications such as the screening of enzyme inhibitors and the quantification of 
sugar in drinks were demonstrated during the course by this research. Many other 
applications, including those concerning the detection of enzymatic activity, are possible 
and may be achieved by the simple functionalization of the interior space of the barrel 
through modification of the peptide sequence. 
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Chapter III: EXPERIMENTAL SECTION 
1. General 
1.1. Reagents, solvents, equipment 
Amino acid derivatives, coupling reagents EDC, and HOBt were from 
Novabiochem. Coupling reagent HATU was from Applied BioSystems. EYPC was from 
Avanti Polar Lipids. ANTS and DPX were from Molecular Probes. Safranin O and CF 
were from Fluka. All buffers, HEPES, MES, TES, inorganic salts, Triton X-100, Trypan 
Blue were of the best grade available from Sigma and used as received. Melittin and 
Valinomycin, all enzymes, polypeptides, polysaccharides, polynucleotides and ATP, 
dATP, ADP, D-fructose 1,6-diphosphate, D-fructose 6-phosphate, α-D-glucose, α-D-
glucose 6-phosphate were from Sigma. dTMP, dTTP and dAMP were from Biochemika. 
D(+)-saccharose was from AppliChem. 
Characteristics of the polymers are the following: pLE: DP = 90, pDE: DP = 86, 
pLR: DP = 134, pLK: DP = 134, heparin LMW (low molecular weight ~3000) ~5 dimeric 
units / chain, hyaluronic acid: ~6230 dimeric units / chain, β-D-glucan: ~3490 units / 
chain, poly(dTdA): 6175 bases / chain. 
 
Dry CH2Cl2, DMF and TEA used for synthesis were distilled over CaH2. Solvents 
were evaporated using a R-200 Rotavapor from Büchi, equipped with a vacuum 
controller PVK 610 from MLT Labortechnik AG and heating bath from Büchi. Water 
used was always bidistilled. 
 
1.2. Chromatographic methods 
Column chromatographies were done on silica gel 60 (Fluka, 40-63µm). 
Abbreviation in the text: (eluent, retention time Rf). 
Analytical thin layer chromatographies (TLC) were performed on glass plates (20 
x 20 cm) covered with silica gel 60 F254 (0.2 mm) from Merck or on glass plates (20 x 20 
cm) covered with silica gel 60 F254 (1 mm) from Analteck. Abbreviation in the text: 
(eluent, retention time Rf). 
UV and fluorescence were detected with UV-lamp from CAMAG at 254 or 366 
nm. Primary amines were stained with ninhydrin (0.2 % ninhydrin in ethanol). Poor UV 
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active compounds were dectected using a cesium-molybdenum staining reagent made 
from Ce(SO4)2 (2 g), H3PMo12O40 (4 g), and H2SO4 (40 g) in 160 mL water. 
 
1.3. Equipment for product characterization 
UV-Vis spectra were recorded on a Varian Cary Bio 1 Spectrophotometer using 
quartz cells with a pathlength of 1 cm. 
Optical rotation measurements were carried out at room temperature on a Perkin-
Elmer 241 Polarimeter using a sodium lamp (λ = 587nm) in water thermostatized quartz 
cells of 10 cm length. Abbreviation in the text: [α]20D = …(c = concentration in g/100 mL 
in solvent). 
Fourier transform infrared (FT-IR) spectra were recorded in KBr-pellets on a 
Perkin-Elmet FT-IR Spectrometer Paragon 500 at room temperature. Intensities of the 
vibrational bands are reported as w = weak, m = medium, s = strong, vs = very strong. 
Abbreviations in the text: IR (medium): ν (cm-1) (intensity). 
Melting points were measured on a heating microscope from Reicher (Austria) and 
are given in degrees Celsius. Abbreviation in the text: mp: temperature range ˚C. 
1H and 13C NMR spectra were recorded on Bruker 400 or 500 MHz Spectrometer. 
Chemical shifts δ are reported in ppm downfield relative to TMS internal reference in 
solvent. Spin multiplicities are reported as singlet (s), doublet (d), triplet (t), quartet (q), 
or multiplet (m) and coupling constants are given in Hz. Resonances were assigned with 
the aid of 2D NMR spectra (H-COSY, HSQC, HMBC). The nomenclature follows 
directly from the structures shown in Figure III-1. 
ESI-MS (ElectroSpray Ionization Mass Spectroscopy) was performed on a 
Finnigan MAT SQ 7000. Abbreviation in the text: MS (ESI, solvent): m/z [interpretation] 
Elemental analyses were carried out by Dr. H. Elder on a Vario EL from 
Elementa. Abbreviation in the text: Anal. calcd for CxHyNzOwSv•nsolvent (molecular 
weight): C…(%), H…(%), N…(%). Found: C…(%), H…(%), N…(%). 
The system used to carry out high performance liquid chromatography (HPLC) 
was equipped with a Jasco PU-980 pump, coupled with a Jasco UV-970/Vis detector and 
a Jasco FP-920 Fluorescence detector. Spectra were evaluated using the software Borwin 
Version 1.21.07 or 1.50. Columns were from YMC for normal and reverse phase 
separation. Description in the text: (reverse phase RP)-HPLC (column, length x diameter, 
eluent, flowrate, retention time tR) 
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1.4. Equipment used during experiments 
Autoclavable micropipettes from Nichiriyo (Japan), Socorex (Switzerland), Brand 
(Germany) and Vaudoux-Eppendorf (Switzerland) calibrated for amounts 0-10 µL, 10-50 
µL, 20-200 µL, 100-1000 µL were used to prepare stock solutions or transfer solutions. 
pH values were determined using a Piccolo Plus pH-meter from HANNA 
instruments or a Consort C832 multi-parameter analyzer, calibrated with Titrisol 
solutions from Merck at pH 4.00 and 7.00. 
Fluorescence spectra were recorded on FluoroMax 2 or FluoroMax 3 from Jobin 
Yvon-Spex equipped with an injector port, a magnetic stirrer and a temperature 
controller. Measurements were taken at 25 ˚C. Abbreviation in the text: Fluorescence: λex 
(nm), λem (nm). 
Circular Dichroism (CD) spectra were taken on Jasco-715 spectropolarimeter 
using quartz cells with a pathlength of 1 cm. Measurements were taken at 25 ˚C in a 
thermostatized cell holder. 
 
2. Synthesis of 8-LRLHL 
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Figure III-1: Nomenclature for amino acids (upper row) and protecting groups (lower row). 
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Fmoc-His(Trt)-Leu-NH2 39c was synthesized following reference 33 using Fmoc-
His(Trt)-OH 39b (1.52 g, 2.45 mmol) and H-Leu-NH2•HCl 39a (420 mg, 2.45 mmol). 
Pure Fmoc-His(Trt)-Leu-NH2 39c was obtained (1.14 g, 64 %) as a white powder. NMR 
data were significative with the  
1H NMR (400 MHz, CD3OD, 25 °C):  δ= 7.73 (d, 3J = 7.6 Hz, 2H, C5(Fmoc)H), 
7.54 (d, 3J = 7.5 Hz, 2H, C2(Fmoc)H), 7.31–7.19 (m, 14H, C3(Trt)H, C4(Trt)H, 
C4(Fmoc)H, C3(Fmoc)H, C2(His)H), 7.04-7.02 (m, 6H, C2(Trt)H), 6.75 (s, 1H, C5(His)H), 
4.40-4.38 (m, 2H, Cα(His)H, Cα(Leu)H), 4.20 (d, 3J = 7.1 Hz, 2H, C(Fmoc)H2), 4.07 (t, 3J 
= 7.1 Hz, 1H, C(Fmoc)H), 3.06 (dd, 2J = 14.9 Hz, 3J = 4.8 Hz, 1H, Cβ(His)H), 2.84 (dd, 
2J = 14.9 Hz, 3J = 9.1 Hz, 1H, Cβ(His)H), 1.70-1.56 (m, 3H, Cβ(Leu)H2, Cγ(Leu)H), 0.86 
(d, 3J = 6.3 Hz, 3H, C(Leu)H3), 0.83 (d, 3J = 6.3 Hz, 3H, C(Leu)H3). 
 
H-His(Trt)-Leu-NH2 39d was synthesized following reference 33 using Fmoc-His(Trt)-
Leu-NH2 39c (1.14 g, 1.56 mmol). Pure H-His(Trt)-Leu-NH2 39d (0.738 g, 92.3 %) was 
obtained as a white powder. 1H NMR data were significative with  
1H NMR (500 MHz, CD3OD, 25 °C): δ= 7.38–7.35 (m, 10H, C3(Trt)H, C4(Trt)H, 
C2(His)H), 7.15-7.13 (m, 6H, C2(Trt)H), 6.75 (s, 1H, C5(His)H), 4.36 (dd, 3J = 4.9 Hz, 3J 
= 4.6 Hz, 1H, Cα(Leu)H), 3.6 (dd, 3J = 7.1 Hz, 3J = 5.3 Hz, 1H, Cα(His)H), 2.93 (dd, 2J = 
14.7 Hz, 3J = 5.3 Hz, 1H, Cβ(His)H), 2.76 (dd, 2J = 14.7 Hz, 3J = 7.1 Hz, 1H, Cβ(His)H), 
1.67-1.53 (m, 3H, Cβ(Leu)H2, Cγ(Leu)H), 0.92 (d, 3J = 6.5 Hz, 3H, C(Leu)H3), 0.88 (d, 3J 
= 6.2 Hz, 3H, C(Leu)H3). 
 
Z-Leu1-His(Trt)-Leu3-NH2 39f was synthesized following reference 33 using H-
His(Trt)-Leu-NH2 39d (715 mg, 1.40 mmol) and Z-Leu-OH 39e (440 mg, 1.66 mmol). 
Pure Z-Leu-His(Trt)-Leu-NH2 39f (616 mg, 60 %) was obtained as a white powder. 1H 
NMR were significative with  
1H NMR (400 MHz, CD3OD):  δ= 7.35–7.25 (m, 15H, C2(His)H), C3(Trt)H, 
C4(Trt)H, CAr(Z)H), 7.11-7.09 (m, 6H, C2(Trt)H), 6.80 (s, 1H, C5(His)H), 5.05 (d, 2J = 
12.5 Hz, 1H, C(Z)H2), 4.91 (d, 2J = 12.5 Hz, 1H, C(Z)H2), 4.55 (dd, 3J = 7.4 Hz, 3J = 5.4 
Hz, 1H, Cα(His)H), 4.32 (t, 3J = 7.5 Hz, 1H, Cα(Leu3)H), 4.06 (t, 3J = 7.1 Hz, 1H, 
Cα(Leu1)H), 3.02 (dd, 2J = 14.9 Hz, 3J = 5.4 Hz, 1H, Cβ(His)H), 2.93 (dd, 2J = 14.9 Hz, 
3J = 7.4 Hz, 1H, Cβ(His)H), 1.66-1.48 (m, 6H, Cβ(Leu1,3)H2, Cγ(Leu1,3)H), 0.90 (d, 3J = 
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6.3 Hz, 3H, C(Leu3)H3), 0.88 (d, 3J = 6.3 Hz, 3H, C(Leu3)H3), 0.82 (d, 3J = 6.3 Hz, 3H, 
C(Leu1)H3), 0.81 (d, 3J = 5.9 Hz, 3H, C(Leu1)H3). 
 
H-Leu1-His(Trt)-Leu3-NH2 39g was generated following reference 33 using Z-
Leu-His(Trt)-Leu-NH2 39f (615 mg, 0.81 mmol). Pure H-Leu-His(Trt)-Leu-NH2 39g 
(468 mg, 93 %) was obtained as a white solid. 1H NMR data were significative with 
1H NMR (400 MHz, CD3OD, 25 °C):  δ= 7.36–7.32 (m, 10H, C2(His)H, C3(Trt)H, 
C4(Trt)H), 7.13-7.09 (m, 6H, C2(Trt)H), 6.76 (s, 1H, C5(His)H), 4.55 (dd, 3J = 7.6 Hz, 3J 
= 5.6 Hz, 1H, Cα(His)H), 4.36 (dd, 3J = 5.3 Hz, 3J = 4.8 Hz, 1H, Cα(Leu3)H), 3.27 (t, 3J = 
5.3 Hz, 1H, Cα(Leu1)H), 3.02 (dd, 2J = 14.9 Hz, 3J = 5.6 Hz, 1H, Cβ(His)H), 2.90 (dd, 2J 
= 14.9 Hz, 3J = 7.6 Hz, 1H, Cβ(His)H), 1.64-1.57 (m, 4H, Cβ(Leu3)H2, Cγ(Leu1,3)H), 1.43 
(m, 1H, Cβ(Leu1)H2), 1.24 (m, 1H, Cβ(Leu1)H2), 0.90 (d, 3J = 6.3 Hz, 3H, C(Leu3)H3), 
0.88 (d, 3J = 6.6 Hz, 6H, C(Leu3)H3, C(Leu1)H3), 0.87 (d, 3J = 6.6 Hz, 3H, C(Leu1)H3). 
 
Z-Arg(Pmc)-Leu2-His(Trt)-Leu4-NH2 39i (general procedure A) 
Z-Arg(Pmc)-OH•CHA (756 mg, 1.13 mmol) was suspended in 20 mL EtOAc and 
extracted twice with 15 mL H2SO4 10%, washed with brine, dried over anhydrous 
Na2SO4, and concentrated in vacuo, yielding 650 mg of Z-Arg(Pmc)-OH 39h. 1-(3-
Dimethylaminopropyl)-3-ethyl-carbodiimide•HCl (EDC) (285 mg, 1.05 mmol), 1-
hydroxybenzotriazole (HOBt) (122 mg, 0.90 mmol), Z-Arg(Pmc)-OH 39h (524 mg, 0.91 
mmol) and triethylamine (607 µL, 4.27 mmol) were added to a solution of of H-Leu-
His(Trt)-Leu-NH2 39g (467 mg, 0.749 mmol) in CH2Cl2 (15 mL) at 0 °C. After stirring 
for 8 h in the dark at RT, the reaction mixture was diluted with CH2Cl2, extracted with 
saturated aqueous NaHCO3, washed with brine, extracted with 1 M aqueous KHSO4, 
washed with brine, dried over anhydrous Na2SO4, and concentrated in vacuo. Purification 
of the crude product by column chromatography (CH2Cl2/MeOH 15:1, Rf = 0.3) yielded 
pure Z-Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39i (820 mg, 93%) as a colorless solid.  
[α]589 = -16.4° (c = 1.00 in MeOH);  m.p.: 134.5 – 135.8 °C; IR (KBr):  3459 (m), 
2960 (s), 1684 (s), 1654 (s), 1559 (s), 1540 (s), 1457 (s), 1106 (w) cm-1;  1H NMR (400 
MHz, CD3OD, 25 °C):  δ= 7.35 (s, 1H, C2(His)H), 7.34–7.21 (m, 14H, C3(Trt)H, 
C4(Trt)H, CAr(Z)H), 7.10-7.05 (m, 6H, C2(Trt)H), 6.77 (s, 1H, C5(His)H), 5.04 (d, 2J = 
12.4 Hz, 1H, C(Z)H2), 4.98 (d, 2J = 12.4 Hz, 1H, C(Z)H2) 4.54 (dd, 3J = 8.3 Hz, 3J = 5.6 
Hz, 1H, Cα(His)H), 4.31-4.25 (m, 2H, Cα(Leu2,4)H), 4.07 (dd, 3J = 7.8 Hz, 3J = 5.6 Hz, 
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1H, Cα(Arg)H), 3.23-3.17 (m, 2H, Cδ(Arg)H2), 3.05 (dd, 2J = 14.9 Hz, 3J = 5.6 Hz, 1H, 
Cβ(His)H), 2.90 (dd, 2J = 14.9 Hz, 3J = 8.3 Hz, 1H, Cβ(His)H), 2.56 (t, 3J = 6.8 Hz, 2H, 
C4(Pmc)H2), 2.51 (s, 3H, C15(Pmc)H3), 2.50 (s, 3H, C14(Pmc)H3), 2.04 (s, 3H, 
C13(Pmc)H3), 1.76 (t, 3J = 6.8 Hz, 2H, C3(Pmc)H2), 1.77-1.45 (m, 10H, Cβ(Arg)H2, 
Cγ(Arg)H2, Cβ(Leu)H2, Cγ(Leu)H), 1.25 (s, 6H, C11(Pmc)H3, C12(Pmc)H3), 0.86 (d, 3J = 
5.6 Hz, 3H, C(Leu4)H3), 0.86 (d, 3J = 6.3 Hz, 3H, C(Leu4)H3), 0.81 (d, 3J = 6.3 Hz, 3H, 
C(Leu2)H3), 0.80 (d, 3J = 5.8 Hz, 3H, C(Leu2)H3);  13C NMR (125 MHz, CD3OD):  δ = 
177.6 (s x2, CO), 177.2 (s x2, CO), 158.7 (s, CO), 155.04 (s), 154.7 (s x2), 143.6 (s x3), 
139.6 (d, C2-His), 138.0 (s), 137.7 (s), 136.6 (s), 136.0 (s), 134.7 (s), 130.9 (d x6, C2-Trt), 
129.5-129.4-129.3-129.0-128.9 (d x14, C3,4-Trt, CH-Z), 121.2 (d, C5-His), 119.3 (s), 76.9 
(s, C-Trt), 74.8 (s, C2-Pmc), 67.9 (t, CH2-Z), 56.4 (d, Cα-Arg), 55.2 (d, Cα-His), 53.8 (d, 
Cα-Leu4), 53.2 (d, Cα-Leu2), 41.7 (t x2, Cβ-Leu2,4), 41.5 (t, Cδ-Arg), 33.8 (t, C3-Pmc), 
31.1 (t, Cβ-His), 31.0 (t, Cβ-Arg), 27.02 (t, Cγ-Arg), 27.01 (q x2, C11,12-Pmc), 25.8 (d, Cγ-
Leu4), 25.7 (d, Cγ-Leu2), 23.7 (q, CH3-Leu4), 23.6 (q, CH3-Leu4), 22.4 (t, C4-Pmc), 21.8 
(q, CH3-Leu2), 21.7 (q, CH3-Leu2), 19.1 (q, C15-Pmc), 18.0 (q, C14-Pmc), 12.4 (q, C13-
Pmc);  MS (ESI, MeOH, m/z):  1201.7 [M + Na]+;  Anal. calcd for C65H82N10O9S•CH3OH 
(1211.52):  C 65.43, H 7.15, N 11.56.  Found:  C 65.28, H 7.12, N 13.06.  
 
H-Arg(Pmc)-Leu2-His(Trt)-Leu4-NH2 39j: 
A catalytic amount of Pd/C was added to a solution of -Arg(Pmc)Leu-His(Trt)-
Leu-NH2 39i (793 mg, 0.67 mmol) in MeOH (15 mL). The suspension was degassed at 
least four times and set under a H2-atmosphere. After stirring for 4 h, the Pd/C was 
filtered off and the crude product was concentrated in vacuo. Column chromatography 
(CH2Cl2/MeOH 10:1, Rf = 0.15) H-Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39j (640 mg, 91%) 
as a colorless solid.  
[α]589 = -10.7 (c = 1.00 in MeOH);  m.p.:  129.5 – 130.0 °C;  IR (KBr):  3442 (m), 
3360 (m), 2928 (s), 1684 (s), 1654 (s), 1559 (s) cm-1;  1H NMR (400 MHz, CD3OD, 25 
°C):  δ = 7.33–7.31 (m, 10H, C2(His)H, C3(Trt)H, C4(Trt)H), 7.10-7.07 (m, 6H, 
C2(Trt)H), 6.78 (s, 1H, C5(His)H), 4.58 (dd, 3J = 7.4 Hz, 3J = 5.6 Hz, 1H, Cα(His)H), 4.31 
(dd, 3J = 9.3 Hz, 3J = 5.6 Hz, 2H, Cα(Leu)H), 3.33-3.31 (m, 1H, Cα(Arg)H), 3.18-3.08 
(m, 2H, Cδ(Arg)H2), 3.05 (dd, 2J = 14.9 Hz, 3J = 5.6 Hz, 1H, Cβ(His)H), 2.85 (dd, 2J = 
14.9 Hz, 3J = 7.4 Hz, 1H, Cβ(His)H), 2.62 (t, 3J = 6.8 Hz, 2H, C4(Pmc)H2), 2.54 (s, 3H, 
C15(Pmc)H3), 2.52 (s, 3H, C14(Pmc)H3), 2.06 (s, 3H, C13(Pmc)H3), 1.79 (t, 3J = 6.8 Hz, 
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2H, C3(Pmc)H2), 1.74-1.42 (m, 10H, Cβ(Arg)H2, Cγ(Arg)H2, Cβ(Leu)H2, Cγ(Leu)H), 1.27 
(s, 6H, C11(Pmc)H3, C12(Pmc)H3), 0.90 (d, 3J = 5.8 Hz, 3H, C(Leu4)H3), 0.89 (d, 3J = 6.9 
Hz, 3H, C(Leu4)H3), 0.87 (d, 3J = 6.6 Hz, 3H, C(Leu2)H3), 0.84 (d, 3J = 6.1 Hz, 3H, 
C(Leu2)H3;  13C NMR (125 MHz, CD3OD, 25 °C):  δ = 177.6 (s, CO), 177.5 (s, CO), 
174.7 (s, CO), 173.1 (s, CO), 157.9 (s), 154.7 (s), 143.6 (s x3), 139.5 (s), 137.6 (d, C2-
His), 136.5 (s), 136.0 (s), 134.9 (s), 130.7 (d x6, C2-Trt), 129.3 (d x9, C3,4-Trt), 124.9 (s), 
121.2 (d, C5-His), 119.3 (s), 76.8 (s, C-Trt), 74.8 (s, C2-Pmc), 55.5 (d, Cα-Arg), 54.9 (d, 
Cα-Arg), 53.5 (d, Cα-Leu4), 53.1 (d, Cα-Leu2), 41.9 (t x2, Cβ-Leu2,4), 41.8 (t, Cδ-Arg), 
33.8 (t, C3-Pmc), 33.3 (t, Cβ-Arg), 31.0 (t, Cβ-His), 26.9 (q x2, C11,12-Pmc), 26.6 (t, Cγ-
Arg), 25.85 (d, Cγ-Leu4), 25.80 (d, Cγ-Leu2), 23.7 (q, CH3-Leu4), 23.5 (q, CH3-Leu4), 22.4 
(t, C4-Pmc), 21.9 (q, CH3-Leu2), 21.75 (q, CH3-Leu2), 19.0 (q, C15-Pmc), 17.9 (q, C14-
Pmc), 12.4 (q, C13-Pmc);  MS (ESI, MeOH, m/z):  1045.6 (70) [M + H]+, 1067.6 (100) [M 
+ Na]+;  Anal. calcd for C57H76N10O7S•CH3OH (1077.40):  C 64.66, H 7.48, N 13.00. 
Found: C 64.26, H 7.49, N 13.06. 
 
Z-Leu1-Arg(Pmc)-Leu3-His(Trt)-Leu5-NH2 39k: 
Coupling of H-Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39j (617 mg, 0.59 mmol) with Z-
Leu-OH 39e (192 mg, 0.73 mmol) following procedure A and purification of the crude 
product by column chromatography (CH2Cl2/MeOH 10:1, Rf = 0.25) yielded HPLC-pure 
(YMC-Pack SIL, 50 x 4 mm, CH2Cl2/MeOH 97/3 1 mL/min, tR = 7.52 min) Z-Leu-
Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39k (643 mg, 84%) as a colorless solid.  
[α]589 = -14.8 (c = 1.00 in MeOH);  m.p. : 138.5 – 139.0 °C;  IR (KBr):  3336 (m), 
2955 (m), 2926 (w), 1654 (s), 1540 (s), 1452 (m), 1111 (w) cm-1(w);  1H NMR (400 
MHz, CD3OD, 25 °C):  δ = 7.33–7.29 (m, 15H, C2(His)H), C3(Trt)H, C4(Trt)H, CAr(Z)H), 
7.10-7.07 (m, 6H, C2(Trt)H), 6.80 (s, 1H, C5(His)H), 4.98 (d, 2J = 12.1 Hz, 1H, C(Z)H2), 
4.92 (d, 2J = 12.1 Hz, 1H, C(Z)H2), 4.54 (dd, 3J = 8.3 Hz, 3J = 5.5 Hz, 1H, Cα(His)H), 
4.32 (dd, 3J = 10.1 Hz, 3J = 3.7 Hz, 1H, Cα(Arg)H), 4.30-4.20 (m, 2H, Cα(Leu3)H, 
Cα(Leu5)H), 3.81 (t, 3J = 7.8 Hz, 1H, Cα(Leu1)H), 3.21-2.96 (m, 4H, Cδ(Arg)H2, 
Cβ(His)H), 2.61 (t, 3J = 6.6 Hz, 2H, C4(Pmc)H2), 2.51 (s, 3H, C15(Pmc)H3), 2.50 (s, 3H, 
C14(Pmc)H3), 2.05 (s, 3H, C13(Pmc)H3), 1.78 (t, 3J = 6.6 Hz, 2H, C3(Pmc)H2), 1.76-1.45 
(m, 13H, Cβ(Arg)H2, Cγ(Arg)H2, Cβ(Leu)H2, Cγ(Leu)H), 1.26 (s, 6H, C11(Pmc)H3, 
C12(Pmc)H3), 0.88-0.82 (m, 12H, C(Leu1,5)H3), 0.81 (d, 3J = 5.8 Hz, 3H, C(Leu3)H3), 
0.80 (d, 3J = 6.1 Hz, 3H, C(Leu3)H3;  13C NMR (125 MHz, CD3OD, 25 °C):  δ = 177.6 (s, 
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CO), 176.3 (s, CO), 175.2 (s, CO), 174.7 (s, CO), 173.4 (s, CO), 158.8 (s, CO), 158.0 (s), 
154.7 (s), 143.7 (d, C2-His), 143.5 (s), 139.6 (s), 137.9 (s), 137.9 (s), 136.5 (s), 136.0 (s), 
134.8 (s), 130.9 (d x6, C2-Trt), 129.6- 129.2- 129.1- 128.5 (d x14, C3,4-Trt, CH-Z), 124.7 
(s), 121.1 (d, C5-His), 119.4 (s), 109.6 (s), 76.8 (s, C-Trt), 74.8 (s, C2-Pmc), 67.8 (t, CH2-
Z), 55.9 (d, Cα-Leu1), 55.6 (d, Cα-His), 55.4 (d, Cα-Leu5), 54.3 (d, Cα-Leu3), 53.3 (d, Cα-
Arg), 41.7 (t x3, Cβ-Leu1,3,5), 41.2 (t, Cδ-Arg), 33.8 (t, C3-Pmc), 31.2 (d, Cβ-His), 29.4 (t, 
Cβ-Arg), 27.0 (q x2, C11,12-Pmc), 26.9 (t, Cγ-Arg), 25.95 (d, Cγ-Leu5), 25.86 (d, Cγ-Leu3), 
25.8 (d, Cγ-Leu1), 23.8 (q, CH3-Leu5), 23.7 (q, CH3-Leu5), 23.1 (q x2, CH3-Leu1), 22.4 (t, 
C4-Pmc), 21.6 (q x2, CH3-Leu3), 19.0 (q, C15-Pmc), 17.9 (q, C14-Pmc), 12.4 (q, C13-Pmc);  
MS (ESI, MeOH, m/z):  647.0 (100) [M + 2H]2+, 1293.1 (90) [M + H]+;  Anal. calcd for 
C71H93N11O10S•2CH3OH (1356.72):  C 64.57, H 7.50, N 11.35.  Found:  C 64.37, H 7.34, 
N 11.51.  
 
H-Leu1-Arg(Pmc)-Leu3-His(Trt)-Leu5-NH2 39:  
Deprotection of Z-Leu-Arg(Pmc)-Leu-His(Trt)-Leu-NH2 39k (184 mg, 0.141 
mmol) following procedure B and purification of the crude product by column 
chromatography (CH2Cl2/MeOH 8:1, Rf = 0.35) yielded HPLC-pure (YMC-Pack SIL, 50 
x 4 mm, CH2Cl2/MeOH 1% TFA 92/8 1 mL/min, tR = 4.43 min) H-Leu1-Arg(Pmc)-Leu3-
His(Trt)-Leu5-NH2 39 (131 mg, 80%) as a colorless solid.  
[α]589 = -11.8 (c = 1.00 in MeOH);  m.p.:  131.5 - 132 °C;  IR (KBr):  3437 (m), 
3340 (m), 2359 (m), 1654 (s), 1559 (s), 1541 (s), 1110 (w) cm-1;  1H NMR (400 MHz, 
CD3OD, 25 °C): δ = 7.39–7.35 (m, 10H, C2(His)H), C3(Trt)H, C4(Trt)H), 7.13-7.11 (m, 
6H, C2(Trt)H), 6.82 (s, 1H, C5(His)H), 4.61 (dd, 3J = 8.1 Hz, 3J = 5.8 Hz, 1H, Cα(His)H), 
4.43 (dd, 3J = 10.1 Hz, 3J = 3.7 Hz, 1H, Cα(Arg)H), 4.43-4.31 (m, 2H, Cα(Leu3)H, 
Cα(Leu5)H), 3.38 (dd, 3J = 8.1 Hz, 3J = 6.3 Hz, 1H, Cα(Leu1)H), 3.30-3.18, 3.15-3.05 
(2m, 2H, Cδ(Arg)H2), 3.15-3.05, 2.95-2.88 (2m, 2H, Cβ(His)H), 2.65 (t, 3J = 6.8 Hz, 2H, 
C4(Pmc)H2), 2.56 (s, 3H, C15(Pmc)H3), 2.55 (s, 3H, C14(Pmc)H3), 2.09 (s, 3H, 
C13(Pmc)H3), 1.82 (t, 3J = 6.8 Hz, 2H, C3(Pmc)H2), 1.81-1.41 (m, 12H, Cβ(Arg)H2, 
Cγ(Arg)H2, Cβ(Leu)H2, Cγ(Leu)H), 1.38 (ddd, 2J = 13.7 Hz, 3J = 6.6 Hz, 2J = 5.6 Hz, 1H, 
Cβ(Leu)H2), 1.31 (s, 6H, C11(Pmc)H3, C12(Pmc)H3), 0.94 (d, 3J = 6.8 Hz, 3H, C(Leu5)H3), 
0.93 (d, 3J = 5.6 Hz, 3H, C(Leu5)H3), 0.91 (d, 3J = 6.6 Hz, 3H, C(Leu1)H3), 0.89 (d, 3J = 
7.1 Hz, 3H, C(Leu1)H3), 0.87 (d, 3J = 6.1 Hz, 6H, C(Leu3)H3);   13C NMR (125 MHz, 
CD3OD, 25 °C):  δ = 177.2 (s, CO), 176.5 (s, CO), 173.6 (s, CO), 173.2 (s, CO), 172.2 (s, 
Chapter III:  Experimental section 
 III–93
CO), 157.1 (s), 153.7 (s), 142.7 (s x3), 138.6 (d, C2-His), 136.7 (s), 135.5 (s), 135.0 (s), 
133.8 (s), 129.9 (d x6, C2-Trt), 128.3 (d x9, C3,4-Trt), 123.9 (s), 120.2 (d, C5-His), 118.3 
(s), 75.9 (s, C-Trt), 73.9 (s, C2-Pmc), 54.0 (d, Cα-His), 53.4 (d, Cα-Leu1), 52.9 (d, Cα-
Arg), 52.7 (d, Cα-Leu5), 52.2 (d, Cα-Leu3), 44.6 (t x3, Cβ-Leu1,3,5), 40.8 (t, Cδ-Arg), 32.8 
(t, C3-Pmc), 30.3 (t, C3-Pmc), 29.1 (t, Cβ-Arg), 25.9 (q x2, C11,12-Pmc), 25.8 (t, Cγ-Arg), 
24.8 (d x3, Cγ-Leu1,3,5), 22.7 (q, CH3-Leu5), 22.6 (q, CH3-Leu5), 22.5 (q, CH3-Leu1), 21.5 
(q, CH3-Leu1), 21.4 (t, C4-Pmc), 20.83 (q, CH3-Leu3), 20.76 (q, CH3-Leu3), 18.1 (q, C15-
Pmc), 16.9 (q, C14-Pmc), 11.4 (q, C13-Pmc);  MS (ESI, MeOH, m/z):  1158.7 (100) [M + 
H]+, 1180.7 (90) [M + Na]+;  Anal. calcd for C63H87N11O8S•2CH3OH (1222.59): C 63.85, 
H 7.83, N 12.60.  Found:  C 63.85, H 7.57, N 13.30.  
 
13,23,32,43,52,63,72,83-Octakis(Gla-Leu-Arg(Pmc)-Leu-His(Trt)-Leu-NH2)-p-
octiphenyl 41:  
A solution of H-Leu1-Arg(Pmc)-Leu3-His(Trt)-Leu5-NH2 39 (89 mg, 76 µmol) in 
DMF (300 µl) was added to a solution of 13,23,32,43,52,63,72,83-
octakis(hydroxycarbonylmethyleneoxy)-p-octiphenyl 40 (10 mg, 8.00 µmol), HATU (34 
mg, 90 µmol) and TEA (28 µl, 283 µmol) in 300 µl DMF. After stirring for 3 h in the 
dark at rt, the reaction mixture was evaporated and dried in vacuo. Purification of the 
crude product by flash column chromatography (CHCl3/MeOH 4:1, Rf = 0.9) and then by 
PTLC CHCl3/MeOH 9:1, Rf = 0.3) yielded HPLC-(YMC-Pack SIL, 50 x 4 mm, 
CH2Cl2/MeOH 92:8, 1 mL/min, tR = 0.98 min.) pure 41 (54.3 mg, 66%) as a colorless 
solid.  1H NMR (400 MHz, CD3OD/CDCl3, 25 °C):  8.05 (b, 8H, NH2), 7.52-7.20 (m, 104 
H, 72 C3,4(Trt)H, 24 Ar-H, 8 C2(His)H), 7.10-7.00 (m, 48H, C2(Trt)H), 6.94 (d, 2H, Ar-
H), 6.77-6.75 (m, 8H, C5(His)H), 4.86-4.30 (several m, 56H, 16 ArOCH2, 24 
Cα(Leu1,3,5)H, 8 Cα(Arg)H, 8 Cα(His)H), 3.30-2.80 (m, 32H, Cβ(His)H2), 2.59-2.48 (m, 
64H, C15(Pmc)H3, C14(Pmc)H3, C4(Pmc)H2), 2.01-2.00 (m, 24H, C13(Pmc)H3), 1.9-1.17 
(m, 168H, 16 C3(Pmc)H2, 16 Cβ(Arg)H2, 16 Cγ(Arg)H2, 48 Cβ(Leu)H2, 24 Cγ(Leu)H, 24 
C11(Pmc)H3, 24 C12(Pmc)H3 ), 0.95-0.55 (m, 144H, C(Leu1,3,5)H3;  MS (ESI, 
CH3CN/H2O/AcOH 37:12:1, m/z):  2066.4 (100) [M + 5H]5+, 1722.5 (50) [M + 6H]6+. 
 
13,23,32,43,52,63,72,83-Octakis(Gla-Leu-Arg-Leu-His-Leu-NH2)-p-octiphenyl 38m:  
A solution of 13,23,32,43,52,63,72,83-octakis(Gla-Leu-Arg(Pmc)-Leu-His(Trt)-Leu-
NH2)-p-octiphenyl 41 (37.5 mg, 3.6 µmol) in TFA (4 mL) was stirred for 1 h at rt.  After 
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addition of CH2Cl2 (2 mL) and evaporation of the solvents, the crude solid was washed 
with hexane (500 µl, 4x) and CH2Cl2 (500 µl, 2x), redissolved in TFA (2 mL), stirred for 
1 h at rt, diluted with CH2Cl2 (2 mL), evaporated, dried in vacuo, washed with hexane 
(500 µl, 4x) and CH2Cl2 (500 µl, 2x), dissolved in MeOH (1 mL), dried over anhydrous 
Na2SO4, evaporated and dried in vacuo to give RP-HPLC-pure (YMC-Pack ODS-A, 250 
x 10 mm, MeOH/H2O/TFA 84:15:1, 2 mL/min, tR = 5.67 min) 38m (19.7 mg, 90%) as a 
colorless solid.  1H NMR (400 MHz, CD3OD, 25 °C):  8.60–6.97 (several m, 42H), 4.50-
4.10 (m, 56H), 3.10-2.90 (m, 16H), 1.85-1.23 (m, 72H), 0.94-0.85 (m, 144H);  MS (ESI, 
MeOH/CH3CN/H2O/AcOH 50:37:12:1, m/z):  1614 (15) [M + 6H+ + 2H2PO4-]4+, 1292 
(30) [M + 7H+ + 2H2PO4-]5+, 1077 (50) [M + 8H+ + 2H2PO4-]6+, 1060 (75) [M + 7H+ + 
H2PO4-]6+, 1044 (60) [M + 6H+]6+, 909 (100) [M + 8H+ + H2PO4-]7+, 895 (65) [M + 7H]7+, 
783 (55) [M +8H]8+. 
 
13,23,32,43,52,63,72,83-Octakis(Gla-Leu-Asp-Leu-Asp-Leu-NH2)-p-octiphenyl 17m was 
available in the laboratory. The synthesis is described in the reference 36. 
 
13,23,32,43,52,63,72,83-Octakis(Gla-Leu-Arg-Try-His-Val-NH2)-p-octiphenyl 42m was 
available in the laboratory. The synthesis is described in Bioorganic & Medicinal 
Chemistry.102 
 
 
3. Preparation of vesicles 
3.1. EYPC-LUVs ⊃ ANTS/DPX 
A stock solution of TES (100 mM, pH 7.0) was prepared by addition of 4.58 mg 
TES to 100 mL H2O, adjustment to pH 7.0 with ~ 4.6 mL NaOH (1 M), and dilution to 
200 mL with H2O.  
Buffer A (12.5 mM ANTS, 45.0 mM DPX, 5 mM TES, 20 mM KCl, pH 7.0) was 
prepared by addition of 2.5 mL TES (100 mM, pH 7.0), 1 mL KCl (1 M), 500 µl NaOH 
(1 M), 267 mg ANTS, and 950 mg DPX to 20 mL H2O, adjustment to pH 7.0 with ~100 
µl NaOH (1 M), and dilution to 50 mL with H2O. 
Buffer B (5 mM TES, 100 mM KCl, pH 7.0) was prepared by addition of 50 mL 
TES (100 mM, pH 7.0) and 100 mL KCl (1M) and dilution to 1 L with H2O. 
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To 25 µL of EYPC (solution in ethanol 1g/mL) were added 1 mL MeOH and 1 
mL CHCl3. A thin film was obtained by slow solvent evaporation on a rotovap then it was 
dried in vacuo (> 2 h), hydrated with 1 mL buffer A (> 30 min), subjected to > 5 freeze-
thaw cycles (using liquid N2 to freeze and a warm water bath to thaw), and > 10 times 
extruded using a Mini-Extruder with a 100 nm polycarbonate membrane (Avanti).27 
External dye was isoosmotically removed by gel filtration (Sephadex G-50) using buffer 
B and diluted to 6 mL to give EYPC-LUVs ⊃ ANTS/DPX stock solutions with the 
following characteristics: ~ 5 mM EYPC; inside: 12.5 mM ANTS, 45.0 mM DPX, 5 mM 
TES, 20 mM KCl, pH 7.0; outside: 5 mM TES, 100 mM KCl, pH 7.0. 
 
3.2. EYPC-LUVs ⊃ ANTS/DPX polarized vesicles 
Buffer Apol (12.5 mM ANTS, 45.0 mM DPX, 5 mM TES, 20 mM KCl, pH 7.0) 
was prepared by addition of 2.5 mL TES (100 mM, pH 7.0), 1 mL KCl (1 M), 500 µl 
NaOH (1 M), 267 mg ANTS, and 950 mg DPX to 20 mL H2O, adjustment to pH 7.0 with 
~100 µl NaOH (1 M), and dilution to 50 mL with H2O. 
Buffer Bpol (5 mM TES, 100 mM NaCl, pH 7.0) was prepared by addition of 50 
mL TES (100 mM, pH 7.0) and 100 mL NaCl (1M) and dilution to 1 L with H2O. 
To 25 µL of EYPC (solution in ethanol 1g/mL) were added 1 mL MeOH and 1 
mL CHCl3. A thin film was obtained by slow solvent evaporation on a rotovap then it was 
dried in vacuo (> 2 h), hydrated with 1 mL buffer Apol (> 30 min), subjected to > 5 freeze-
thaw cycles (using liquid N2 to freeze and a warm water bath to thaw), and > 10 times 
extruded using a Mini-Extruder with a 100 nm polycarbonate membrane (Avanti).27 
External dye was isoosmotically removed by gel filtration (Sephadex G-50) using buffer 
Bpol and diluted to 6 mL to give EYPC-LUVs ⊃ ANTS/DPX polarized vesicles stock 
solutions with the following characteristics: ~ 5 mM EYPC; inside: 12.5 mM ANTS, 45.0 
mM DPX, 5 mM TES, 20 mM KCl, pH 7.0; outside: 5 mM TES, 100 mM NaCl, pH 7.0; 
and were used within 4 days. 
 
3.3. EYPC-LUVs ⊃ CF 
Buffer ACF (10 mM HEPES, 50 mM CF, 10 mM NaCl, pH 7.1) was prepared by 
addition of 940 mg CF, 0.5 mL HEPES (1M), 0.5 mL NaCl (1M), to 30 mL H2O, 
adjustment to pH 7.1 with ~ 6.7 mL NaOH (1 M) and dilution to 50 mL with H2O. 
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Buffer BCF (10 mM HEPES, 107 mM NaCl, pH 7.1) was prepared by addition of 
2.383 g HEPES and 6.253 g NaCl to 800 mL H2O, adjustment to pH 7.1 with ~3.5 mL 
NaOH (1M) and dilution to 1 L with H2O. 
To 25 µL of EYPC (solution in ethanol 1g/mL) were added 1 mL MeOH and 1 
mL CHCl3. A thin film was obtained by slow solvent evaporation on a rotovap then it was 
dried in vacuo (> 2 h), hydrated with 1 mL buffer ACF (> 30 min), subjected to > 5 freeze-
thaw cycles (using liquid N2 to freeze and a warm water bath to thaw), and > 10 times 
extruded using a Mini-Extruder with a 100 nm polycarbonate membrane (Avanti).27 
External dye was isoosmotically removed by gel filtration (Sephadex G-50) using buffer 
BCF and diluted to 6 mL to give EYPC-LUVs ⊃ CF stock solutions with the following 
characteristics: ~ 5 mM EYPC; inside: 10 mM HEPES, 50 mM CF, 10 mM NaCl, pH 7.1; 
outside: 10 mM HEPES, 107 mM NaCl, pH 7.1. 
 
4. pH Profile 
Buffer C (10 mM MES, 100 mM KCl, pH 4.0 to 7.5) was prepared by addition of 
10 mL KCl (1M) and 0.195 g of MES in 80 mL H2O, adjustment to pH 4 to 7.5 was done 
by addition of NaOH (0.1 M) and dilution to 100 mL with H2O. 
EYPC-LUVs ⊃ ANTS/DPX (100 µL) were placed with 1900 µL buffer C and 
gently stirred. Relative emission intensity It (λex = 353 nm, λem = 510 nm) was recorded as 
a function of time t during a) addition of 20 µL pore 38 (16 µM in DMSO) at t = 50s, and 
b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. 
Fluorescence kinetics were normalized to relative emission intensity I using the equation:  
0
0  
II
III t −
−=
∞
 Equation 5  
were I0 = It before pore addition a) and I∞ = It at saturation after lysis b). 
 
5. Concentration dependence 
Buffer C (10 mM MES, 100 mM KCl, pH 4.5) was prepared by addition of 10 mL 
KCl (1M) and 0.195 g of MES in 80 mL H2O, adjustment to pH 4.5 to 7.5 with ~ 400 µL 
NaOH (0.1 M) and dilution to 100 mL with H2O. 
EYPC-LUVs ⊃ ANTS/DPX (100 µL) were placed with 1900 µL buffer C and 
gently stirred. Relative emission intensity It (λex = 353 nm, λem = 510 nm) was recorded as 
a function of time t during a) addition of 20 µL pore 38 (0.8, 2, 4, 8, 15, 20, 44 µM in 
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DMSO) at t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve 
complete lysis. Fluorescence kinetics were normalized to relative emission intensity I 
using the Equation 5. 
 
6. Circular Dichroism 
Solutions of 4.5 mL of pLE or pDE 5µM in buffer (10 mM MES, 100 mM KCl) at 
pH 4.5 were slowly basified by step-wise addition of 10 to 60 µL NaOH 0.01 M or after 
pH 5.4 of NaOH 0.1 M. pH was followed, and CD measurement were done every pH 
jump of ~ 0.1, with 5 scans, speed of 200 nm/min and window of 250-190 nm. Molar CD 
(∆ε) were calculated at 222 nm with respect to polymer concentration at each step. 
Fractional denaturation fD was then calculated following: 
4.5
4.5
 - 
  - 
εε
εε
∆∆
∆∆=
∞
Df  Equation 6 
were ∆ε 4.5 = ∆ε at pH 4.5 and ∆ε ∞ = ∆ε at complete denaturation of the helix. 
 
7. pLE blockage 
7.1. pLE in unpolarized vesicles 
pLE stock solution of 5 mM was prepared by dissolving 48.9 mg of pLE in 0.72 
mL of H2O. Following dilutions were done in buffer of appropriate pH (10 mM MES, 
100 mM KCl, pH 4.5 to 6.0). No further pH adjustment was required for concentrations 
less than 10 µM. 
EYPC-LUVs ⊃ ANTS/DPX (100 µL) were placed with buffer C (1900 µL, 10 
mM MES, 100 mM KCl, 0 to 1 µM pLE, pH 4.5 to 6.0), and gently stirred. Relative 
emission intensity It (λex = 353 nm, λem = 510 nm) was recorded as a function of time t 
during a) addition of 20 µL pore 38 (30, 40, 50, or 60 µM in DMSO for experiments at 
pH 4.5, 5.0, 5.5, 6.0 respectively) at t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 
at t = 300 s to achieve complete lysis. Fluorescence kinetics were normalized to relative 
emission intensity I using the Equation 5. Fractional pore activity Y, defined with Y = 1 
without blocker before lysis b), and Y = 0 at saturation of blocker concentration before 
lysis b) was then derived from I (Equation 5), right before lysis using: 
S
S
II
IIY −
−= 0   Equation 7 
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were I0 = I without pLE before lysis b) and IS = I with excess blocker pLE before 
lysis b).  
Dissociation constant KD and Hill coefficient n were calculated using: 
Dlog]blockerlog[
1log Knn
Y
Y −=−  Equation 1 
 
7.2. pLE in polarized vesicles 
pLE stock solution of 5 mM was prepared by dissolving 48.9 mg of pLE in 0.72 
mL of H2O. Following dilutions were done in buffer of appropriate pH (10 mM MES, 
100 mM NaCl, pH 4.5 and 6.0). No further pH adjustment was required for 
concentrations less than 10 µM. 
EYPC-LUVs ⊃ ANTS/DPX (100 µL) were placed with buffer (1860 µL, 10 mM 
MES, 100 mM NaCl, 0 to 1 µM pLE, pH 4.5 or 5.5), and gently stirred. Relative emission 
intensities It of ANTS (λex = 353 nm, λem = 510 nm) and safranin O (λex = 522 nm, λem = 
581 nm) were simultaneously recorded as a function of time t during: a) addition of 20 µL 
Safranin O (6 µM) at t = 0s; b) addition of 20 µL valinomycin (60 µM) at t = 50s; c) 
addition of 20 µL pore 38 (30 or 50 µM in DMSO for experiments at pH 4.5 and 5.5 
respectively) at t = 250s; and d) addition of 40 µL melittin (1.3 mg / mL in H2O) at t = 
450s to achieve complete lysis.  
Equation 5, Equation 7 and Equation 1 were used to determine the Hill 
coefficients, using I0 = It before pore addition c) and I∞ = It at saturation after lysis d). 
0
0  
II
III t −
−=
∞
 Equation 5 
S
S
II
IIY −
−= 0   Equation 7 
Dlog]blockerlog[
1log Knn
Y
Y −=−  Equation 1 
 
8. KD measurements with 8-LRWHV 
Stock solutions of blocker are prepared in buffer (10 mM HEPES, 107 mM NaCl); 
particular attention was paid to insure pH adjustment to 6.5 following the procedure 
described in ChemBioChem.37 
EYPC-LUVs ⊃ CF (100 µL) were placed with buffer (1900 µL, 10 mM HEPES, 
107 mM NaCl, variable concentration of blocker, pH 6.5) and gently stirred. Relative 
Chapter III:  Experimental section 
 III–99
emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t 
during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 
µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis.  
Equation 5, Equation 7and Equation 1 were used to determine the Hill coefficients 
using I0 = It before pore addition c) and I∞ = It at saturation after lysis b). 
0
0  
II
III t −
−=
∞
 Equation 5 
S
S
II
IIY −
−= 0   Equation 7 
Dlog]blockerlog[
1log Knn
Y
Y −=−  Equation 1 
 
9. Enzyme sensing 
9.1. Proteases 
9.1.1. papain 
pLE (10 µM) was incubated with papain (EC 3.4.22.2 from Papaya latex, 9.24 
u/mL‡) in buffer (10 mM HEPES, 0.2 M NaCl, 1 mM EDTA (ethylenediaminetetraacetic 
acid), 5 mM cysteine, pH 5.0) at 37 ºC. After τ = 15 min, 20 µL of the reaction mixture 
was taken and added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 
107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 
25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a 
function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and 
b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. 
Fluorescence kinetics were normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8  
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 35, 75 and 135 min. From the 
normalized curves, I(τ=15), I(τ=35), I(τ=75), and I(τ=135) were obtained as I before lysis by 
Triton-X and converted into fractional pore activity YE using: 
                                                 
‡ One unit will hydrolyse 1.0 µmole of BAEE (Nα -Benzoyl-L-Arginine ethyl ester) per min at pH 
6.2 at 25°C 
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)0()(
  =∞=
=
−
−= ττ
ττ
II
IIYE   Equation 9 
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (2.64 u/mL) papain or no papain. 
 
Table III-1: Data for pLE degradation at different concentrations of papain. 
9.24 u/mL 2.64 u/mL 0 
τ min YE τ min YE τ min YE 
0 0.00 0 0.00 0 0 
15 0.15 20 0.12 20 0 
35 0.41 50 0.35 50 0 
75 0.71 100 0.50 100 0 
135 0.99 190 0.72 190 0 
- - 330 0.94 330 0 
- - 420 0.97 420 0 
 
 
pLR (10 µM) was incubated with papain (EC 3.4.22.2 from Papaya latex, 7.92 
u/mL‡) in buffer (10 mM HEPES, 0.2 M NaCl, 1 mM EDTA, 5 mM cysteine, pH 9.8) at 
37 ºC. After τ = 0.33 h, 20 µL of the reaction mixture was taken and added to a 
suspension of 2 mL vesicles (1900 µL buffer (10 mM MES, 100 mM KCl, pH 6.5), 100 
µL EYPC-LUVs ⊃ ANTS/DPX) gently stirred and thermostatized at 25 ˚C. Relative 
emission intensity It (λex = 353 nm, λem = 510 nm) was recorded as a function of time t 
during a) addition of 20 µL pore 17 (25 µM in DMSO) at t = 50s, and b) addition of 40 
µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 17 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 1, 2 and 4.66 h. From the normalized 
curves, I(τ=0.33), I(τ=1), I(τ=2), and I(τ=4.66) were obtained as I before lysis by Triton-X and 
converted into fractional pore activity YE using: 
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IIYE   Equation 9 
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (2.64 u/mL) papain or no papain. 
 
Table III-2: Data for pLR degradation at different concentrations of papain. 
7.92 u/mL 2.64 u/mL 0 
τ h YE τ h YE τ h YE 
0 0.00 0 0.00 0 0 
0.33 0.22 0.33 0.73 0.33 0 
1.00 0.61 1.00 0.89 1.00 0 
2.00 0.72 2.00 0.97 2.00 0 
4.66 0.95 4.66 - 4.66 0 
 
 
9.1.2. Ficin 
pLE (10 µM) was incubated with ficin (EC 3.4.22.3 from Fig Tree latex, 0.03-0.06 
u/mL§) in buffer (10 mM HEPES, 0.2 M NaCl, 1 mM EDTA (Ethylenediaminetetraacetic 
acid), 5 mM cysteine, pH 5.0) at 37 ºC. After τ = 0.33 h, 20 µL of the reaction mixture 
was taken and added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 
107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 
25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a 
function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and 
b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. 
Fluorescence kinetics were normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8  
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 0.75, 1.25, 1.33, 2 h. From the 
                                                 
§ One unit will produce a ∆A280 of 1.0 per min at pH 7.0 at 37°C when measuring TCA (2,4,6-
trichloroanisole) soluble products from casein in a final volume of 10 mL (1 cm light path)  
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normalized curves, I(t=0.33), I(t=0.75), I(t=1.25), I(t=1.33), and I(t=2) were obtained as I before lysis 
by Triton-X and converted into fractional pore activity YE using: 
)0()(
)0()(
  =∞=
=
−
−= ττ
ττ
II
IIYE   Equation 9 
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.01-0.02 u/mL) ficin or no ficin. 
 
Table III-3: Data for pLE degradation at different concentrations of ficin. 
0.03-0.06 u/mL 0.01-0.02 u/mL 0 
τ h YE τ h YE τ h YE 
0 0.00 0 0.00 0 0 
0.33 0.31 0.33 0.17 0.33 0 
0.75 0.68 1.00 0.29 0.75 0 
1.25 0.85 3.00 0.53 3.00 0 
1.33 0.89 4.00 0.65 5.00 0 
2.00 1.00 5.00 0.82 6.00 0 
- - 6.00 0.94 8.00 0 
- - 8.00 1.00 - - 
 
 
9.1.3. Pronase E 
pLE (10 µM) was incubated with pronase E (EC 3.4.24.4, protease from 
Steptomyces griseus, 10.08 u/mL**) in buffer (10 mM HEPES, 107 mM NaCl, pH 7.5) at 
37 ºC. After τ = 1 h, 20 µL of the reaction mixture was taken and added to a suspension 
of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL 
EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission 
intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t during a) 
addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 µL 1.2 % 
                                                 
** One unit will hydrolyse casein to procedure color equivalent to 1.0 µmole (181 µg) of tyrosine 
per min at pH 7.5 at 37°C (color by Folin-Ciocalteu reagent) 
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Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 3 and 6 h. From the normalized 
curves, I(τ=1), I(τ=3) and I(τ=6) were obtained as I before lysis by Triton-X and converted 
into fractional pore activity YE using: 
)0()(
)0()(
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−
−= ττ
ττ
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IIYE   Equation 9 
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (3.24 u/mL) pronase E or no enzyme. 
 
Table III-4: Data for pLE degradation at different concentrations of pronase E. 
10.08 u/mL 3.24 u/mL 0 
τ h YE τ h YE τ h YE 
0 0.00 0 0.00 0 0 
1.00 0.75 0.33 0.11 1.00 0 
3.00 0.88 0.83 0.19 3.00 0 
6.66 0.99 1.50 0.31 6.66 0 
- - 3.50 0.74 - - 
- - 8.00 1.00 - - 
 
 
9.1.4. Elastase 
pLE (10 µM) was incubated with elastase (EC 3.4.21.36, type II-A from porcine 
pancreas, 0.525 u/mL††) in buffer (10 mM HEPES, 0.2 M NaCl, pH 5.0) at 37 ºC. After τ 
= 1 h, 20 µL of the reaction mixture was taken and added to a suspension of 2 mL 
vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs 
                                                 
†† One unit will release one nanomole of p-nitrophenol per sec from BOC-L-alanine p-nitrophenyl 
ester at pH 6.5 at 37°C 
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⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission intensity It (λex = 492 
nm, λem = 514 nm) was recorded as a function of time t during a) addition of 20 µL pore 
42 (25 µM in DMSO) at t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s 
to achieve complete lysis. Fluorescence kinetics were normalized to relative emission 
intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 4, 8 and 25 h. From the normalized 
curves, I(τ=0.1), I(τ=4), I(τ=8) and I(τ=25) were obtained as I before lysis by Triton-X and 
converted into fractional pore activity YE using: 
)0()(
)0()(
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=
−
−= ττ
ττ
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IIYE   Equation 9 
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure without enzyme. 
 
Table III-5: Data for pLE degradation at different concentrations of elastase. 
0.525 u/mL 0 
τ h YE τ h YE 
0. 0.00 0. 0 
1.00 0.17 1.00 0 
4.00 0.42 8.00 0 
8.00 0.63 25.0 0 
25.0 1.00 - - 
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9.1.5. Subtilisin and pLE 
pLE (10 µM) was incubated with subtilisin (Subtilisin Carlsberg, EC 3.4.21.62, 
from Bacillus licheniformis, 0.351 u/mL‡‡) in buffer (10 mM HEPES, 0.2 M NaCl, pH 
5.0) at 37 ºC. After τ = 0.17 h, 20 µL of the reaction mixture was taken and added to a 
suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 
100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission 
intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t during a) 
addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 µL 1.2 % 
Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 0.5, 0.75, 1, 1.5 and 2.17 h. From the 
normalized curves, I(τ=0.17), I(τ=0.5), I(τ=0.75) , I(τ=1) , I(t=1.5) and I(τ=2.17) were obtained as I 
before lysis by Triton-X and converted into fractional pore activity YE using: 
)0()(
)0()(
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=
−
−= ττ
ττ
II
IIYE   Equation 9 
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.1755 u/mL) subtilisin or without enzyme. 
 
                                                 
‡‡ One unit will hydrolyse casein to produce color equivalent to 1.0 µmole (181 µg) of tyrosine per 
min at pH 7.5 at 37°C (color by Folin-Ciocalteu) 
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Table III-6: Data for pLE degradation at different concentrations of subtilisin. 
0.351 u/mL 0.1755 u/mL 0 
τ h YE τ h YE τ h YE 
0 0.00 0 0.00 0.00 0 
0.17 0.11 0.33 0.27 0.33 0 
0.50 0.49 2.00 0.76 2.00 0 
0.75 0.66 3.00 0.85 3.00 0 
1.00 0.78 5.33 0.98 5.33 0 
1.50 0.93 - - - - 
2.17 0.98 - - - - 
 
 
9.1.6. Subtilisin and pLE/pDE 
pDE (10 µM) was incubated with subtilisin (Subtilisin Carlsberg, EC 3.4.21.62, 
from Bacillus licheniformis, 0.351 u/mL‡‡) in buffer (10 mM HEPES, 0.2 M NaCl, pH 
5.0) at 37 ºC. After τ = 0.17 h, 20 µL of the reaction mixture was taken and added to a 
suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 
100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission 
intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t during a) 
addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 µL 1.2 % 
Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 0.5, 2, 2.83, 5, 16 and 19 h. From the 
normalized curves, I(τ=0.5), I(τ=2), I(τ=2.83) , I(τ=5) , I(τ=16) and I(τ=19) were obtained as I before 
lysis by Triton-X and converted into fractional pore activity YE using: 
)0()(
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−= ττ
ττ
II
IIYE   Equation 9  
All YE were plotted as a function of reaction time τ. Control experiments consisted of 
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repetition of the procedure with same concentration of enzyme (0.351 u/mL)., and with 
different ratio of pLE : pDE . pLE (10 - y µM) and pDE (y µM) with y = 0; 2.5; 5; or 10 
were thus incubated in the conditions described above, corresponding to y = 10, i.e. for 
pure pDE. The molar ratio of pLE in the substrate mixture is defined by: 
[ ]
[ ] [ ]pDEpLE
pLEx +=  
 
Table III-7: Data for subtilisin degradation of different ratio of pLE : pDE mixtures. 
y = 0; x = 1 y = 0.25; x = 0.75 y = 0.5; x = 0.5 y = 10; x = 0 
τ h YE τ h YE τ h YE τ h YE 
0 0.00 0.17 0.05 1.00 0.07 0.50 0.09 
0.17 0.11 0.25 0.16 2.50 0.09 2.00 0.04 
0.50 0.49 0.33 0.17 6.00 0.09 2.83 0.06 
0.75 0.66 0.58 0.22 25.00 0.09 5.00 0.05 
1.00 0.78 0.92 0.23 55.00 0.10 16.00 0.06 
1.50 0.93 1.50 0.24 79.00 0.09 19.00 0.09 
2.17 0.98 3.00 0.32 192.00 0.08 - - 
 
 
9.2. Polynucleotides 
9.2.1. DNA exonuclease 
[Poly(dA,dT)]2 (73 nM) was incubated with DNA exonuclease III (EC 3.1.11.2 
from Escherichia coli BE25/psGR3, 0.833 u/mL§§) in buffer (50 mM Tris-HCl, 50 mM 
NaCl, 3 mM MgCl2, 1 mM 2-mercaptoethanol, pH 8.0) at 30 ºC. After τ = 15 min, 20 µL 
of the reaction mixture was taken and added to a suspension of 2 mL vesicles (1900 µL 
buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently 
stirred and thermostatized at 25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 
nm) was recorded as a function of time t during a) addition of 20 µL pore 42 (25 µM in 
DMSO) at t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve 
                                                 
§§ One unit releases 11 nmol of acid-soluble mucleotides from sonicated calf thymus DNA in 30 
min at 37°C. 
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complete lysis. Fluorescence kinetics were normalized to relative emission intensity I 
using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 20, 25, 50 and 70 min. From the 
normalized curves, I(τ=15), I(τ=20), I(τ=25) , I(τ=50) and I(τ=70) were obtained as I before lysis 
by Triton-X and converted into fractional pore activity YE using: 
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All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.416 u/mL) subtilisin or without enzyme. 
 
Table III-8: Data for [Poly(dA,dT)]2 degradation at different concentrations of DNA exonuclease III. 
0.833 u/mL 0.416 u/mL 0 
τ min YE τ min YE τ min YE 
0 0.00 0 0.00 0 0 
15 0.15 20 0.18 35 0 
20 0.33 35 0.60 60 0 
25 0.64 60 0.70 105 0 
50 0.91 105 0.98 - - 
70 0.97 - - - - 
 
 
9.2.2. DNA polymerase 
dATP (250 µM), dTTP (250 µM) and [poly(dA,dT)]2 (3.64 nM) were incubated 
with DNA polymerase I Klenow Fragment (EC 2.7.7.7 from Escherichia coli, 125 
u/mL***) in buffer (41 mM KH2PO4, pH 7.5) at 37 ºC. After τ = 0.17 h, 20 µL of the 
reaction mixture was taken and added to a suspension of 2 mL vesicles (1900 µL buffer 
                                                 
*** One unit converts 10 nanomoles of deoxyribonucleoside triphosphates into acid insoluble 
material in 30 min at 37°C 
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(HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and 
thermostatized at 25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was 
recorded as a function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at 
t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete 
lysis. Fluorescence kinetics were normalized to relative emission intensity I using: 
0
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−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). 
This procedure was repeated with 20 µL aliquots taken at 0.42, 0.92, 2.25, 4.59 and 24 h. 
From the normalized curves, I(τ=0.17), I(τ=0.42), I(τ=0.92), I(τ=2.25), I(τ=4.59) and I(τ=24) were 
obtained as I before lysis by Triton-X and converted into fractional pore activity YE using: 
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All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (50 u/mL) DNA polymerase or without enzyme. 
 
Table III-9: Data for polynucleotides polymerization at different concentrations of DNA polymerase. 
125 u/mL 50 u/mL 0 
τ h YE τ h YE τ h YE 
0 1.00 0 1.00 0 1 
0.17 0.95 0.58 0.80 0.17 1 
0.42 0.64 2.17 0.62 0.42 1 
0.92 0.50 2.25 0.56 2.25 1 
2.25 0.35 6.00 0.44 6.00 1 
4.58 0.19 24.00 0.29 24.00 1 
24.00 0.00 - - - - 
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9.3. Polysaccharides 
9.3.1. Hyaluronidase 
Hyaluronic acid (140 nM) was incubated with hyaluronidase (EC 3.2.1.35, type 
IV-S from bovine testes, 0.024 u/mL†††) in buffer (0.1 M NaH2PO4, 0.15 M NaCl, pH 5.3) 
at 30 ºC. After τ = 0.08 h, 20 µL of the reaction mixture was taken and added to a 
suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 
100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission 
intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t during a) 
addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 µL 1.2 % 
Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
0
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were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 0.17, 0.5, 0.75, 3.67 and 4.67 h. 
From the normalized curves, I(τ=0.08), I(τ=0.17), I(τ=0.5), I(τ=0.75), I(τ=3.67) and I(τ=4.67) were 
obtained as I before lysis by Triton-X and converted into fractional pore activity YE using: 
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All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.0171 u/mL) hyaluronidase or without enzyme. 
 
                                                 
††† One unit is based on the change in absorbance at 600nm (change in turbidity) of a USP 
Reference Standard Hyaluronidase which is assayed concurrently with each lot of this product 
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Table III-10: Data for hyaluronic acid degradation at different concentrations of hyaluronidase. 
0.0240 u/mL 0.0171 u/mL 0 
τ min YE τ min YE τ min YE 
0 0.00 0.17 0.07 0.00 0 
0.08 0.39 0.50 0.22 0.5 0 
0.17 0.47 1.08 0.45 1.08 0 
0.50 0.74 2.67 0.69 425 0 
0.75 0.84 4.25 0.78 23.67 0 
3.67 0.97 7.00 0.87 - - 
4.67 0.99 23.67 0.98   
 
 
9.3.2. Heparinase 
Hyaluronic acid (140 nM) was incubated with heparinase I (EC 4.2.2.7, from 
Flavobacterium heparinum, 50 u/mL‡‡‡, dissolved right before use in 0.15 M NaCl, 2 
mM TES, pH 7.0141) in buffer (10 mM HEPES, 107 mM NaCl, 5 mM CaCl2, pH 7.5) at 
rt. After τ = 0.08 h, 20 µL of the reaction mixture was taken and added to a suspension of 
2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-
LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission intensity It (λex 
= 492 nm, λem = 514 nm) was recorded as a function of time t during a) addition of 20 µL 
pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 
300 s to achieve complete lysis. Fluorescence kinetics were normalized to relative 
emission intensity I using: 
0
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−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 2, 3.25, 7, 18.5, 25 and 43 h. From 
the normalized curves, I(τ=0.08), I(τ=2), I(τ=3.25), I(τ=7), I(τ=18.5), I(τ=25) and I(τ=43) were obtained 
as I before lysis by Triton-X and converted into fractional pore activity YE using: 
                                                 
‡‡‡ One unit will form 0.1 µmoe of unsaturated uronic acid per h at pH 7.5 at 25°C. One internatianl 
unit is equivalent to appproximatively 600 Sigma units. 
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All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.0171 u/mL) hyaluronidase or without enzyme. 
 
Table III-11: Data for heparin degradation at different concentrations of heparinase. 
50 u/mL 12.5 u/mL 0 
τ h YE τ h YE τ h YE 
0 0.00 0 0.00 0 0 
0.08 0.62 0.45 0.17 2 0 
2.00 0.73 2.00 0.29 18.5 0 
3.25 0.74 2.50 0.35 43 0 
7.00 0.83 2.75 0.38 93 0 
18.50 0.90 9.00 0.51 - - 
25.00 0.94 25.00 0.63 - - 
43.00 1.00 43.00 0.74 - - 
- - 93.00 0.94 - - 
 
 
9.3.3. Digestion of cellulase 
Cellulase (EC 3.2.1.4 from Trichoderma reesei, 5 mg/mL) was boiled during 5 
min and then incubated with Ficin (EC 3.4.22.3 from Fig Tree latex, 0.25 mg/mL) in 
buffer (0.1 M NaNO3, pH 7.0) at 37°C. After τ = 30 min, 20 µL of the reaction mixture 
was taken and added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 
107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 
25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a 
function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and 
b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. As It=300 < 
Ipore it was concluded that the degradation of cellulase by ficin was not complete after 30 
min of enzymatic reaction in these conditions. 
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Cellulase (EC 3.2.1.4 from Trichoderma reesei, 1 mg/mL) was boiled during 5 
min and then incubated with Ficin (EC 3.4.22.3 from Fig Tree latex, 0.25 mg/mL) in 
buffer (0.1 M NaNO3, pH 7.0) at 37°C. After τ = 30 min, 20 µL of the reaction mixture 
was taken and added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 
107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 
25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a 
function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and 
b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. 
Fluorescence kinetics were normalized to relative emission intensity I using: 
0
0  
II
III t −
−=
∞
 Equation 11  
were I0 = It before pore addition a) and I∞ = It at saturation after lysis b). 
As I = Ipore it was concluded that the degradation of cellulase by ficin was 
complete after 30 min of enzymatic reaction in these conditions i.e. with a ratio cellulase : 
ficin = 4 : 1. This experiment was done four times in parallel to verify the reproducibility 
of the result (RM1 (reaction mixture 1), RM2, RM3, RM4, Figure III-2). 
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Figure III-2: Reproducibility of cellulase digestion by ficin with a ratio cellulase : ficin = 4 : 1. Changes in 
CF emission intensity were recorded over time after addition of 250 nM rod 42m (triangles) and in presence 
of aliquots of RM1, RM2, RM3, RM4 (dashed lines ovelapping) after 30 min of incubation. 
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9.3.4. Digestion of cellulose: coupled reaction ficin and cellulase 
β-D-Glucan (10 mg/mL) was incubated with cellulase (EC 3.2.1.4 from 
Trichoderma reesei, 1 mg/mL) in buffer (0.1 M NaNO3, pH 7.0) at 37°C. After τ = 1 h, 
110 µL of the reaction mixture was taken and boiled for 5min. To this boiled mixture was 
added 5 µL of ficin ((EC 3.4.22.3 from Fig Tree latex, 6 mg/mL dissolved in same buffer: 
0.1 M NaNO3, pH 7.0 ) and it was incubated at 37°C for 30 min. 100 µL of this second 
reaction mixture was taken and added to a suspension of 1.9 mL vesicles (1800 µL buffer 
(HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and 
thermostatized at 25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was 
recorded as a function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at 
t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete 
lysis. Even with up to τ = 19 h the emission intensity curves recorded were similar to that 
of the control whithout enzyme, i.e. did not show any degradation of β-D-Glucan. 
 
9.4. Inhibitors 
Compensation of inhibitor’s pore blockage:  
Reference curve: EYPC-LUVs ⊃ CF (100 µL) were placed with buffer (1900 µL, 
10 mM HEPES, 107 mM NaCl, pH 6.5) and gently stirred at 25°C. Relative emission 
intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t during 
addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s (Figure III-3 B). The fluorescence 
emission intensity due to the pore recorded at 250s once the activity reached the 
saturation is Ip. 
Calibration curve: Stock solutions of inhibitors are prepared in buffer (10 mM 
HEPES, 107 mM NaCl); particular attention was paid to insure pH adjustment to 6.5 
following the procedure described in ChemBioChem.37 
EYPC-LUVs ⊃ CF (100 µL) were placed with 1900 µL of buffer (10 mM 
HEPES, 107 mM NaCl, pH 6.5) containing variable concentrations of inhibitor and 
gently stirred at 25°C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was 
recorded as a function of time t during addition of 20 µL pore 42 (25 µM in DMSO, 
Figure III-3 B1) at t = 50s to give I estimated during time coursing without final lysis. If I 
< Ip , pore 42 (5~40 µL, concentration optimized to minimize dilution, Figure III-3 B2) 
was added stepwise to reach I ~ Ip. Total pore concentration used was calculated and 
reminded as Cp. 
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Figure III-3: Representative reference (solid line) and calibration (dashed line) curves, in the case of [pLE] 
= 33 nM for the adjustment of barrel concentration to measure co-substrate inhibition.  
Table III-12: Calibration of pore concentration required for heparinase inhibitors screening 
Inhibitor 
Molar ratio 
inhibitor / heparin 
 Inhibitor 
concentration in nM 
Cp pore 42  
in nM 
No - - 250 
0.002 / 1 0.066 250 
0.005 / 1 0.165 250 
0.01 / 1 0.33 250 
0.1 / 1 3.3 312.5 
0.25 / 1 8.25 375 
pLE 
1 / 1 33 735 
1 / 1 33 262 Rod-COO- 
40 3 / 1 99 312 
0.5 / 1 16.5 250 
1 / 1 33 250 Trypan Blue 43 
1.5 / 1 49.5 250 
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Heparin (3.3 µM) and inhibitor were incubated with heparinase I (EC 4.2.2.7, from 
Flavobacterium heparinum, 50 u/mL‡‡‡, dissolved right before use in 0.15 M NaCl, 2 
mM TES, pH 7.0141) in buffer (10 mM HEPES, 107 mM NaCl, 5 mM CaCl2, pH 7.5) at 
rt. After τ = 0 and 2 h, 20 µL of the reaction mixture was taken and added to a suspension 
of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL 
EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative emission 
intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t during a) 
addition of pore 42 (providing concentration Cp determined as described above in cell 
measurment ) at t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to 
achieve complete lysis. Fluorescence kinetics were normalized to relative emission 
intensity I using: 
0
0  
II
III t −
−=
∞
 Equation 5  
were I0 = It before pore addition a) and I∞ = It at saturation after lysis b). 
From the normalized curves, I(τ=0), I(τ=2) and I(τ=∞) [I(τ=∞) is the calibration curve, 
obtained without heparin, reflecting the pore activity using Cp as pore concentration] were 
obtained as I before lysis by Triton-X and converted into fractional pore activity YE using: 
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Inhibition percentages were then calculated following: 
100   I % ×−= c
E
i
E
c
E
Y
YY
 Equation 3 
were YcE = YE without inhibitor (control) and YiE = YE in presence of inhibitor. 
 
Chapter III:  Experimental section 
 III–117
Table III-13: Data for heparin degradation at different concentrations of heparinase. 
sample I(τ=0) I(τ=2) I(τ=∞) YE % I 
PLE 0.01 / 1 0.51 0.53 0.72 0.08 87 
PLE 0.005 / 1 0.53 0.57 0.75 0.20 67 
control 0.47 0.64 0.75 0.61 - 
8-COO- 1 / 1 0.76 0.64 0.51 0.52 0 
8-COO- 3 / 1 0.56 0.67 0.79 0.49 8 
control 0.51 0.64 0.76 0.53 - 
trypan 0.5 / 1 0.49 0.59 0.69 0.51 4 
trypan 1 / 1 0.53 0.60 0.75 0.29 44 
trypan 1.5 / 1 0.57 0.60 0.72 0.17 69 
 
 
9.5. Selectivity using glycolytic enzymes 
Stock solutions of ATP (4 mM), ADP (4 mM), MgCl2 (2 mM), G-6-P (100 mM), 
F-6-P (100 mM) were prepared in buffer (10 mM HEPES, 107 mM NaCl) and particular 
attention was paid on pH adjustment to 6.5 made following the procedure described in a 
ChemBioChem.37 
 
9.5.1. Simulation curves 
Conversion of Mg-ATP into Mg-ADP: 1780 µL of buffer (10 mM HEPES, 107 
mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF, (40-x) µL of ATP, x µL of ADP (with x 
= 0, 10, 20, 30 or 40) and 80 µL of MgCl2 stock solutions were gently stirred in a 
thermostated cell and relative emission intensity It (λex = 492 nm, λem = 514 nm) was 
recorded as a function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at 
t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete 
lysis. Fluorescence kinetics were normalized to relative emission intensity I using: 
0
0  
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pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). 
Fractional pore activity was then calculated with: 
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were I0 = I with DMSO before lysis b) and Ip = I without blocker before lysis b). Y values 
were plotted in function of molar ratio of ATP: x= [ATP] / ([ATP] + [ADP]). 
 
Conversion of G-6-P into F-6-P: 1540 µL of buffer (10 mM HEPES, 107 mM 
NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF, (360-y) µL of G-6-P and y µL of F-6-P (with 
y = 0, 90, 180, 270, 360) stock solutions were gently stirred in a thermostated cell and 
fluorescence intensity was recorded as above. Two extras curves were recorded, one 
without blocker to obtain pore activity and a background without pore by adding 20 µL of 
DMSO at time a). Fluorescence kinetics were normalized to relative emission intensity I 
using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). 
Fractional pore activity was then calculated with: 
p
p
II
IIY −
−= 0   Equation 13 
were I0 = I with DMSO before lysis b) and Ip = I without blocker before lysis b). Y values 
were plotted in function of molar ratio of ATP: x= [F-6-P] / ([F-6-P] + [G-6-P]). 
 
9.5.2. Determination of the selectivity of pore 42 
Glucose (8 mM), ATP (8 mM) and MgCl2 (8 mM) were incubated incubated with 
hexokinase (EC 2.7.1.1, Type IV from Baker’s yeast, 0.26 u/mL§§§) in buffer (100 mM 
Tris-HCl, pH 8.0) at 30 ºC. After τ = 0.17 h, 20 µL of the reaction mixture was taken and 
added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, 
pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative 
emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t 
during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 
µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
                                                 
§§§ One unit will phosphorylate 1.0 µmole of D-glucose per min at pH 7.6 at 25°C 
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were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 0.5, 0.66, 0.75 and 1.33 h. From the 
normalized curves, I(τ=0.17), I(τ=0.5), I(τ=0.66) , I(τ=0.75) and I(τ=1.33) were obtained as I before 
lysis by Triton-X and converted into fractional pore activity YE using: 
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All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.1 u/mL) hexokinase or without enzyme. 
 
Table III-14: Data for glucose conversion into G-6-P at different concentrations of hexokinase. 
0.26 u/mL 0.10 u/mL 0 
τ h YE τ h YE τ h YE 
0.00 0.00 0.00 0.00 0.00 0.00 
0.17 0.45 0.17 0.19 1.00 0.00 
0.50 0.72 1.00 0.44 2.00 0.00 
0.67 0.83 1.25 0.48 3.50 0.00 
0.75 0.85 2.00 0.66 7.33 0.00 
1.33 1.00 2.67 0.74 - - 
- - 3.50 0.83 - - 
  7.33 0.95 - - 
 
 
F-6-P (8 mM), ATP (8 mM) and MgCl2 (8 mM) were incubated with 
phosphofructokinase (EC 2.7.1.11, type VII from Bacillus stearothermophilus, 1.0 
u/mL****) in buffer (100 mM Tris-HCl, pH 8.0) at 30 ºC. After τ = 0.57 h, 20 µL of the 
reaction mixture was taken and added to a suspension of 2 mL vesicles (1900 µL buffer 
(HEPES 10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and 
                                                 
**** One unit will convert 1.0 µmole of fructose-6-phosphate and ATP to fructose 1,6-diphosphate 
and ADP per min at pH 8.0 at 37°C 
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thermostatized at 25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was 
recorded as a function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at 
t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete 
lysis. Fluorescence kinetics were normalized to relative emission intensity I using: 
0
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were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken at 0.83, 1.16, 2.16 and 3.75 h. From the 
normalized curves, I(τ=0.57), I(τ=0.83), I(τ=1.16) , I(τ=2.16) and I(τ=3.75) were obtained as I before 
lysis by Triton-X and converted into fractional pore activity YE using: 
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All YE were plotted as a function of reaction time τ. Control experiments consisted of 
repetition of the procedure with less (0.5 u/mL) phosphofructokinase or without enzyme. 
 
Table III-15: Data for F-6-P conversion into FBP at different concentrations of phosphofructokinase. 
1.0 u/mL 0.5 u/mL 0 
τ h YE τ h YE τ h YE 
0.00 0.00 0.00 0.00 0.00 0 
0.50 0.25 0.50 0.19 0.50 0 
0.83 0.46 1.50 0.50 1.50 0 
1.17 0.58 3.00 0.70 7.00 0 
2.17 0.89 5.00 0.79 - - 
3.75 1.02 7.00 0.93 - - 
 
 
9.6. Sucrose 
9.6.1. Selectivity of hexokinase 
D-Glucose (8 mM), ATP (8 mM) and MgCl2 (8 mM) were incubated with 
hexokinase (EC 2.7.1.1, Type IV from Baker’s yeast, 0.017 mg/mL) in buffer (100 mM 
Tris-HCl, pH 8.0) at 30 ºC. After τ = 1 h, 20 µL of the reaction mixture was taken and 
Chapter III:  Experimental section 
 III–121
added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, 
pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative 
emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t 
during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 
µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis.  
The nature of the saccharide was then varied to test the selectivity of hexokinase. 
D-Fructose (8mM), D-mannose (8 mM), D-galactose (8 mM), and saccharose (8 mM) 
were succesfully incubated in the same conditions as D-glucose and the relative emission 
intensity of 20 µL of the reaction mixtures were recorded as described for D-glucose. The 
controls consisted of  
1- ATP (8 mM) and MgCl2 (8 mM) in buffer (100 mM Tris-HCl, pH 8.0) 
2- ADP (8 mM) and MgCl2 (8 mM) in buffer (100 mM Tris-HCl, pH 8.0) 
and were also tested for their relative emission intensity. 
Fluorescence kinetics were normalized to relative emission intensity I using: 
0
0  
II
III t −
−=
∞
 Equation 5  
were I0 = It before pore addition a) and I∞ = It at saturation after lysis b). 
As shown on Figure III-4, D-fructose, D-glucose and D-mannose were 
phosphorylated while galactose and saccharose were not. 
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Figure III-4: Selectivity of saccharide phosphorylation by hexokinase. Changes in CF emission recorded 
during the incubation of different saccharides in presence of MgCl2, ATP and hexokinase.  
 
Chapter III:  Experimental section 
 III–122
9.6.2. Development of the hexokinase step 
We have prouved that hexokinase phosphorylates the D-glucose as well as the D-
fructose. Is it also the case when both substrates are mixed, or are in excess compare to 
ATP, as it can be during the determination of sucrose in drinks.  
D-Glucose (8 mM), D-fructose (8 mM), ATP (8 mM) and MgCl2 (8 mM) were 
incubated with hexokinase (EC 2.7.1.1, Type IV from Baker’s yeast, 0.05 mg/mL) in 
buffer (100 mM Tris-HCl, pH 8.0) at 30 ºC. After τ = 20 min, 20 µL of the reaction 
mixture was taken and added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 
10 mM, 107 mM NaCl, pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and 
thermostatized at 25 ˚C. Relative emission intensity It (λex = 492 nm, λem = 514 nm) was 
recorded as a function of time t during a) addition of 20 µL pore 42 (25 µM in DMSO) at 
t = 50s, and b) addition of 40 µL 1.2 % Triton-X 100 at t = 300 s to achieve complete 
lysis.  
D-Glucose (40 mM), D-fructose (40 mM), ATP (8 mM) and MgCl2 (8 mM) were 
incubated and tested for fluorecence asay in the same conditions. 
The controls consisted of  
1- ATP (8 mM) and MgCl2 (8 mM) in buffer (100 mM Tris-HCl, pH 8.0) 
2- ADP (8 mM) and MgCl2 (8 mM) in buffer (100 mM Tris-HCl, pH 8.0) 
and were also tested for their relative emission intensity. 
Fluorescence kinetics were normalized to relative emission intensity I using: 
0
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 Equation 5  
were I0 = It before pore addition a) and I∞ = It at saturation after lysis b). 
As shown on Figure III-5, the presence of D-glucose and D-fructose in excess in 
the reaction mixture resulted in the observation of the same curves attesting for the 
complete conversion of ATP into ADP. 
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Figure III-5: Exemplification of the conversion of 8 mM ATP into 8 mM ADP by hexokinase in presence 
of 8 mM MgCl2 and mixtures of D-glucose with D-fructose in excess, or in presence of stoichiometric 
amount of D-fructose (8 mM). 
 
9.6.3. Combination of invertase and hexokinase steps on a known solution of 
saccharose. 
Bufferinvertase : Sodium acetate 50 mM, pH 4.5 
Bufferhexokinase : Tris-HCl 100 mM, pH 8.0 
Stock solution of saccharose: 85 mg/mL = 0.25 M in H2O 
x: dilution factor 
 
To 10 µL of a solution of saccharose (stock solution diluted xa= 4 times in 
bufferinvertase) was added 20 µL invertase (EC 3.2.1.26, Type VII from Baker’s yeast, 355 
u/mg††††), 70 µg/mL in bufferinvertase) and 10 µL of Bufferinvertase. This reaction mixture 
was incubated for 45 min at 55˚C. Then 40 µL ATP (80 mM in bufferhexokinase), 40 µL 
MgCl2 (80 mM in bufferhexokinase), 20 µL hexokinase (EC 2.7.1.1, Type IV from Baker’s 
yeast, 1 mg/mL in bufferhexokinase) and 260 µL bufferhexokinase were added in the reaction 
mixture and incubated for 20 min at 30˚C. 20 µL of the reaction mixture was taken and 
added to a suspension of 2 mL vesicles (1900 µL buffer (HEPES 10 mM, 107 mM NaCl, 
pH 6.5), 100 µL EYPC-LUVs ⊃ CF) gently stirred and thermostatized at 25 ˚C. Relative 
emission intensity It (λex = 492 nm, λem = 514 nm) was recorded as a function of time t 
                                                 
†††† One unit will hydrolyse 1.0 µmole of sucrose to invert sugar per min at pH 4.5 at 55°C. 
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during a) addition of 20 µL pore 42 (25 µM in DMSO) at t = 50s, and b) addition of 40 
µL 1.2 % Triton-X 100 at t = 300 s to achieve complete lysis. Fluorescence kinetics were 
normalized to relative emission intensity I using: 
0
0  
II
III
pore
t
E −
−=  Equation 8 
were I0 = It before pore addition a) and Ipore = It due to only pore 42 before lysis b). This 
procedure was repeated with 20 µL aliquots taken for a saccharose solution diluted xb = 
1.66 times. From the normalized curves, I(xa) and I(xb) were obtained as I before lysis by 
Triton-X and converted into fractional pore activity YE using: 
)0()(
)0()(
  =∞=
=
−
−= ττ
τ
II
IIY
x
E   Equation 14 
were I(τ=0) = I for Mg-ATP (80 µM) and I(τ=∞) = I for only Mg-ADP (80 µM). 
For 0.2 < YE < 1, sucrose content in the initial stock solution of saccharose was 
calculated: 
g/Lin        342
2
4010.8S
3
××××=
− xYE  Equation 4 
The values obtained Sa = 77g/L and Sb = 81 g/L determined for the 2 
measurements done with xa and xb dilution factors, correspond to an error level of 7% 
which is calculated following: 
85
100
2
)SbSa(100levelerror ×+−=  Equation 15 
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Figure III-6: Exemplification of sucrose determination in the case of a known solution of 85 mg/mL. 
Changes in CF emission intensity were recorded over time after addition of 250 nM rod 42m, and in 
presence of 80 µM Mg-ATP or 80 µM Mg-ADP (black lines) for the controls, or samples (grey lines), a) 
for xa dilution and b) for xb dilution). Corresponding fractional pore activities YE are given. 
9.6.4. Determination of sucrose content in drinks 
The procedure described in paragraph 9.6.3 was applied to different drinks to 
determine their concentration of saccharose. Thus the initial volume of 10 µL, which is 
added to 20 µL invertase, corresponds to a solution made of the drink diluted x times in 
bufferinvertase. The drinks tested, the dilution factors x , and the results obtained are 
summarized in Table III-16. 
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Table III-16: Sucrose determination in drinks. 
Drink Figure x YE 
sucrose in 
g/La 
sucrose in 
drink in 
g/Lb 
8.00 0.06 25 
6.65 0.22 83 
2.88 0.60 95 
Pepsi® Figure III-7 
2.50 0.69 94 
95 
3 0.36 59 
Monbazillac Figure III-8 
2 0.64 70 
65 
3 0.43 71 Orange juice 
(Migros) Figure III-9 2 0.70 77 
74 
Squeeze of 
orange Figure III-9 0 0.36 20 20 
Coke light®  0 0 0 0 
4.4 0.36 87 Ice tea 
(Migros) 
Figure 
III-10 2.6 0.66 94 
90 
a values obtained applying the Equation 4 to the values of Y
E
 determined 
b final value obtained by averaging the values from the previous colums satisfying Y
E
 > 0.2. Values negligted in the calculation are shaded. 
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Figure III-7: Sucrose determination in Pepsi. Changes in CF emission intensity were recorded over time 
after addition of 250 nM rod 42, and in presence of 80 µM Mg-ATP or 80 µM Mg-ADP (black lines) for 
the controls, or samples (grey lines) with the dilution series: xa = 8 (a); xb = 6.65 (b); xc = 2.88 (c); xd = 2.5 
(d). Sucrose concentrations deducted from the curves are reported in g /L.  
 
0.21
0.28
0.35
0.42
0.49
65 130 195 260 325
Time/s
I
E
Mg-ADP
Mg-ATP
a)
b)
Equation 4
sucrose
g /L
59
70
 
Figure III-8: Sucrose determination in Monbazillac. Changes in CF emission intensity were recorded over 
time after addition of 250 nM rod 42, and in presence of 80 µM Mg-ATP or 80 µM Mg-ADP (black lines) 
for the controls, or samples (grey lines) with the dilution series: xa = 3 (a); xb = 2 (b). Sucrose 
concentrations deducted from the curves are reported in g /L. 
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Figure III-9: Sucrose determination in Orange juice (Migros), and in a squeeze of orange. Changes in CF 
emission intensity were recorded over time after addition of 250 nM rod 42, and in presence of 80 µM Mg-
ATP or 80 µM Mg-ADP (black lines) for the controls, for the commercial orange juice (grey lines, a and b) 
and the squeeze of orange (dashed grey line, c) with the dilution series: xa = 3 (a); xb = 2 (b), xc = 1 (c). 
Sucrose concentrations deducted from the curves are reported in g /L. 
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Figure III-10: Sucrose determination in Ice tea (Migros). Changes in CF emission intensity were recorded 
over time after addition of 250 nM rod 42, and in presence of 80 µM Mg-ATP or 80 µM Mg-ADP (black 
lines) for the controls, for the ice tea samples (grey lines) with the dilution series: xa = 4.4 (a); xb = 2.6 (b). 
Sucrose concentrations deducted from the curves are reported in g /L. 
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